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DISSERTATION ABSTRACT 
 
Gregory Charles Finnigan 
 
Doctor of Philosophy 
 
Department of Biology 
 
June 2011 
 
Title: Evolution of the Vacuolar H
+
-ATPase Enzyme Complex 
Approved:  _______________________________________________ 
Dr. George Sprague 
 
The vacuolar proton-translocating ATPase (V-ATPase) is a multisubunit enzyme 
complex responsible for acidification of cellular organelles.  The V-ATPase hydrolyzes 
ATP to pump protons across membranes to create an electrochemical gradient.  
Acidification of vesicular compartments is critical in numerous biological processes 
including protein trafficking, endocytosis, and ion homeostasis; defects in V-ATPase 
function can also lead to human diseases.  While the function of the V-ATPase enzyme is 
highly conserved across eukaryotes, the molecular architecture of this protein complex has 
undergone unique structural changes through evolutionary time.  The goal of this work is to 
investigate the assembly, transport, and evolution of this critical molecular machine in the 
model organism Saccharomyces cerevisiae. 
 A series of genetic screens was performed in budding yeast to identify factors and 
pathways that are involved in promoting full V-ATPase function.  I utilized several 
“assembly factor” alleles to serve as sensitized genetic backgrounds to partially reduce 
enzyme function; this work implicated sphingolipid composition in promoting full 
vacuolar ATPase enzyme function. 
 I also used ancestral gene reconstruction to analyze the two isoforms of subunit a 
v 
 
of the V0 subdomain (Vph1p and Stv1p) by recreating the most recent common ancestral 
subunit (Anc.a).  Characterization of Anc.a demonstrated that this ancient subunit was 
able to properly assemble and function within a hybrid V-ATPase complex.  While the 
Vph1p-containing complex localized to the vacuole membrane and the Stv1p-containing 
complex was present on the Golgi/endosome, incorporation of Anc.a caused the V-
ATPase to localize to both types of cellular compartments. 
 Finally, I used ancestral reconstruction to investigate the lineage-specific gene 
duplication of one of the proteolipid subunits of the V0 subcomplex that occurred within 
the fungal clade.  I demonstrate that inclusion of a third proteolipid subunit within fungi 
(as compared to two subunits within metazoans) could have occurred via neutral 
processes by asymmetric degeneration of subunit-subunit interfaces that “ratcheted” the 
duplicated subunit with the V0 ring.  These results present a model that describes how 
macromolecular machines can increase in complexity through evolutionary time. 
This dissertation includes previously published co-authored material and 
unpublished co-authored material. 
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 CHAPTER I 
INTRODUCTION TO THE V-ATPASE ENZYME 
1. Structure and function of the V-ATPase enzyme complex 
 The multi-subunit v-type, proton-translocating ATPase enzyme (V-ATPase) is a 
highly conserved molecular machine that serves to acidify eukaryotic organelles (Figure 
1) (FORGAC 2007).  The V-ATPase enzyme is highly conserved within all eukaryotes.  
Three types of ion translocating ATPase enzymes are thought to originate from a shared 
ancestor; the F1F0 (ATP-synthase), A1A0 (archeal ATP synthase), and V1V0 (vacuolar 
ATPase) share common structural motifs yet differ in their specific molecular functions 
(GRÜBER et al. 2001).  The V-ATPase is composed of two subdomains:  the V1 portion 
(subunits A, B, C, D, E, F, G, and H) is responsible for hydrolysis of ATP whereas the V0 
portion (subunits a, d, e, c, c’, and c”) is responsible for transporting protons across a 
lipid bilayer (KANE 2006; FORGAC 2007).  Whereas the V-ATPase is essential in most 
eukaryotes, disruption of V-ATPase function is not lethal within the budding yeast, 
Saccharomyces cerevisiae (KANE 2006).  In this way, yeast serves as an excellent model 
system for studying the V-ATPase enzyme.  There are fourteen different protein subunits 
that are required for full V-ATPase enzyme function and some are found in multiple 
copies per complex (GRAHAM et al. 2003).   
 Seen in Figure 1, the central core of the V1 subdomain is composed of alternating 
A and B subunits.  The two domains are connected through a grouping of additional 
subunits that serve as the “stalk.”  Following ATP hydrolysis, energy from the 
conformation change within V1 is translated into rotation motion through this region to 
the “proteolipid ring” within the V0 subdomain (FORGAC 2007).  In yeast, this ring is 
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composed of three different membrane-bound subunits that shuttle protons across the 
lipid bilayer (WANG et al. 2007).  The proteolipid ring rotates relative to the largest V-
ATPase subunit, subunit a.  This subunit serves as both a stationary “stator” as well as 
aids in proton translocation (FORGAC 2007).  In S. cerevisiae there are two isoforms of 
subunit a, Stv1p or Vph1p, and only one is incorporated into the final enzyme complex 
(MANOLSON et al. 1992, 1994).  Subunit a is significant as it dictates both the 
subcellular localization and regulation of the V-ATPase complex (KAWASAKI-NISHI 
et al. 2001a; KAWASAKI-NISHI et al. 2001b). 
 
Figure 1.  Model of the yeast V-ATPase complex.  The 14 subunit complex is composed 
of two subdomains:  the V1 portion is responsible for ATP hydrolysis and the membrane-
bound V0 domain functions to translocate protons across the lipid bilayer.  In yeast, there 
are two isoforms of subunit a; this subunit isoform determines the subcellular localization 
of the V-ATPase in S. cerevisiae. 
 
2. Assembly of the yeast V0 subcomplex 
 Within budding yeast, assembly of the V0 and V1 subdomains occurs within the 
endoplasmic reticulum (ER) and cytoplasm, respectively (KANE 2006).  Studies have 
focused on assembly of the V-ATPase V0 subdomain to understand how large, multi-
subunit complexes can be properly built within the ER.  Both proteomic and genetic 
! 3!
approaches have lead to the identification of additional proteins (Vma21p, Vma12p, 
Vma22p, Pkr1p, and Voa1p) that are required for proper assembly of a functional V-
ATPase complex (HIRATA et al. 1993; HILL and STEVENS 1995; MALKUS et al. 
2004; DAVIS-KAPLAN et al. 2006; RYAN et al. 2008).  While none of these factors are 
components of the final enzyme complex, they associate with different groups of subunits 
and are proposed to act as chaperones for particular stages of V0 assembly.  For instance, 
the Vma12p-Vma22p complex has been shown to physically associate with subunit a 
(Vph1p or Stv1p) while Vma21p and Voa1p associate with the proteolipid ring early in 
assembly (HIRATA et al. 1993; HILL and STEVENS, 1995; MALKUS et al. 2004; 
RYAN et al. 2008).  Interestingly, Vma21p remains associated with the complete V0 
subcomplex and is transported out of the ER to the Golgi (MALKUS et al. 2004).  This 
assembly factor is then retrieved back to the ER to participate in multiple rounds of 
assembly.  It is possible that Vma21p may also act in regulating exit of the completed V-
ATPase subdomain out of the ER. 
 Recent studies have identified homologs of Vma21p within other organisms 
including C. elegans, A. thaliana, and H. sapiens (unpublished results; NEUBERT et al. 
2008).  This confirms that assembly factors are required for full V-ATPase function in 
organisms outside of budding yeast.  More surprisingly was that expression of these 
homologs within S. cerevisiae resulted in functioning V-ATPase enzyme complexes 
(unpublished results; NEUBERT et al. 2008).  The conservation of Vma21p function 
across species has prompted searches for additional factors in higher eukaryotes that 
might assist in early V0 assembly.  However, while the overall molecular function 
(acidification of organelles) of the V-ATPase has been tightly conserved across the tree 
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of life, the molecular architecture of the V-ATPase has continued to evolve and increase 
in complexity.  One of the many questions that remain involves comparing the molecular 
differences between the metazoan and fungal proteolipid rings and their association with 
the assembly factor, Vma21p. 
 
3. Regulation of the V-ATPase complex 
 Studies have also focused on the different ways the cells are able to modulate the 
activity of the V-ATPase (KAWASAKI-NISHI et al. 2001b; KANE 2006).  Since 
acidification of the endo-membrane system is critical to numerous cellular functions, it is 
essential that V-ATPase activity can be accurately and efficiently regulated.  While many 
enzymes are regulated through transcript expression (either temporal or spatial control), 
this seems unreasonably slow for an enzyme complex that is approximately 1 MDa, has 
fourteen essential peptides, and requires the assistance of at least five accessory proteins.  
 Instead, the V-ATPase can undergo rapid, reversible dissociation of the V1 and V0 
subdomains (KANE 2006; FORGAC 2007).  Dissociation of these two components 
completely eliminates enzyme activity and does not allow for disruption of the vesicular 
pH gradient through potential leakage of protons back across the membrane bound V0 
subdomain (ZHANG et al. 1992; KAWASAKI-NISHI et al. 2001a).  In yeast, this 
controlled dissociation occurs in the absence of glucose and might be conserved in higher 
eukaryotes as well (KANE 2006).   
 Secondly, the local lipid environment has been shown to differentially affect the 
two V-ATPase isoforms in yeast (QI and FORGAC 2007).  Vph1p and Stv1p control the 
transport of the V-ATPase to either the vacuolar membrane or Golgi/endosome, 
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respectively (MANOLSON et al. 1992, 1994).  Interestingly, the subcellular location of 
the V-ATPase also influences in vivo dissociation:  complexes residing on the 
Golgi/endosome are unable to undergo glucose-induced dissociation whereas either 
isoform can be regulated when located on the vacuolar membrane (KAWASAKI-NISHI 
et al. 2001b).  Understanding how the local lipid composition influences V-ATPase 
function is also a relatively unexplored field.  The effects of the lipidome have been 
described for the transport and activity of other protein cargo such as Pma1p and Gap1p 
(WANG and CHANG 2002; GAIGG et al. 2006; LAUWERS et al. 2007). 
 Finally, it has been proposed that cells are also able to subtly modulate the 
efficiency by which the V-ATPase couples ATP hydrolysis with proton translocation 
instead of completely abolishing enzyme activity through in vivo dissociation.  There is a 
small difference in this enzyme efficiency between the Golgi and vacuolar isoforms and 
mutations have also been described (in subunit d and subunit A) that actually increase 
this coupling efficiency (FORGAC 2007). 
 
4. Additional cellular functions of the V-ATPase and roles in human disease 
 While the primary role of the V-ATPase is to acidify membrane-bound 
compartments, additional functions have been attributed to this unique molecular 
machine.   Many of these cellular processes are a consequence of the pH gradient 
generated by the V-ATPase such as endocytosis, vesicular transport, development, and 
ion homeostasis (FORGAC 2007).  However, recent work has implicated the V-ATPase 
in both membrane fusion and pH sensing (FORGAC 2007).  Interactions between the V-
ATPase and SNARE (Soluble NSF Attachment Protein Receptor) proteins have been 
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described in recent reports (HIESINGER et al. 2005).  Also, one model of vacuole 
fusion/fission, albeit controversial, proposes that the V-ATPase is necessary for 
membrane fusion (BAARS et al. 2007).  Other physical interactions of V-ATPase 
subunits with vesicle formation regulators (such as the small GTPase Arf6p) have been 
shown to be pH dependent (HURTADO-LORENZO et al. 2006). 
 The V-ATPase has also been implicated in a number of human diseases.  Entry of 
viruses and toxins (including influenza virus, Semliki forest virus, and vesicular 
stomatitus virus) into the cell has been shown to occur via an acidified compartment 
(GRUENBERG and VAN DER GOOT 2006).  A similar mechanism is responsible for 
allowing entry of bacterial agents (such as diphteria toxin and anthrax toxin).  Targeting 
of specific V-ATPase complexes and selective inhibition of enzyme function might allow 
for protection from viruses and toxins (FORGAC 2007). 
 While yeast are restricted to only two isoforms of the V-ATPase (containing 
either Stv1p or Vph1p), mammals have evolved a number of additional forms.  Different 
isoforms of some of the subunits (include four different genes for subunit a) as well as 
differential splice variants create a more complex pool of V-ATPase complexes (QI and 
FORGAC 2008).  Mammals have acquired a V-ATPase complex that functions on the 
plasma membrane and is involved in acidification of the extracellular space (OKA et al. 
2001a; TOYOMURA et al. 2003).  This process is critical in specific cell types such as 
those found in the distal tubule of the kidney.  Similarly, plasma membrane-localized V-
ATPases are responsible for bone resorption in osteoclasts.  Defects in the V-ATPase in 
these specialized cells can lead to distal renal tubular acidosis and osteopetrosis, 
respectively (KARET et al. 1999; FRATTINI et al. 2000).  Finally, connections have 
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been made between the V-ATPase and tumor metastasis and also tumor cell survival 
(MARTINEZ-ZAGUILÁN et al. 1999).  Selective inhibition of the V-ATPase complex 
is currently an attractive field for combating these conditions. 
 
5. An evolutionary approach to study the V-ATPase across eukaryotes 
 As recent work highlights the central role of the V-ATPase in numerous cellular 
processes and even human disease states, the importance of characterizing the many 
isoforms of the V-ATPase in mammalian systems has become evident.  However, much 
of the basic biology and biochemistry that has been performed on the V-ATPase has been 
done in the model organism S. cerevisiae (see reviews GRAHAM et al. 2003; KANE 
2006; FORGAC 2007).  Work within budding yeast has many advantages as very 
tractable and efficient genetic and biochemical systems have been developed over the 
years to rapidly generate tens of thousands of interactions between mutants of interest 
(TONG and BOONE 2006).  For this reason, work in yeast has been able to uncover 
many of the essential components, regulatory processes, and accessory proteins that are 
involved in the assembly, transport, and function of the yeast V-ATPase.  Much of the 
work within budding yeast has been applicable to the same molecular machine in other 
species.  In fact, many of the subunits from higher eukaryotes from both the fungal, plant, 
and animal clades are functional when expressed in S. cerevisiae in place of the yeast 
subunit (HARRISON et al. 1994; FINBOW et al. 1994; AVIEZER-HAGAI et al. 2000; 
IKEDA et al. 2001; NISHI et al. 2003; unpublished results). 
 However, this approach is not sufficient to address particular questions about the 
structural architecture, transport, or assembly of the V-ATPase enzyme.  It is necessary to 
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properly address the relationship between the information obtained in yeast and the 
homologous enzyme complexes in other eukaryotes.  For example, while the overall 
function of the enzyme is essentially identical in all eukaryotes--proton translocation 
across a membrane--the stoichiometry of the subunits, the number of enzyme isoforms, 
and the subcellular localization of the V-ATPase has dramatically changed through 
evolutionary time (see Chapter III and IV).  Some of the most significant differences 
involve components of the V0 subcomplex.   
 Firstly, within the metazoan clade the V0 proteolipid ring only contains two 
subunits, subunit c and subunit c” whereas fungi contain three subunits c, c’, and c” 
(unpublished results).  Second, the number of separate genes encoding subunit a varies 
greatly within the eukaryotic tree of life; some fungi such as S. cerevisiae contain two 
isforms (VPH1 and STV1) while other fungi such as N. crassa and S. pombe contain only 
a single isoform (CHAVEZ et al. 2006).  Other species contain three or more isoforms of 
subunit a (OKA et al. 2001a; OKA et al. 2001b; TOYOMURA et al. 2003; WASSMER 
et al. 2006). 
 Comparison of the fungal V0 subdomain to that of other species has been difficult; 
this type of horizontal evolutionary approach (HARMS and THORNTON 2010) that 
involves transfer of a subunit from one modern species to another modern species has 
been successful for some of the subunits of the V-ATPase that are extremely well 
conserved but remains problematic for comparison of (i) the proteolipid ring and (ii) the 
stator subunit.  Investigation of the proteolipid ring is crucial; studies in yeast have 
demonstrated that this portion of the V0 is closely chaperoned by dedicated assembly 
factors (unpublished results; MALKUS et al. 2004; RYAN et al. 2008).  In yeast, 
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Vma21p binds directly to subunit c’ (unpublished results; MALKUS et al. 2004) but it is 
unclear how H. sapiens Vma21p would function since humans do not contain subunit c’.   
 Furthermore, this raises a number of interesting questions regarding the evolution 
of protein complexity.  How did the two and three-proteolipid rings evolve in metazoans 
and fungi, respectively?  It is unclear if there is a selective advantage to having two 
versus three different proteolipid subunits.  One possibility is that the increase in subunit 
composition can be attributed to neutral evolution and subsequent accumulation of an 
additional subunit through degeneration of existing subunit-subunit interfaces.   
 Subunit a of the V0 subdomain is a second, interesting case study within the V-
ATPase enzyme as it has a plethora of functional roles both internal to the complex itself 
as well as interacting with additional cellular partners (reviewed in FORGAC 2007).  
Understanding how each of the many subunit a isoforms contribute to assembly, 
localization, coupling efficiency, in vivo dissociation, and other functions such as 
membrane fusion or pH sensing is of great interest.  Attempts to characterize subunit a 
isoforms from other species within budding yeast have not been successful (unpublished 
results).  There is a large degree of sequence divergence among subunit a isoforms 
between eukaryotic clades (see Chapter III).  However, prior to comparing subunit a 
proteins across different species, it will become necessary to address the mechanistic 
differences between V-ATPase complexes that evolved within each organism.  
Biochemical and genetic characterization of subunit a will be critical in uncovering the 
specialized roles of this protein within the complex.  One of the most significant 
molecular functions of subunit a is localization of the V-ATPase enzyme to different 
subcellular compartments.  This will aid in identifying mechanisms for differentially 
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targeting the V-ATPase to specific organelles; it is currently unknown how isoforms of 
the V-ATPase are separately targeted within eukaryotes.  
 
6. Experimental design to address the evolution of the V-ATPase complex 
 The work presented here addresses a number of different questions regarding the 
function, transport, and evolution of the V-ATPase complex.  The goal of characterizing 
the mechanistic details of V0 assembly within budding yeast is to (i) inspire further study 
of similar (if not identical) processes within other eukaryotic systems including mammals 
and (ii) contribute to our knowledge of assembly of complex macromoleular machines.  
The work in Chapter II presents a series of genetic screens to search for additional 
factors, proteins, and/or genetic pathways that affect V-ATPase assembly, transport, or 
function.  Characterizing novel (or previously overlooked) genetic pathways that are 
involved in V-ATPase activity and/or regulation can assist in understanding the evolution 
of this critical machine.  This work has been done in collaboration with two additional 
co-authors (M. Ryan and T. H. Stevens) and is now published in the journal Genetics. 
 The aim of the third chapter is to investigate the evolution of one subunit within 
the V-ATPase complex.  As previously mentioned, subunit a within the V0 subdomain 
plays numerous critical roles in assembly, function, and trafficking of the V-ATPase 
enzyme.  To address questions regarding the origins of subunit a within the fungal clade, 
I have used an evolutionary technique called ancestral gene reconstruction.  This work 
has been done in collaboration with several co-authors.  V. Hanson-Smith, B. D. Houser, 
H. J. Park, and T. H. Stevens have all contributed to this work.  The creation and 
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subsequent characterization of the ancestral subunit a (Anc.a) has provided a model for 
the evolution of the two subunit a isoforms in budding yeast, Vph1p and Stv1p. 
 Finally, in Chapter IV, I use the V-ATPase as a model macromolecular machine 
to address the question of increasing [protein] complexity within biological systems.  For 
these experiments, I used reconstructed ancestors of the subunits of the yeast proteolipid 
ring.  This work was done in collaboration with co-authors V. Hanson-Smith, J. W. 
Thornton, and T. H. Stevens.  The aim of this work was to understand how the 
proteolipid ring within the fungal clade could increase in complexity (whereas the 
metazoan ring did not).  Together, these three studies have greatly increased our 
knowledge of both the elements governing V-ATPase function, but also the evolutionary 
history of this critical protein complex. 
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CHAPTER II 
GENOME WIDE ENHANCER SCREEN IMPLICATES SPHINGOLIPID 
COMPOSITION IN VACUOLAR ATPASE FUNCTION IN SACCHAROMYCES 
CEREVISIAE 
 This work was published in volume 187 of the journal Genetics in March, 2011.  
G. C. Finnigan performed the synthetic genetic array screens and subsequent 
characterization of HPH1/HPH2 and ORM1/ORM2 gene pairs; M. Ryan assisted in 
performing the V-ATPase enzyme activity assays.  G. C. Finnigan wrote the manuscript 
with editorial help from M. Ryan and T. H. Stevens.  T. H. Stevens was the principle 
investigator for this work.  All three co-authors are affiliated with the University of 
Oregon Institute of Molecular Biology (Eugene, OR, 97403). 
 
1. Introduction 
 The vacuolar H+-ATPase (V-ATPase) is a multisubunit complex that is highly 
conserved across eukaryotes (GRAHAM et al. 2003).  It functions to actively acidify 
cellular compartments by coupling the hydrolysis of ATP to the translocation of protons 
across membranes through a conserved rotary mechanism (HIRATA et al., 2003; 
YOKOYAMA et al. 2003; IMAMURA et al. 2005).  Organelle acidification plays a 
crucial role in various cellular functions such as vesicular trafficking, endocytosis, 
neurotransmitter uptake, membrane fusion, and ion homeostasis (KANE 2006; FORGAC 
2007).  Specialized isoforms of the V-ATPase complex can be found on different cellular 
membranes including the plasma membrane (FORGAC 2007).  A number of human 
diseases have been associated with or directly linked to defects in the V-ATPase complex 
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osteopetrosis (FRATTINI et al. 2000), renal tubular acidosis (KARET et al. 1999), and 
cancer cell migration (MARTINEZ-ZAGUILÁN et al. 1999).  The V-ATPase is an 
essential complex for all eukaryotes with the exception of some fungi. 
 The budding yeast Saccharomyces cerevisiae requires the V-ATPase to survive 
under specific environmental conditions including alkaline conditions or otherwise toxic 
levels of metals (KANE 2006; EIDE et al. 2005).  Yeast utilize the proton gradient 
created by the V-ATPase to drive sequestration of Ca2+ and Zn2+ ions within the vacuole 
(KLIONSKY et al. 1990).  A variety of proton-exchange antiporter pumps reside on the 
vacuolar membrane and other organelles that participate in maintaining nontoxic 
cytosolic levels of various ions and metals including calcium and zinc (MISETA et al. 
1999; MACDIARMID et al. 2002).  Deletion of any of the V-ATPase component 
proteins results in a number of specific growth and cellular phenotypes including 
sensitivity to excess metals and a lack of vacuolar acidification.  This makes yeast a 
useful model system to study the V-ATPase complex (GRAHAM et al. 2003; KANE 
2006).  Complete disruption of V-ATPase function in yeast results in a characteristic 
Vma– phenotype:  failure to grow on media buffered to pH 7.5 (KANE 2006).  
Additionally, numerous genetic screens have demonstrated that a loss of the V-ATPase 
renders yeast sensitive to a variety of metals (including zinc and calcium) and drugs 
(KANE 2007; EIDE et al. 2005).  Yeast lacking the V-ATPase complex do not acidify 
their vacuoles as shown through a lack of quinacrine staining (WEISMAN et al. 1987). 
 The V-ATPase enzyme in yeast contains 14 protein subunits within two domains:  
the V1 portion is responsible for hydrolyzing ATP and the V0 portion shuttles protons 
across a lipid bilayer (FORGAC 2007).  The V1 domain (subunits A, B, C, D, E, F, G, 
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and H) is peripherally associated, and the V0 domain (subunits a, d, e, c, c’, and c”) is 
imbedded within the membrane except subunit d which is a peripheral membrane protein.  
The functional V-ATPase enzyme requires the presence of all of these subunits.  Subunit 
a has two isoforms in yeast, the absence of one of them is not sufficient to cause a Vma– 
phenotype.  Yeast contain two populations of the V-ATPase complex and their 
localization is dictated by the incorporation of one of two isoforms of subunit a, Stv1p or 
Vph1p (MANOLSON et al. 1992, 1994).  While higher eukaryotes contain numerous 
isoforms for many of the different V-ATPase subunits (MARSHANSKY and FUTAI 
2008), Stv1p/Vph1p is the only structural difference between the two yeast enzymes.  V-
ATPase complexes containing the Vph1 protein are trafficked to the vacuolar membrane 
while Stv1p-containing V-ATPases are retained within the Golgi/endosomal network 
(MANOLSON et al. 1994).  Similarly, higher eukaryotes use different isoforms of 
subunit a to alter the localization of the V-ATPase to specific cellular compartments 
(FORGAC 2007).  One mechanism of V-ATPase regulation occurs through the rapid, 
reversible dissociation of the V1 and V0 domains (KANE 2006). 
 In the absence of any V1 subunit, the V0 domain is still properly assembled and 
targeted to the vacuole (GRAHAM et al. 2003).  In the absence of the V0 domain, V1 is 
still assembled (TOMASHEK et al. 1997).  Loss of any V0 subunit protein prevents 
proper V0 assembly and ER exit (GRAHAM et al. 2003), and Vph1p undergoes 
ubiquitin-dependent ER associated degradation (ERAD; HILL and COOPER 2000).  
Assembly of the V0 domain occurs in the ER and requires the presence of a number of 
additional proteins (FORGAC 2007).  Five ER-localized assembly factors have been 
identified in yeast that are required for full V-ATPase function yet are not part of the final 
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complex:  Vma21p, Vma22p, Vma12p, Pkr1p, and Voa1p (DAVIS-KAPLAN et al. 
2006; MALKUS et al. 2004; HILL and STEVENS, 1995; HIRATA et al. 1993; RYAN 
et al. 2008).  Deletion of VMA21, VMA12, or VMA22 causes a failure of the V0 subunits 
to properly assembly in the ER and a complete loss of V-ATPase function, resulting in a 
full Vma– phenotype (GRAHAM et al. 2003).  Yeast lacking PKR1 show a limited 
amount of V0 assembly (DAVIS-KAPLAN et al. 2006) and yeast lacking VOA1 display 
only a slight reduction in V-ATPase enzyme activity (RYAN et al. 2008).  Consequently, 
pkr1! cells score a partial Vma– phenotype while voa1! cells appear normal. 
 Genetic screens in S. cerevisiae have been critical in identifying the components 
of the V-ATPase and its associated factors (HO et al. 1993; OHYA et al. 1991; 
SAMBADE et al. 2005).  However, the most recently discovered V-ATPase assembly 
factor, Voa1p, was identified by proteomics and voa1" cells have no detectable growth 
phenotype (RYAN et al. 2008).  Voa1p physically associates with the Vma21p-V0 
complex early in V-ATPase assembly and deletion of VOA1 displays a dramatic growth 
phenotype in conjunction with a specific mutant allele of the VMA21 assembly factor, 
vma21QQ (RYAN et al. 2008).  In yeast it has been shown that Vma21p plays a critical 
role in V-ATPase assembly and chaperones the completed V0 subcomplex out of the ER 
to the Golgi (HILL and STEVENS 1994; MALKUS et al. 2004).  Vma21p is retrieved 
back to the ER through a conserved, C-terminal dilysine motif and participates in 
multiple rounds of assembly and transport (HILL and STEVENS 1994; MALKUS et al. 
2004).  Mutation of the dilysines to diglutamine residues, as in vma21QQ, results in 
mislocalization of yeast Vma21p to the vacuolar membrane and a significant loss of V-
ATPase function. 
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 The identification of V-ATPase assembly factors like Voa1p that do not display a 
full Vma– are not likely to be found using traditional forward genetic screens.  Also, 
pathways involved in promoting full V-ATPase function that may act independently of 
V1 and/or V0 assembly and require a sensitized genetic background to produce a 
detectible growth phenotype.  However, vma21QQ mutant yeast and, more so, the 
vma21QQ voa1! double mutant are two cases where the V-ATPase is partially 
compromised for function (HILL and STEVENS 1994; RYAN et al. 2008).  We have 
chosen to use these two assembly mutants in genome-wide enhancer screens to identify 
additional factors that assist in promoting full V-ATPase function by searching for genes 
that will cause an increase in calcium or zinc sensitivity when deleted. 
 Here we report the identification of HPH1 and ORM2 in a genome-wide search 
for V-ATPase effectors.  We describe the characterization of these two redundant yeast 
gene pairs, HPH1/HPH2, and ORM1/ORM2, both of which display synthetic growth 
defects when deleted in combination with the vma21QQ mutant.  Both sets of genes were 
found to have specific growth phenotypes on zinc and calcium media.  Deletion of either 
gene pair did not affect vacuolar acidification or assembly of the V0 domain.  However, 
deletion of ORM1 and ORM2 results in a reduction of V-ATPase activity.  The Orm 
proteins have very recently been shown to be negative regulators of sphingolipid 
synthesis (BRESLOW et al. 2010; HAN et al. 2010).  Consistent with these reports, we 
find that disruption of sphingolipid biogenesis is able to suppress Orm-related growth 
defects. 
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2. Materials and methods 
 Plasmids and yeast strains: Bacterial and yeast manipulations were done using 
standard laboratory protocols for molecular biology (SAMBROOK and RUSSEL 2001).  
Plasmids for this study are listed in Table 1.  ORM1 plus flanking sequence was 
amplified by polymerase chain reaction (PCR) from BY4741 (Invitrogen, Carlsbad, CA) 
from genomic DNA using primers containing an upstream BamHI restriction site and 
downstream SalI restriction site.  This fragment was inserted into pCR4Blunt-TOPO 
(Invitrogen), digested, and ligated into the BamHI and SalI sites of YEp351 to create 
pGF127.  pGF87 was created using homologous recombination and in vivo ligation by 
gapping pRS415 and co-transforming a PCR fragment containing 
prVPH1::VPH1::GFP::HIS3 (amplified from pGF06) with flanking sequence to the 
pRS415 vector. 
Table 1.  Plasmids used in this study. 
 
Plasmid Description Reference 
pRS415 CEN, LEU2 SIMONS et al. 1987 
pRS316 CEN, URA3 SIKORSKI and 
HIETER 1989 
YEp351 2µ, LEU2 HILL et al. 1986 
pGF127 YEp351 ORM1 This study 
pGF87 pRS415 VPH1::GFP::HIS3 This study 
pGF06 pRS316 VPH1::GFP::HIS3 RYAN et al. 2008 
pGF20 pRS316 VMA2::mCherry::NatR This study 
 
 Yeast strains used in this study are listed in Table 2.  GFY164 was created by 
PCR amplifying the hph1!::KanR cassette plus 500 base pairs flanking sequence from 
corresponding BY4741 strains of the genome deletion collection (Open Biosystems, 
Huntsville, AL).  It was subcloned into pCR4Blunt-TOPO, reamplified by PCR, 
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transformed into SF838-1D!, and selected on YEPD plus G418 (Gold Biotechnology, St. 
Louis, MO).  Strains containing deletion cassettes other than KanR (HygR or NatR) were 
created by PCR amplifying either the HygR or NatR cassette from pAG32 or pAG25, 
respectively (GOLDSTEIN and MCCUSTER 1999) and transforming the fragment into 
the corresponding KanR genome deletion strain to exchange drug resistance markers.  
Deletions in the SF838-1D! strain (GFY164, GFY165, GFY166, GFY168, GFY169, and 
GFY170) were constructed by PCR amplifying the appropriate gene locus (including 500 
base pairs of 5' UTR and 3' UTR flanking sequence), transforming into wild-type SF838-
1D!, and selecting for the appropriate drug resistance.  GFY167, GFY171, and GFY172 
were created using LGY183 as the parental strain.  GFY173 was created using MRY5 as 
the parental strain.   
 All deletion strains in SF838-1D! were confirmed by diagnostic PCR from 
genomic DNA with primers complementary to the 5' UTR (750-1000 base pairs upstream 
of the start codon) and internal to the drug resistance gene.  A disruption cassette was 
created to delete TSC3 by first PCR amplifying the TSC3 open reading frame with 500 
base pairs of flanking UTR, subcloning in PCR4Blunt-TOPO, and introducing a unique 
restriction site within the ORF.  The TSC3 gene was subcloned into pRS316 and the 
entire ORF was replaced by the NatR cassette using homologous recombination.  The 
deletion cassette was amplified and cloned into PCR4Blunt-TOPO for use in creating 
GFY174 (using SF838-1D! as the parental strain), GFY175 (using GFY170 as the 
parental strain), and GFY313 (using MRY5 as the parental strain).  pGF20 was created 
by first swapping GFP for mCherry (SHANER et al. 2004) in pRS316 VMA2-GFP and 
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introducing a unique PmeI restriction site downstream of mCherry using site directed 
mutagenesis.   
Table 2.  Yeast strains used in this study. 
 
Strain Genotype Reference 
SF838-
1D! 
MAT! ura3-52 leu2-3,112 his4-519 ade6 pep4-3 
gal2 
ROTHMAN and 
STEVENS 1986 
Y7092 MAT! can1"::STE2pr-Sp_HIS5 lyp1" ura3"0 
leu2"0 his3"1 met15"0 LYS2 
TONG and 
BOONE 2006 
GFY36 Y7092; vma21QQ::HA::NatR This study 
GCY2 Y7092; vma21QQ::HA voa1"::KanR This study 
GCY3 Y7092; vma21QQ::HA voa1"::NatR This study 
GFY104 Y7092; vma21QQ::HA voa1::HygR This study 
TASY006 SF838-1D!; vma21"::KanR COMPTON et al. 
2006 
LGY183 SF838-1D!; vma21QQ::HA RYAN et al. 2008 
MRY5 SF838-1D!; vma21QQ::HA voa1::HygR RYAN et al. 2008 
MRY14 SF838-1D!; voa1::HygR  RYAN et al. 2008 
GFY163 SF838-1D!; vma21QQ::HA::NatR This study 
GFY164 SF838-1D!; hph1"::KanR This study 
GFY165 SF838-1D!; hph2"::KanR This study 
BY4741 MATa leu2"!ura3" met15" his3" Yeast Deletion 
Collection 
GFY181 BY4741; hph1"::KanR hph2"::HygR This study 
GFY166 SF838-1D!; hph1"::KanR hph2"::HygR  This study 
GFY167 SF838-1D!; vma21QQ::HA hph1"::KanR 
hph2"::Nat
R 
This study 
GFY168 SF838-1D!; orm1"::KanR This study 
GFY169 SF838-1D!; orm2"::KanR This study 
GFY170 SF838-1D!; orm1"::HygR orm2"::KanR This study 
GFY171 SF838-1D!; vma21QQ::HA orm2"::KanR This study 
GFY172 SF838-1D!; vma21QQ::HA orm1"::HygR 
orm2"::Kan
R 
This study 
GFY173 SF838-1D!; vma21QQ::HA voa1::HygR 
hph1"::Kan
R 
This study 
GFY174 SF838-1D!; tsc3"::NatR  This study 
GFY175 SF838-1D!; orm1"HygR orm2"::KanR tsc3"::NatR This study 
GFY304 SF838-1D!; VMA2::mCherry::NatR This study 
GFY305 SF838-1D!; VMA2::mCherry::NatR vma21"::KanR This study 
GFY302 SF838-1D!; VMA2::mCherry::NatR orm1"::HygR 
orm2"::Kan
R 
This study 
GFY313 SF838-1D!; vma21QQ::HA voa1::HygR 
tsc3"::Nat
R 
This study 
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 Secondly, in vivo ligation was used to insert the ADH terminator and NatR 
cassette at the 3' end of VMA2-mCherry.  A single, C-terminal mCherry (PCR amplified 
from pGF20 including the NatR cassette) was integrated at the VMA2 locus in strains 
GFY170, SF838-1D!, and TASY006.  This created yeast strains GFY302, GFY304, and 
GFY305, respectively. 
 The synthetic genetic array (SGA) query strains were created from yeast parental 
strain Y7092 (TONG and BOONE 2006).  After PCR amplifying the 
vma21QQ::HA::Nat
R locus with 500 base pairs of flanking sequence from GFY163 
genomic DNA, the PCR product was transformed into Y7092 to create GFY36. To create 
GCY3, GCY2 (vma21QQ::HA voa1!::KanR) was transformed with the NatR cassette to 
replace the KanR cassette.  Both the VMA21 and VOA1 loci were PCR amplified with 
flanking sequence and the PCR product was transformed into Y7092.  GFY104 was 
created by PCR amplifying both the VMA21 and VOA1 loci from MRY5 (vma21QQ::HA 
voa1::Hyg
R) with 500 base pairs of flanking sequence and transforming the fragment into 
GCY3. 
 Culture conditions: Yeast were cultured in YEPD (1% yeast extract, 2% 
peptone, and 2% dextrose), YEPD buffered to pH 5.0 using 50 mM succinate/phosphate 
plus 0.01% adenine, or synthetic minimal media with dextrose (SD) and the appropriate 
amino acids.  Growth tests were performed by culturing exponentially growing yeast in 
rich medium to a cell density of 1.0 OD600, serial diluted 5-fold, and spotted onto agar 
plates.  Plates used included YEPD pH 5.0, YEPD + 4.0 mM or 5.0 mM ZnCl2, YEPD + 
100 mM CaCl2, and YEPD + 25 mM or 50 mM CaCl2 pH 7.5 (using 50 mM HEPES). 
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 Synthetic genetic array screen: A synthetic genetic enhancer screen was 
performed as previously described (TONG et al. 2001; TONG and BOONE 2006).  
Briefly, the query strains (GFY36, GCY3, and GFY104) were mated to the MATa 
haploid genome deletion collection (BY4741, his3!1 leu2!0, met15!0, ura3!0) and 
double or triple haploid mutants were selected.  The final haploid mutant array was 
spotted onto YEPD pH 5.0, YEPD + ZnCl2, or YEPD + CaCl2 pH 7.5 and incubated at 
30°C for 2-3 days.  Scans of each plate were visually scored for colony size on each plate 
type used; colonies were scored for increased sensitivity to calcium or zinc.  The genome 
deletion collection was also arrayed under identical conditions and scored in the same 
way.  Colonies that showed equivalent sensitivity to either metal as a single deletion 
strain and as part of the double (or triple) mutant collection were not scored as positive 
hits.  Only mutants that displayed a synthetic growth defect that was not present (or not 
as strong) in either of the single mutant strains were scored as positive hits.  Gene 
Ontology (GO) analysis was performed using the Saccharomyces Genome Database 
(SGD) GO Term Finder (version 0.83) using a p-value cut-off of 0.01. 
 Whole cell extract preparation and immunoblotting: Whole cell extracts were 
prepared as previously described (RYAN et al. 2008).  Briefly, cultures were grown 
overnight in SD dropout media and then diluted to 0.25 OD600/mL in YEPD pH 5.0 and 
grown to a cell density of OD600=1.0.  10 OD600 of the culture was centrifuged, 
resuspended in 0.25 mL Thorner buffer (8M urea, 5% SDS, and 50 mM TRIS pH 6.8) 
and vortexed with 0.2 mL of glass beads.  Following centrifugation, protein 
concentrations were determined using a modified Lowry protein assay (MARKWELL et 
al. 1978).  Equal amounts of protein were separated by SDS-PAGE, transferred to 
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nitrocellulose membrane, and probed with antibodies.  Antibodies used included 
monoclonal primary anti-Vph1p (10D7; Invitrogen, Carlsbad, CA), anti-Vma1p (8B1; 
Invitrogen), and anti-Dpm1p (5C5; Invitrogen), and secondary horseradish peroxidase-
conjugated anti-mouse antibody (Jackson ImmunoResearch Laboratories, West Grove, 
PA).  Blots were visualized by ECL detection. 
 Fluorescence microscopy: Yeast were stained with quinacrine as previously 
described (FLANNERY et al. 2004).  Briefly, cells were grown overnight in YEPD pH 
5.0 plus adenine, and diluted to a cell density of 0.25 OD600/mL in YEPD.  Yeast were 
harvested at a density of 0.8-1.0 OD600/mL and one mL of culture was placed on ice for 
five minutes.  Cells were pelleted and resuspended in 200 µM quinacrine, 100 mM 
HEPES pH 7.6, and 50 µg/mL of concanavalin A tetramethylrhodamine (Invitrogen) in 
YEPD for ten minutes at 30°C.  Following staining with quinacrine, cells were placed on 
ice and washed three times in 100 mM HEPES pH 7.6 plus 2% glucose (4°C).  
Microscopy images were obtained using an Axioplan 2 fluorescence microscope (Carl 
Zeiss, Thornwood, NY).  A 100x objective was used as well as AxioVision software 
(Carl Zeiss). 
 V-ATPase activity assay: Yeast vacuoles were isolated from wild-type (SF838-
1D! and BY4741), vma21!::KanR (TASY006), vma21QQ::HA (LGY183), 
orm1!::Hyg
R
 orm2!::Kan
R (GFY170), vma21QQ::HA voa1::HygR (MRY5), 
vma21QQ::HA orm1!::HygR orm2!::KanR (GFY172), and hph1!::KanR hph2!::HygR 
(GFY166 and GFY181) strains as previously published (UCHIDA et al. 1985).  
Modifications to this protocol included harvesting cells at 1.8-2.2 OD600/mL and use of a 
tighter-fitting dounce homogenizer (5 strokes).  Fresh vacuoles were assayed by a 
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coupled spectrophotometric assay (CONIBEAR and STEVENS 2002).  In this assay 
system ATP hydrolysis is coupled to NADH oxidation (340 nm) in a reaction mixture 
containing 50 µg/mL vacuole membrane protein, 25 mM MES, 25 mM MOPS, 25 mM 
KCl, 5 mM MgCl2, 1 mM NaN3, 0.05 mM Na3VO4, 2 mM phosphoenolpyruvate, 0.5 
mM NADH, 30 U/mL pyruvate kinase and 37 U/mL lactate dehydrogenase; pH 7 
(KOH), with and without 1 µM concanamycin A.  Reactions were initiated by adding 
Mg2+-ATP to 2 mM and thermostatted at 30 °C.  For each mutant strain, one to three 
separate vacuole preparations were assayed, and the assay was repeated 2-6 times for 
each preparation.  Concanamycin A-sensitive ATPase activities were determined by 
calculating the activity as a percentage of wild-type activity for each biological replicate.  
For samples with multiple vacuole preparations, these percentages were averaged and the 
error was presented as the standard error of the mean.  For samples with only a single 
biological preparation, the error is presented as the standard deviations for replicate 
assays. 
 
3. Results 
 Genome-wide synthetic genetic array (SGA) screen for V-ATPase effectors: 
To identify new genes that assist in promoting full V-ATPase function, we performed 
three synthetic genetic array (SGA) Vma– enhancer screens using the S. cerevisiae 
haploid deletion mutant collection (4,741 mutants).  Since a loss of VOA1 only displayed 
a synthetic growth defect upon combination with the vma21QQ mutation, additional 
factors might only be identified in a sensitized genetic background.  The three query 
mutants used were vma21QQ::NatR, vma21QQ voa1!::NatR, and vma21QQ voa1::HygR 
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(subsequent experiments were all performed with the voa1::HygR allele, designated as 
voa1!). The VMA21 and VOA1 loci are tightly linked; only 146 base pairs separate their 
open reading frames.  We chose to use both mutants containing the VOA1 disruption as it 
has been shown that a complete deletion of this open reading frame results in a decrease 
in the steady-state levels of Vma21p, whereas the voa1::HygR allele does not lower 
Vma21p levels (RYAN et al. 2008).  Therefore, the voa1!::NatR allele served as an 
additional sensitized genetic background. 
 Yeast that contain Vma21p having the mutated retrieval/retention signal, 
vma21QQ, show a partial growth defect on elevated calcium media buffered to pH 7.5 
and have reduced V-ATPase activity (RYAN et al. 2008; HILL and STEVENS 1994).  
Additionally, vma21QQ voa1! yeast are also compromised for V-ATPase function yet do 
not display a full Vma– phenotype (RYAN et al. 2008).   
 The haploid double or triple mutant yeast were plated onto rich media, and media 
containing either zinc (2.75 mM or 7.0 mM) or calcium (50 mM or 100 mM) buffered to 
pH 7.5 in quadruplicate.  Yeast that displayed increased sensitivity to these conditions 
were scored as positive hits.  Genes were identified from a diverse set of cellular 
processes such as protein modification, metabolism, chromatin remodeling, and 
transcriptional regulation (Figure 1, Table S1, see Appendix A).  A comprehensive gene 
ontology (GO) analysis was performed for categories of genes that were enriched in our 
SGA screens (Table S2, see Appendix A).  Some of most highly enriched categories 
included vacuolar transport (p-value of 4.94 x 10-17), vesicle-mediated transport (p-value 
of 3.48 x 10-15), and intracellular transport (p-value of 9.46 x 10-10).  Genes identified by 
the three SGA screens that correspond to elements of protein trafficking, vacuolar 
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morphology, and the V-ATPase complex are listed in Table 3 and several were chosen 
for further study. 
 
Figure 1.  Molecular function of 144 genes identified in at least 2 of 3 SGA screens for 
an enhanced Vma- phenotype.  Genes were categorized according to their presumed 
molecular function.  The miscellaneous category includes lipids/sphingolipids, cellular 
morphogenesis, nuclear import, and several other processes, and also genes with no 
molecular characterization.  A comprehensive list of all genes identified and a 
comprehensive GO analysis can both be found in Appendix A. 
 
 Since we were searching for genes that showed increased sensitivity to zinc or 
calcium when deleted in combination with vma21QQ or vma21QQ voa1!, we did not 
identify any of the essential V-ATPase subunits or assembly factors (those with a VMA 
designation) as expected.  Also, VOA1 was not identified in the vma21QQ SGA screen 
because it is genetically linked to the VMA21 locus.  In order for the voa1! locus to be 
paired with the vma21QQ mutation during the SGA protocol, a cross-over event would 
be required between these two loci.  However, we did identify V-ATPase subunits VPH1, 
STV1, the assembly factor PKR1, and genes within the vacuolar transporter chaperone 
(VTC) and regulator of vacuolar and endosomal membrane (RAVE) complexes. 
 In addition, genes involved in ER-resident processes including protein folding and 
degradation were identified (Table 3).  A number of genes were found that have been 
poorly characterized according to the Saccharomyces Genome Database (SGD) and these 
were most interesting to us.   
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Table 3.  Genes found in our screens that are involved in either protein trafficking or are 
ER-localized are listed.  A comprehensive list of all genes identified in all three screens 
can be found in Table S1 (see Appendix A).  Screens were performed with query strains 
vma21QQ voa1::Hyg
R (GFY104), vma21QQ voa1!NatR (GCY3), and vma21QQ-NatR 
(GFY36).  Colonies from the final double or triple mutant strains were analyzed for 
fitness defects on rich media plus 2.75 mM or 7.0 mM ZnCl2 or rich media buffered to 
pH 7.5 plus 50 mM or 100 mM CaCl2.  The haploid deletion library was also tested and 
scored under identical media conditions.  Fitness defects of single knockout strains were 
noted and considered when determining synthetic growth effects.  HPH1 and ORM2 
(shown in bold) were chosen for further study.  A comprehensive Gene Ontology (GO) 
analysis for enriched categories of genes can be found in Table S2 (see Appendix A). 
 
Trafficking Related Genes 
AP-3 (4) apl5!, apl6!, apm3!, aps3! 
Vesicle formation (5)  arf1!, cdc50!, drs2!, vps1!, yap1801! 
Rabs/vesicle targeting factors 
(5) 
gyp1!, sro7!, vps21!, vps9!, ypt7! 
TGN trafficking (11) age2!, arl1!, arl3!, cog5!, cog6!, cog7!, cog8!, 
coy1!, gyp36!, sys1!, vps13! 
ESCRT/MVB sorting (13) vps2!, vps22!, vps23!, vps24!, vps25!, vps27!, 
vps36!, vps37!, vps4!, vps46!, vps55!, vps60!, 
vta1! 
Vacuole Inheritance (2)  cla4!, vac8! 
HOPS/CORVET (4) vam6!, vps3!, vps33!, vps41!  
 
Endocytosis/Exocytosis (5) chs5!, chs6!, gsf2!, lst4!, rcy1!, drs2! 
ER-Golgi trafficking (12)  bst1!, erd1!, erp3!, erv46!, gcs1!, get1!, get2!, 
get3!, gsg1!, pho86!, sec28!, ubp3! 
Autophagy (5)  atg15!, atg21!, atg27!, atg8!, vps62! 
GARP (2) vps52!, vps53! 
SNAREs and fusion (8)  gos1!, pep12!, sec22!, snx4!, swf1!, tlg2!, 
vam10!, vam7! 
Phosphatidylinositol synthesis 
(3) 
inp53!, sac1!, vac14! 
Retromer (5)  vps17!, vps26!, vps29!, vps35!, vps5! 
H+-V-ATPase (7) pkr1!, rav1!, rav2!, stv1!, vph1!, vtc1!, vtc4! 
Miscellaneous (5) apm1!, ccz1!, mon1!, vps19!, yck3! 
Genes whose protein products are ER-localized 
Protein degradation (2) cue1!, ubc7! 
Protein import and maturation 
(5) 
cne1!, cwh41!, emc1!, scj1!, sec66! 
Miscellaneous (16) alg6!, alg8!, bsd2!, csg2!, erg3!, erg6!, flc2!, 
hph1!, ice2!, ilm1!, mga2!, orm2!, ost3!, ost4!, 
per1!, scs2!, spf1!, sur4! 
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 We chose to examine Orm2p for further study because it was an ER-localized, 
integral membrane protein.  Also, Hph1p has been identified as an ER-localized binding 
partner of calcineurin (HEATH et al. 2004).  Due to the genetic link between calcineurin 
and the V-ATPase (TANIDA et al. 1995), we also chose HPH1 for further study.  
 HPH1/HPH2 or ORM1/ORM2 null mutants cause synthetic growth defects in 
vma21QQ yeast:  The hph1! mutation was moved to the SF838-1D! genetic background 
and carefully tested by serial dilution in comparison to Vma– and Vma–compromised 
strains.  The growth phenotypes of vma21QQ voa1" yeast deleted for HPH1 were tested 
on media containing 50 mM calcium buffered to pH 7.5 (Figure 2A).  Whereas wild-type 
yeast were able to grow under these conditions, yeast deleted for VMA21 were unable to 
grow as they lack functional V-ATPase complexes.  vma21QQ voa1" yeast showed a 
compromised level of growth under these conditions and a deletion of HPH1 in this strain 
caused a further increase in sensitivity (Figure 2A).  HPH1 has a homolog in S. 
cerevisiae, HPH2, and both Hph1p and Hph2p reside in the ER membrane (HEATH et 
al. 2004).  It has been reported that deletions in HPH1 and HPH2 display a synthetic 
growth defect under alkaline conditions of pH 8.8 (HEATH et al. 2004).  Since a 
reduction in V-ATPase function results in increased sensitivity to calcium or zinc, we 
determined if a loss of the HPH genes results in a metal-specific phenotype.  Loss of 
either HPH1 or HPH2 did not result in any sensitivity to excess zinc yet deletion of both 
HPH genes caused a dramatic growth defect on 5.0 mM ZnCl2 (Figure 2B).  Both HPH1 
and HPH2 were also deleted in a strain containing the vma21QQ mutation and tested on 
the less stringent conditions of 4.0 mM ZnCl2.  Both vma21QQ and hph1" hph2" yeast 
grew comparable to WT but the vma21QQ hph1" hph2" mutant was fully sensitive 
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under these conditions and unable to grow (Figure 2C).  Interestingly, the hph1! hph2! 
double mutant did not show any sensitivity to 4.0 mM ZnCl2 but displayed a dramatic 
shift in sensitivity between 4.0 mM and 5.0 mM ZnCl2. 
 
Figure 2. HPH1 and HPH2 display synthetic growth defects with V0 assembly mutants.  
(A) Exponentially growing cultures of wild-type (WT; SF838-1D!), vma21! (21"; 
TASY006), vma21QQ voa::HygR (21QQ voa1!; MRY5), vma21QQ voa1::HygR hph1! 
(21QQ voa1! hph1!; GFY173) were serially diluted and spotted onto rich media 
buffered to pH 5.0 or rich media buffered to pH 7.5 plus 50 mM CaCl2.  (B) 
Exponentially growing cultures of wild-type, hph1! (hph1!; GFY164), hph2! (hph2!; 
GFY165), hph1! hph2! (hph1! hph2!; GFY166) were spotted onto rich media or rich 
media plus 5.0 mM ZnCl2.  (C) Cultures of wild-type, vma21!, vma21QQ (21QQ; 
LGY183), hph1! hph2!, and vma21QQ hph1! hph2! (21QQ hph1! hph2!; GFY167) 
were serially diluted and spotted onto rich media buffered to pH 5.0 or rich media plus 
4.0 mM ZnCl2. 
 
 The SGA screens also identified cells lacking ORM2 as an enhancer of the 
assembly factor mutant strains vma21QQ and vma21QQ voa1! on media containing 
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either zinc or calcium.  The orm2! was recreated in SF838-1D! cells expressing 
vma21QQ and tested on media containing 25 mM calcium buffered to pH 7.5.  Loss of 
ORM2 in vma21QQ yeast caused a slight increase in the sensitivity of this strain 
compared to vma21QQ yeast (Figure 3A).  ORM2 has a homolog in S. cerevisiae, ORM1, 
and the double orm1" orm2" mutant shows synthetic growth defects under various 
environmental stress conditions including elevated mercury or the reducing agent DTT 
(HJELMQVIST et al. 2002).  We tested whether a loss of both ORM1 and ORM2 caused 
an increase in sensitivity to 25 mM calcium at pH 7.5.  While deletion of ORM1 did not 
result in any growth defect, yeast deleted for ORM2 were partially sensitive under these 
conditions (Figure 3B).  However, the orm1" orm2" double mutant displayed a synthetic 
growth defect under these conditions.  Due to the high similarity between ORM1 and 
ORM2 (~67% identical), we tested whether ORM1 and ORM2 are functionally redundant.  
Overexpression of Orm1p was able to fully rescue the growth defect of an orm2" strain 
(Figure 3C).  These data suggest that ORM1 and ORM2 are a functionally redundant gene 
pair; we chose to examine the effect of a loss of both Orm1p and Orm2p on the V-
ATPase. 
 Finally, we compared the growth of vma21QQ and orm1" orm2" yeast to the 
triple vma21QQ orm1" orm2" mutant using less stringent conditions of unbuffered 100 
mM CaCl2.  Since a loss of both ORM1 and ORM2 was only sensitive under stringent 
growth conditions, we tested whether reducing V-ATPase function using the vma21QQ 
mutant would result in a more dramatic growth phenotype.  Similar to the HPH1/2 genes, 
a loss of both ORM genes in vma21QQ yeast caused a severe growth defect (Figure 3D).  
This suggests that the ORM genes are required when V-ATPase activity is reduced. 
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Figure 3.  ORM1 and ORM2 display synthetic growth effects in cells expressing 
vma21QQ.  (A) Exponentially growing cultures of wild-type (WT; SF838-1D!), vma21! 
(21!; TASY006), vma21QQ (21QQ; LGY183), and vma21QQ orm2! (21QQ orm2!; 
GFY171) were serially diluted and spotted onto rich media buffered to pH 5.0 or rich 
media buffered to pH 7.5 plus 25 mM CaCl2.  (B) Cultures of wild-type, orm1! (orm1!; 
GFY168), orm2! (orm2!; GFY169), and orm1! orm2! (orm1! orm2!; GFY170) 
spotted onto rich media and rich media buffered to pH 7.5 plus 25 mM CaCl2.  (C) 
Cultures of wild-type, orm2!, and orm2! transformed with a high-copy vector 
expressing ORM1 were spotted onto rich media and rich media buffered to pH 7.5 plus 
50 mM CaCl2. (D) Exponentially growing cultures of wild-type, vma21!, vma21QQ, 
orm1! orm2!, and vma21QQ orm1! orm2! (21QQ orm1! orm2!; GFY172) were 
serially diluted and spotted onto rich media buffered to pH 5.0 or rich media plus 100 
mM CaCl2. 
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 Vacuolar acidification, V0 assembly, and V-ATPase localization are normal 
in HPH and ORM mutants:  Yeast disrupted for V-ATPase function show decreases in 
vacuolar acidification (DAVIS-KAPLAN et al. 2006; RYAN et al. 2008).  In order to 
determine whether the growth defects seen with both the HPH and ORM mutants result 
from a loss of V-ATPase function, we assayed vacuolar acidification by fluorescent 
staining with quinacrine (Figure 4).  Wild-type yeast displayed accumulation of 
quinacrine within the acidified vacuole while vma21! yeast showed no quinacrine 
staining.  As previously shown, yeast mutant for either vma21QQ or voa1! displayed 
wild-type levels of quinacrine staining and vacuolar acidification (RYAN et al. 2008, 
Figure 4).  As expected, the vma21QQ voa1! double mutant accumulated a very low 
level of quinacrine (Figure 4).  Surprisingly, both the double mutants (hph1! hph2! and 
orm1! orm2!) and the triple mutant (vma21QQ hph1! hph2!) had fully acidified 
vacuoles (Figure 4).  Only the vma21QQ orm1! orm2! mutant displayed a partial loss of 
quinacrine staining indicating reduced V-ATPase function.  
 While there was no detectable difference in vacuolar acidification, it is possible 
that the HPH and ORM mutants have slightly reduced levels of the V-ATPase present on 
the vacuole that might not be apparent using fluorescent microscopy but still be 
consistent with the observed growth phenotypes.  We assayed the levels of Vph1p within 
these mutant strains by Western blotting to examine any defects in V0 assembly (Figure 
5).  In wild-type yeast, Vph1 protein is extremely stable (> four hour half life; GRAHAM 
et al. 1998; HILL and COOPER 2000) and incorporated into the V0 subcomplex.  
However, Vph1p is rapidly degraded (25-30 minute half life) if there is a V0 assembly 
defect in the ER (GRAHAM et al. 1998; HILL and COOPER 2000).   
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Figure 4.  Loss of HPH1/HPH2 or ORM1/ORM2 does not result in a loss of vacuolar 
acidification.  Exponentially growing cultures of wild-type (WT; SF838-1D!), vma21! 
(21!; TASY006), vma21QQ (21QQ; LGY183), voa1::H (voa1!; MRY14), vma21QQ 
voa1::H (21QQ voa1!; MRY5), hph1! hph2! (hph1! hph2!; GFY166), and vma21QQ 
hph1! hph2! (21QQ hph1! hph2!; GFY167), orm1! orm1! (orm1! orm2!; GFY170), 
and vma21QQ orm1! orm2! (21QQ orm1! orm2!; GFY172) were stained with 
quinacrine (green) and concanavalin A-tetramethylrhodamine (red) and viewed by either 
fluorescent or DIC microscopy.  
 
 As predicted, the levels of Vph1p in vma21! yeast were greatly reduced 
compared to wild-type levels.  In contrast, voa1!, hph1! hph2!, and orm1! orm2! yeast 
all displayed wild-type levels of Vph1p.  This result indicates there is no V0 assembly 
defect in these strains that would result in increased turnover of Vph1p.  The vma21QQ 
mutant showed a slight decrease in Vph1p levels.  Careful analysis has shown that this 
decrease was mirrored in HPH and ORM mutant strains also containing the vma21QQ 
mutation (vma21QQ hph1! hph2! and vma21QQ orm1! orm2!).  Only vma21QQ 
voa1! yeast showed a clear reduction in Vph1p that was greater than that seen in the 
vma21QQ mutant.  The ER-resident protein Dpm1p was probed as a loading control.  
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The steady-state levels of the V1 subunit Vma1p did not change in any of the queried 
mutants.   
 
Figure 5.  Vph1p levels are not reduced in strains lacking either HPH1/HPH2 or 
ORM1/ORM2. Whole cell extracts were prepared from wild-type (WT; SF838-1D!), 
vma21! (21!; TASY006), vma21QQ (21QQ; LGY183), voa1::H (voa1!; MRY14), 
vma21QQ voa1::H (21QQ voa1!; MRY5), hph1! hph2! (hph1! hph2!; GFY166), and 
vma21QQ hph1! hph2! (21QQ hph1! hph2!; GFY167), orm1! orm1! (orm1! orm2!; 
GFY170), and vma21QQ orm1! orm2! (21QQ orm1! orm2!; GFY172).  Proteins were 
separated by SDS-PAGE and probed with anti-Vph1p and anti-Vma1p antibodies.  Anti-
Dpm1p antibody was used as a loading control.  The molecular mass (kilodaltons) of the 
nearest marker is shown on the left. 
 
 The localization of the V-ATPase was also examined in both the ORM and HPH 
mutant strains.  Yeast expressing both the V0 subunit Vph1p-GFP and the V1 subunit 
Vma2p-mCherry were visualized by fluorescent microscopy.  In wild-type yeast, Vph1p-
GFP localized to the limiting membrane of the vacuole and co-localized with Vma2p-
mCherry (Figure 6).  There was also a pool of Vma2p-mCherry staining within the 
cytosol in a diffuse pattern.  In vma21! yeast, Vph1p-GFP was found in both cortical and 
perinuclear ER structures and Vma2p-mCherry was only localized within the cytosol.  
Yeast mutant for orm1! orm2! showed both V0 and V1 localized to the vacuolar 
membrane similar to wild-type cells (Figure 6).  Strains mutant for hph1! hph2! 
localized Vph1p-GFP to the vacuole (data not shown). 
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Figure 6.  V1 and V0 are localized to the vacuole membrane in Orm mutant yeast.  A 
single mCherry was integrated at the VMA2 locus in the following strains: wild type 
(WT; GFY304), vma21! (21!; GFY305), and orm1! orm2! (orm1! orm2!; GFY302).  
Yeast  strains also contained a vector expressing Vph1p-GFP (pGF87).  Exponentially 
growing cells were visualized by fluorescent and DIC microscopy. 
 
 Loss of the ORM genes (but not the HPH genes) results in reduced V-ATPase 
enzyme activity:  Since it is possible that the growth defects seen in the HPH and ORM 
strains could result from defects in V-ATPase enzyme function (rather than from 
assembly defects), we performed V-ATPase activity assays on isolated vacuole 
membranes in these mutant strains.  We measured vacuole membranes from the hph1! 
hph2! strain to have 88% V-ATPase activity, whereas the orm1! orm2! mutant had 
67% activity relative to wild-type yeast (Table 4).  We also tested V-ATPase enzyme 
activity for the hph1! hph2! mutant in a separate genetic background (BY4741) and 
found no difference from wild-type vacuole membranes (116% of WT; Table 4).  We 
determined the vma21QQ mutant activity to be 22% of wild-type yeast despite the 
appearance of fully acidified vacuoles.  The double vma21QQ voa1! mutant showed a 
dramatic decrease to 9%.  The vma21QQ orm1! orm2! triple mutant had a comparable 
reduction of V-ATPase activity to 8% relative to wild-type yeast.  These results indicate 
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that the Hph proteins do not affect the activity of the V-ATPase and that the Orm proteins 
are required for full V-ATPase function. 
Table 4.  V-ATPase activity and quinacrine staining of mutants.  Loss of both ORM1 and 
ORM2 results in a decrease in V-ATPase activity.  Activity assays were performed for 
wild-type strains (WT; SF838-1D! and WT; BY4741), vma21! (21!; TASY006), 
vma21QQ (21QQ; LGY183), voa1::H (voa1!; MRY14), orm1! orm1! (orm1! orm2!; 
GFY170), vma21QQ voa1::H (21QQ voa1!; MRY5), hph1! hph2! SF838-1D! (hph1! 
hph2!; GFY166), hph1! hph2! BY4741 (hph1! hph2!; GFY181) and vma21QQ 
orm1! orm2! (21QQ orm1! orm2!; GFY172).  A continuous, coupled 
spectrophotometric assay (CONIBEAR and STEVENS 2002) was used to assay freshly 
prepared vacuole membranes for concanamycin A-sensitive ATPase activity.  The wild-
type strain SF838-1D! had an average specific activity of 0.817 µmol min-1 mg-1 
(average of n = 7 independent vacuole isolations) and the wild-type strain BY4741 has a 
specific activity of 0.836 µmol min-1 mg-1 (1 vacuole isolation).  The specific activity of 
mutant samples was divided by the wild-type specific activity measurement for each 
independent vacuolar preparation to produce a relative percentage.  For samples prepared 
more than once (biological replicates indicated in parentheses), the different percentages 
were averaged to produce the percentage wild-type activity measurements +/- the 
standard error of the mean.  Quinacrine staining is derived from Figure 3. 
 
Strain % wild type ATPase 
activity 
Quinacrine 
Wild type (SF838-1D!) 100 ++++ 
Wild type (BY4741) 100 ++++a 
vma21! 1 +/- 0.3 (1)d - 
hph1! hph2! (SF838-1D!) 88 +/- 6 (4)b ++++ 
hph1! hph2! (BY4741) 116 +/- 0.7 (1) d ++++a 
orm1! orm2! 67 +/- 6 (3) ++++ 
voa1! 75c ++++ 
vma21QQ 22 +/- 1 (3) ++++ 
vma21QQ voa1! 9 +/- 0.5 (2) + 
vma21QQ orm1! orm2! 8 +/- 0.5 (2) ++ 
a Data not shown. 
b 3 of 4 measurements for hph1! hph2! (SF838-1D!) averaged 97% of wild-type. 
c From RYAN et al. 2008. 
d For stains with only a single biological preparation, the error is expressed as the 
standard deviation of technical replicates. 
 
 The Orm proteins function in sphingolipid regulation: Two reports have 
recently demonstrated that Orm1p and Orm2p are negative regulators of the serine 
palmitoyltransferase (SPT) complex responsible for the first and rate-limiting enzymatic 
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step of sphingolipid synthesis (BRESLOW et al. 2010; HAN et al. 2010).  Since loss of 
Orm1p and Orm2p has been shown to result in increased sphingolipid production 
(BRESLOW et al. 2010; HAN et al. 2010), we tested whether inhibition of the SPT 
complex alleviated the defects seen in an orm1! orm2! mutant.  Tsc3p is a small protein 
that associates with the SPT enzyme and is required for full activity of this complex 
(GABLE et al. 2000).  We deleted TSC3 in the orm1! orm2! mutant and tested the triple 
mutant strain on media containing elevated calcium and buffered to pH 7.5 (Figure 7A).  
Yeast lacking TSC3 did not display any growth defect under these conditions.  However, 
loss of TSC3 allowed for increased growth of the orm1! orm2! strain.  Additionally, 
suppression by deletion of TSC3 was specific to the orm1! orm2! mutant, as loss of this 
regulator did not suppress the calcium sensitivity of the vma21QQ voa1! mutant (Figure 
7B).  These results suggest that the growth defects seen in the orm1! orm2! mutant 
strain are due to perturbation of sphingolipid synthesis. 
 
Figure 7.  Orm sensitivity to buffered calcium media can be suppressed by inhibition of 
sphingolipid biogenesis.  A) Cultures of wild-type (WT; SF838-1D!), vma21! (21!; 
TASY006), tsc3! (tsc3!; GFY174), orm1! orm2! (orm1! orm2!; GFY170), and 
orm1! orm2! tsc3! (orm1! orm2! tsc3!; GFY175) were spotted onto rich media and 
media containing 25 mM CaCl2 buffered to pH 7.5.  B) Wild-type, vma21QQ voa1! 
(21QQ voa1!; MRY5), tsc3!, and vma21QQ voa1! tsc3! (21QQ voa1! tsc3!; 
GFY313) yeast were spotted onto rich media and media containing 100 mM CaCl2. 
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4. Discussion 
 The goal of this study was to identify additional factors that contribute to V-
ATPase function that may have been missed by previous forward genetic screens.  The 
power of enhancer and suppressor screens is evident from work in both D. melanogaster 
and C. elegans where it is often necessary to use a sensitized background to uncover new 
genetic pathways (ST JOHNSTON 2002; JORGENSEN and MANGO 2002).  In the case 
of the yeast V-ATPase, parallel genetic pathways are most likely not the main obstacles 
for identifying subtle effectors of this complex.  Instead, the V-ATPase enzyme within 
the cell requires a dramatic decrease in enzyme function or assembly before cellular 
growth phenotypes become evident (RYAN et al. 2008).  The discovery of the fourth and 
fifth factors that participate in V0 assembly (Pkr1p and Voa1p) demonstrates the 
complexity of the assembly processes required for the V-ATPase enzyme complex.  
While Voa1p has been shown to physically associate with the V0 subcomplex in the ER 
(RYAN et al. 2008), no physical association has been characterized for Pkr1p despite a 
strong genetic link to the assembly factor Vma21p (DAVIS-KAPLAN et al. 2006; data 
not shown, GRAHAM and STEVENS).  Growth phenotypes associated with perturbation 
of the V-ATPase are only evident upon a significant reduction in enzyme activity to 
about 20% of wild-type as in the case of the mutant assembly factor allele, vma21QQ 
(HILL and STEVENS 1994).  This retrieval-defective mutant allele of the highly 
conserved assembly factor, Vma21p, is a unique scenario to serve as a genetic tool for 
enhancer (and suppressor) screens because (i) the levels of functional V-ATPase are 
sufficiently low to allow for phenotypic scoring, and (ii) the V-ATPase is not 
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compromised for enzyme function, but rather, is defective for assembly due to the limited 
supply of Vma21p in the ER.   
 In performing genome-wide enhancer screens with the vma21QQ and vma21QQ 
voa1! alleles, a large number of genes involved in vesicular trafficking pathways, 
endosomal ESCRT machinery, vesicle formation, and vacuolar morphology were 
identified.  Deletion of some trafficking-related genes has been shown to result in 
sensitivity to zinc, calcium, or alkaline conditions (PAGANI et al. 2007; SAMBADE et 
al. 2005; SERRANO et al. 2004).  Our strategy for screening effectively detected 
reduced V-ATPase activity levels to ~10% of wild-type yeast (scored as <50% of activity 
in the vma21QQ mutant strain).  It is therefore not surprising that we have identified 
additional genes involved in trafficking pathways that were not previously found in 
forward genetic screens.  For instance, many of the vacuolar protein sorting (VPS) genes 
have not been identified in previous genome-wide screens for Vma– phenotypes 
(SAMBADE et al. 2005).  The genetic relationship between these sorting pathways and 
vacuolar acidification most likely results from aberrant sorting of the V-ATPase.  There 
are many ways by which disruption of vesicular trafficking can result in mislocalization 
of the V-ATPase enzyme.  For example, loss of the AAA-ATPase Vps4p results in an 
aberrant multivesicular body that traps vacuole-bound cargo in this compartment 
(RAYMOND et al. 1992).  In addition, loss of the syntaxin Pep12p (another class of 
trafficking mutants) results in mislocalization of Vph1p (GERRARD et al. 2000).  If the 
V-ATPase is not targeted to the vacuolar membrane, the pH gradient necessary to drive 
the sequestration of excess metals is not established, and the result is an increased 
sensitivity in our screen.  Due to the complexity of protein sorting from the Golgi to the 
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vacuole, there are many components that are required for proper transport of the V-
ATPase to the vacuole membrane (BOWERS and STEVENS 2005).  It will be of interest 
to determine if disruption of other trafficking pathways is able to affect metal sensitivity 
without perturbation of V-ATPase localization and function. 
 We chose to characterize two gene families, HPH1 and ORM2, whose protein 
products had been previously reported to localize to the ER; both have homologs within 
budding yeast, HPH2 and ORM1, respectively (HEATH et al. 2004; HJELMQVIST et al. 
2002).  HPH1 and HPH2 have been characterized as new components of calcineurin 
signaling (HEATH et al. 2004).  Genetic screens have also found that deletion of any of 
the essential subunits of the V-ATPase is synthetic lethal with a loss of calcineurin 
(TANIDA et al. 1995; PARSONS et al. 2004).  We therefore investigated the 
involvement of the Hph proteins in the function and/or assembly of the V-ATPase 
complex in the ER. 
 HPH1 and HPH2 have been previously reported to be functionally redundant and 
sensitive to high salinity or alkaline conditions (HEATH et al. 2004).  We have found a 
unique set of growth phenotypes associated with a loss of HPH1 and HPH2 on media 
containing excess metals.  The hph1! hph2! mutant did not display any sensitivity to 
elevated calcium (data not shown) yet displayed a non-linear shift in zinc sensitivity.  
This was unusual, as our previously observed V-ATPase mutants with a partial reduction 
in function, pkr1", vma21QQ, and vma21QQ voa1" (data not shown), exhibit growth 
defects on both zinc and calcium to varying degrees, and have a gradual response to 
increasing concentrations of ZnCl2.  Preliminary work has also demonstrated that the zinc 
sensitivity of the hph1! hph2! mutant was not completely dependent on calcineurin (data 
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not shown).  Based on our results, we propose that the growth defect of hph1! hph2! 
yeast on ZnCl2 likely results from a V-ATPase independent mechanism.  It is unclear if 
the zinc sensitivity in Hph mutants results from an effect on vacuole-localized Zn2+ 
transportation or some other mechanism. 
 Genome-wide screens for zinc or calcium (at pH 7.5) sensitivity have found genes 
that do not directly contribute to V-ATPase function yet show sensitivity to excess metals 
(PAGANI et al. 2007; SAMBADE et al. 2005).  An example is deletion of the vacuolar 
zinc transporter Zrc1p that confers zinc sensitivity even though vacuolar acidification is 
normal (data not shown).  Also, a loss of the serine protease Kex2p results in both 
calcium and zinc sensitivity yet does not cause any defect in vacuolar acidification 
(SAMBADE et al. 2005).  Identifying which genetic pathways are directly linked to 
metal sensitivity independent of V-ATPase function will require further study. 
 The Orm proteins are also functionally redundant, integral membrane proteins 
that localize to the ER in yeast (data not shown).  Since loss of both ORM genes caused a 
reduction in vacuolar acidification and V-ATPase enzyme activity in the context of the 
vma21QQ mutation, we propose that Orm1p and Orm2p are necessary for full V-ATPase 
function.  However, the phenotype associated with disruption of only the ORM genes 
does not completely phenocopy a loss of other assembly factors (such as PKR1 or the 
combination vma21QQ voa1!).  Key differences highlight the potential mechanism 
through which the Orm proteins may impact the V-ATPase including the lack of an 
apparent V0 assembly defect.  It is unlikely that the Orm proteins transiently participate in 
V0 assembly of the V-ATPase, as we were unable to determine any physical association 
of Orm2p with the Vma21p-V0 subcomplex (data not shown). 
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 We also examined whether a variety of cargo proteins (including both 
subdomains of the V-ATPase) were aberrantly targeted upon a loss of the Orm proteins.  
Resident ER (Vma21p), Golgi (Vps10p), plasma membrane (Pma1p, Ste3p, and Snf3p), 
and vacuolar proteins (Sna3p, Zrt3p, Vcx1p, ALP, and Cps1p) did not display changes in 
localization patterns compared to wild-type yeast (data not shown).  Consistent with these 
data, we found normal V1V0 localization of the V-ATPase to the vacuole membrane; 
these suggested an indirect involvement of Orm1p and Orm2p.  A more likely scenario 
involves perturbation of V-ATPase function through other cellular pathways. 
 Recently, two studies have characterized Orm1p and Orm2p as negative 
regulators of sphingolipid synthesis (BRESLOW et al. 2010; HAN et al. 2010).  Both 
groups have reported that the Orm proteins physically associate with and regulate the 
SPT complex in the ER.  Interestingly, inhibition of the SPT enzyme complex was found 
to alleviate phenotypes associated with a loss of ORM1 and ORM2 including cold 
sensitivity and sensitivity to tunicamycin (HAN et al. 2010).  Our data are consistent with 
these findings and it is likely that ORM1 and ORM2 indirectly affect V-ATPase function 
through perturbation of sphingolipid production.  This interpretation is in agreement with 
the effect of the lipid environment on the assembly, transport or function of various 
enzymes including the amino acid permease Gap1p (LAUWERS et al. 2007), uracil 
permease Fur4p (HEARN et al. 2003), and plasma membrane H+-ATPase Pma1p 
(WANG and CHANG 2002; GAIGG et al. 2006).   
 Also, deletion of two components of the fatty acid elongation pathway required 
for sphingolipid C26 acyl group synthesis (fen1! and sur4!) resulted in perturbation of 
vacuolar acidification, a decrease in V-ATPase enzyme activity, and a functionally 
! 42!
compromised V1 domain (CHUNG et al. 2003).  This previous study reported 
destabilization of the V-ATPase, specifically a portion of the V1 subdomain dissociates 
from the membrane during vacuole membrane preparation of the sur4! mutant.  Since 
loss of the Orm proteins results in a similar change in the lipidome as sur4! yeast 
(Breslow et al., 2010), loss of the V1 subdomain during vacuolar preparation could 
explain why vma21QQ orm1! orm2! cells display levels of V-ATPase activity similar to 
vma21Q voa1! yeast but higher vacuolar acidification in vivo.  Since they are negative 
regulators, deletion of ORM1 and ORM2 results in an increase in the sphingolipid 
composition of the cell (BRESLOW et al. 2010).  Loss of the Orm proteins results in a 
subtle decrease in V-ATPase function and this differs from both the sur4! and fen1! 
mutations.  However, this connection between sphingolipid regulation and V-ATPase 
function would have been missed in previous forward genetic screens.  Overproduction 
of sphingolipids likely results in an altered lipid environment for the V-ATPase as 
sphingolipids play crucial roles for many cellular functions (HANADA 2003; COWART 
and OBEID 2007). 
 The use of sensitized genetic backgrounds to identify factors that have subtle 
effects on V-ATPase function has revealed genes involved in a variety of cellular 
pathways.  We have identified the Orm proteins and implicated sphingolipid regulation as 
important contributors to full V-ATPase enzyme activity.  Future genome-wide screens 
that specifically assay V-ATPase function will aid in separating genes, like HPH1 and 
HPH2, which do not directly affect enzyme activity, from those that are dedicated 
effectors of V-ATPase assembly, transport, or enzyme function.  Finally, further 
characterization of the precise mechanism by which alteration of sphingolipids and the 
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cellular lipid composition affect function of the V-ATPase will be of great interest and 
provide a more complete understanding of this crucial molecular machine. 
 
 The work from this Chapter presents a connection between the lipid composition 
of the cell and V-ATPase enzyme function.  This work is consistent with other reports 
that have documented the impact that changes to the lipidome have on other molecular 
cargo include the V-ATPase.  Additionally, these genome wide screens have implicated a 
number of trafficking-related genes and processes in V-ATPase function.   
 For mutants that have lost ORM1/ORM2, there does not seem to be an effect 
either assembly or trafficking of the V-ATPase.  Therefore, it is possible that the local 
lipid environment is affecting either (i) enzyme activity of the enzyme complex and/or 
(ii) regulation of the complex.  Understanding the link between lipids and the V-ATPase 
will require further study.  However, previous observations have shown that the two 
isoforms of the V-ATPase (containing either Stv1p or Vph1p) are differentially regulated 
and have different coupling efficiencies.  It is possible that some of these biochemical 
differences can be attributed to the specific cellular compartments where these enzymes 
reside.  In order to further explore the differences between the Stv1p and Vph1p V-
ATPase complexes, I have taken an evolutionary approach.  Characterization of the 
trafficking, assembly, and regulation of these two isoforms of the V-ATPase will provide 
additional insight into the effects of local cellular environments can have on enzyme 
function. 
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CHAPTER III 
THE RECONSTRUCTED ANCESTRAL SUBUNIT A FUNCTIONS AS BOTH 
V-ATPASE ISOFORMS VPH1P AND STV1P IN EXTANT S. CEREVISIAE 
 The phylogenetic analysis and ancestral reconstruction was performed by V. 
Hanson-Smith (affiliated with the Center for Ecology and Evolutionary Biology and 
Department of Computer Science, University of Oregon, Eugene, OR, 97403).  B. D. 
Houser and H. J. Park (both from the Department of Chemsitry, University of Oregon, 
Eugene, OR 97403) contributed to several figures and unpublished data.  G. C. Finnigan 
performed all other experiments and did all of the writing.  V. Hanson-Smith and T. H. 
Stevens provided editorial comments.  This manuscript has been submitted to Molecular 
Biology of the Cell and is in the first revision.  G. C. Finnigan and T. H. Stevens are 
affiliated with the University of Oregon (Eugene, OR, 97403). 
 
 Abbreviations used:  V-ATPase, vacuolar-type proton translocating ATPase; 
Anc.a, the reconstructed, ancestral subunit a of the vacuolar H+-ATPase within the fungal 
clade; YEPD, yeast extract peptone dextrose; HA, hemagglutinin; BPS, 
bathophenanthrolinedisulfonic acid; GFP, green fluorescent protein; ALP, yeast alkaline 
phosphatase encoded by the PHO8 gene; CPY, vacuolar carboxypeptidase Y encoded by 
the PRC1 gene; mDsRed, monomeric form of a red fluorescent protein from the genus 
Discosoma; mCherry, a mutated form of monomeric red fluorescent protein; ML, 
maximum likelihood; PP, posterior probability. 
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1. Introduction 
 The vacuolar H+-ATPase (V-ATPase) is a multisubunit molecular machine 
responsible for organelle acidification in eukaryotes (Forgac, 2007).  The V-ATPase 
enzyme couples hydrolysis of ATP with proton translocation across membranes using a 
conserved rotary mechanism (Marshansky and Futai, 2008).  The electrochemical 
gradient generated by the V-ATPase is required for a diverse set of biological processes 
including vesicular trafficking, exocytosis, membrane fusion, ion homeostasis, 
development, and pH regulation (Kane 2006; Forgac 2007).  The V-ATPase has also 
been implicated in a number of disease models including cancer cell migration (Martinez-
Zaguilan et al., 1999), osteopetrosis (Frattini et al., 2000), viral entry into cells 
(Gruenberg and van der Goot, 2006), and renal tubular acidosis (Karet et al., 1999). 
 The budding yeast S. cerevisiae serves as an excellent model system to study the 
V-ATPase because the enzyme complex is not required for viability.  Yeast use the 
proton gradient generated by the V-ATPase to maintain pH levels and regulate ion 
homeostasis (Kane, 2006).  Toxic levels of metals are sequestered within the yeast 
vacuole by proton-exchange antiporter pumps (Klionsky et al., 1990).  Disruption of V-
ATPase function results in a loss of vacuolar acidification and renders cells sensitive to 
excess levels of metals such as calcium or zinc.  The yeast V-ATPase complex contains 
14 different subunits, some of which are present in multiple copies (Forgac, 2007).  The 
enzyme contains two subdomains:  the cytosolic V1 portion is responsible for hydrolysis 
of ATP whereas the membrane-bound V0 portion transports protons across the lipid 
bilayer (Graham et al., 2003).  The V1 domain contains subunits A, B, C, D, E, F, G, and 
H whereas the V0 domain contains subunits a, d, e, c, c’ and c”; all of these subunits are 
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required for V-ATPase function.  Assembly of the V0 subdomain occurs within the 
endoplasmic reticulum (ER) and requires the presence of five dedicated assembly factors:  
Vma21p, Vma22p, Vma12p, Pkr1p, and Voa1p (Hirata et al., 1993; Hill and Stevens, 
1995; Malkus et al., 2004; Davis-Kaplan et al., 2006; Ryan et al., 2008).  These ER-
resident proteins aid in chaperoning components of the V0 and are required for full 
enzyme function.  Regulation of V-ATPase function can occur through rapid, reversible 
dissociation of the V1 and V0 subcomplexes, differential assembly, or differences in the 
localization of the enzyme complex (Kane 2006; Forgac 2007). 
 Yeast contain two different V-ATPase complexes depending on the incorporation 
of one of two isoforms of the V0 subunit a, Vph1p or Stv1p (Figure 1; Manolson et al., 
1992, 1994).  The subunit composition of the V-ATPase is identical between these two 
populations yet there are dramatic functional and phenotypic differences for each protein 
complex (Qi and Forgac, 2007; Manolson et al., 1994).  In yeast, subunit a is responsible 
for targeting of the V-ATPase to distinct subcellular compartments; complexes 
containing Vph1p (Vph1p-complex) reside on the vacuolar membrane whereas Stv1p-
containing complexes (Stv1p-complex) are found within the Golgi/endosomal network 
(Manolson et al., 1994).  The cytosolic, N-terminal portion of Stv1p and Vph1p contains 
the targeting information necessary for trafficking of the V-ATPase to these organelles 
(Kawasaki-Nishi et al., 2001a).  Complexes containing the Stv1p isoform (Stv1p-
complex) are retained and/or retrieved between the late Golgi and endosome (Kawasaki-
Nishi et al., 2001a).  Aside from the difference in localization, the Stv1p and Vph1p 
complexes have been shown to differ in transcript expression, protein abundance, 
assembly, coupling efficiency, and reversible dissociation.  The Stv1p-complex is found 
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at much lower protein levels, has a lower ATP coupling efficiency, and does not undergo 
reversible dissociation of V1 and V0 upon glucose starvation compared to the Vph1p-
complex (Manolson et al., 1992, 1994; Kawasaki-Nishi et al., 2001b; Perzov et al., 
2002). 
 There is a relative paucity of information describing the evolutionary mechanisms 
responsible for the presence of multiple isoforms of various V-ATPase subunits.  
Phylogenetic analysis suggests that gene duplication events played a significant role in 
the evolution of subunit a and the entire V-ATPase enzyme in eukaryotes (Müller and 
Grüber, 2003; Cross and Müller, 2004).  Characterization of the two subunit a isoforms 
within budding yeast revealed a number of key biochemical differences in regulation, 
assembly, and trafficking between the V-ATPase complexes.  However, it is unclear how 
subunit a in S. cerevisiae evolved from a pre-duplicated, single isoform into the two 
contemporary Vph1p and Stv1p subunits.   
 Eukaryotes outside of fungi also have multiple genes and many isoforms of 
various V-ATPase subunits including subunit a (Forgac, 2007).  For instance, C. elegans 
has four isoforms of subunit a (Oka et al., 2001b), mice have four isoforms including one 
present on the plasma membrane (Oka et al., 2001a; Toyomura et al., 2003), and 
Paramecium tetraurelia is reported to have 17 distinct subunit a isoforms (Wassmer et 
al., 2006).  The increasing number of separate isoforms allows for a high degree of 
specialization in the subcellular localization of the V-ATPase as well as cell-specific 
expression and regulation (Toei et al., 2010). 
 Although most eukaryotes use several distinct V-ATPase isoforms of subunit a, 
there are groups of species that have only a single isoform.  How are eukaryotes with 
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only one V-ATPase complex able to properly acidify various cellular compartments?  
Fungal species basal to the clade of budding yeast belong to a group that contains only a 
single subunit a isoform (Chavez et al., 2006).  However, attempts to characterize 
homologs of subunit a from A. thaliana and S. pombe within budding yeast for V-ATPase 
function have been met with no success (Aviezer-Hagai et al., 2000; unpublished results) 
because difficulties in this horizontal evolutionary approach often result from differences 
in genetic background (Harms and Thornton, 2010).  This approach does not address (i) 
sequence changes that have accumulated over evolutionary time that did not contribute to 
protein function and (ii) the effects of epistatic interactions between mutational changes 
that have occurred along lineage-specific evolutionary trajectories (Harms and Thornton, 
2010). 
 To address these questions, we reconstructed the most recent common ancestor of 
Vph1p and Stv1p and tested its function as the only isoform of subunit a in S. cereviaise.  
The ancestral subunit a (Anc.a) functionally replaces both Vph1p and Stv1p through 
acidification of both the Golgi/endosomal network and vacuole.  Anc.a displays a dual 
localization pattern to both of these cellular compartments.  Additionally, trafficking of 
Anc.a does not utilize the sorting machinery that has evolved to retain and/or retrieve 
Stv1p within the trans Golgi.  Rather, it is likely that Anc.a localizes to both structures 
through slowed anterograde transport en route to the yeast vacuole. 
 
2. Materials and methods 
 In silico reconstruction of ancestral protein sequences:  GenBank was queried 
for all fungal V-ATPase subunit a sequences and protein sequences for sixty-eight 
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isoforms were returned (Supplemental Table S1, see Appendix B).  The non-fungal 
subunit a sequences for D. discoideum and A. thaliana were also retrieved and used as a 
phylogenetic outgroup.  Sequences were aligned using PRANK v0.081202 (Loytynoja 
and Goldman, 2005, 2008).  This alignment was best-fit by the Whelan-Goldman matrix 
(WAG) with gamma-distributed rate variation (+G) and proportion of invariant sites (+I), 
according to the Akaike Information Criterion as implemented in PROTTEST (Whelan 
and Goldman, 2001, Abascal et al., 2005).  In-house code modification of PhyML v3.0 
was used to infer the maximum likelihood (ML) topology, branch lengths, and model 
parameters (Guindon and Gascuel, 2003).  Specifically, the topology was optimized by 
using the best result from Nearest-Neighbor-Interchange and Subtree Pruning and 
Regrafting (using PhyML’s implementation).  All other free parameters using our 
implementation of the limited-memory Broyden-Fletcher-Goldfarb-Shanno 
multidimensional optimization algorithm were also optimized (Liu and Nocedal, 1989).  
Phylogenetic branch support was calculated as the approximate likelihood ratio based on 
a Shimodaira-Hasegawa-like procedure (Anismova and Gascuel, 2006). 
 ML ancestral states were reconstructed at each site for all ancestral nodes in the 
ML phylogeny using a set of Python scripts, called Lazarus (Hanson-Smith et al., 2010), 
which wraps PAML version 4.1 (Yang, 2007).  Lazarus parsimoniously placed ancestral 
gap characters according to Fitch’s algorithm (Fitch, 1971).  The overall support for the 
reconstructed Anc.a sequence was characterized by binning the posterior probability of 
the ML state at each ancestral site into 5%-sized bins and counting the proportion of total 
sites within each bin (Supplemental Figure S1, see Appendix B). 
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 Plasmids and yeast strains:  Standard molecular biology procedures were used 
in this study (Sambrook and Russel, 2001).  Plasmids that were used can be found in 
Table 1.  To construct pGF35, plasmid pAAC200 (Cooper and Stevens, 1996) was 
digested with StuI.  Next, a polymerase chain reaction (PCR) product of the C-terminal 
portion of the VPS10 open reading frame (ORF) fused to GFP, the S. pombe HIS5 
cassette (Yeast GFP Collection; Invitrogen, Carlsbad, CA), and VPS10 3' untranslated 
region was obtained.  Using homologous recombination and in vivo ligation, the PCR 
fragment and gapped vector were co-transformed into wild-type (BY4741) yeast and 
selected for growth on media lacking histidine to create pGF35.  The Anc.a sequence was 
synthesized by GenScript (Piscataway, NJ) with a yeast codon bias.  A double 
hemagglutinin (HA) epitope tag was included after site 171 in Anc.a.  This corresponds 
to the same position as the double HA tags found in both Stv1p (site 219) and Vph1p 
(site 185) (Kawasaki-Nishi et al., 2001).  The Anc.a gene was subcloned to a single-copy, 
CEN-based yeast vector and tagged with either the ADH terminator sequence (247 base 
pairs) and NatR drug resistance cassette (Goldstein and McCuster, 1999) or 
GFP::ADH::Hyg
R cassette (amplified from pGF123) using in vivo ligation.  A second 
round of in vivo ligation was used to place the Anc.a gene (with or without the GFP tag) 
under control of either the STV1 promoter (500 base pairs) or VPH1 promoter (380 base 
pairs) to create pGF243-pGF246.  To create pGF341-342, the VPH1 promoter and Anc.a 
gene (containing codons 1-736) were PCR amplified (from pGF245), propagated in 
pCR4Blunt-TOPO (Invitrogen), and subcloned to pRS316.  Similarly, the C-terminal 
portion of Anc.a (codons 737-stop) including the ADH::NatR cassette was cloned into a 
TOPO vector.  The R737Q or R737A mutation was introduced into primers that 
! 51!
contained 40 base pairs of sequence homology to the Anc.a coding region and 
downstream vector sequence.  In vivo ligation was used to recreate a full-length Anc.a 
gene containing the two mutational changes.  For construction of pGF242, the mCherry 
tag (Shaner et al., 2004) was amplified, cloned into TOPO, subcloned to a CEN-vector, 
and tagged with ADH::NatR using in vivo ligation.  The mCherry tag was placed behind 
the promoter of VPH1 (380 base pairs) and included a start codon.  Subsequent 
subcloning removed the ADH::NatR marker.  The PHO8 gene (ALP) was amplified from 
genomic DNA (SF838-1D!), propagated in TOPO, subcloned to pRS316, and tagged 
with ADH::NatR as previously described.  Finally, the PHO8::ADH::NatR sequence was 
amplified and in vivo ligated behind the prVPH1::mCherry sequence to create pGF242.  
Constructs were verified by diagnostic PCR and DNA sequencing. 
Table 1.  Plasmids used in this study. 
 
Plasmid Description Reference 
pRS415 CEN, LEU2 Simons et al. (1987) 
pRS316 CEN, URA3 Sikorski and Hieter 
(1989) 
GFP-ALP pRS426 PrCPY::GFP::ALP Cowles et al. (1997) 
pGF35 pRS315 VPS10::GFP::Sp-HIS5 This Study 
pGF244 pRS415 PrSTV1::Anc.a::2xHA::ADH::Nat
R This Study 
pGF245 pRS415 PrVPH1::Anc.a::2xHA::ADH::Nat
R This Study 
pGF243 pRS415 PrSTV1::Anc.a::2xHA::GFP::ADH::HYG
R This Study 
pGF246 pRS415 PrVPH1::Anc.a::2xHA::GFP::ADH::HYG
R This Study 
pGF342 pRS316 PrVPH1::Anc.a::2xHA::ADH::Nat
R
 R737Q This Study 
pGF341 pRS316 PrVPH1::Anc.a::2xHA::ADH::Nat
R
 R737A This Study 
pGF242 pRS316 PrVPH1::mCherry::ALP::ADH::Nat
R This Study 
 
 Yeast strains can be found in Table 2.  Yeast strains GFY270 and GFY271 were 
created by first switching the drug resistance cassette of vph1!::KanR (LGY120) to either 
vph1!::Hyg
R or vph1!::NatR.  The HygR or NatR cassettes were amplified by PCR, 
transformed into LGY120, and selected for Hyg or Nat resistance and loss of Kan 
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resistance.  Next, the STV1 locus from KEBY4 (stv1!::KanR) was amplified with 500 
base pairs of flanking, untranslated sequence and transformed into vph1!::HygR or 
vph1!::Nat
R to create GFY270 and GFY271, respectively.  To construct GFY251, the 
Anc.a gene was integrated into the genome at the STV1 locus; the parent yeast strain was 
GFY270.  The Anc.a gene (including the double HA tag) was amplified from pGF244 
including the full promoter of STV1 and the ADH::NatR cassette.  Following treatment 
with the restriction enzyme DpnI, the PCR product was transformed into vph1!::HygR 
stv1!::Kan
R yeast, selected for Nat resistance, and the loss of Kan resistance.  The drug 
resistance cassettes all contain 239 base pairs of the same downstream terminator 
allowing for homologous recombination.  Yeast strains GFY250, GFY253, GFY255, and 
GFY256 were all created using a similar method.  The vma21!::KanR deletion cassette 
was PCR amplified from pLG139 and transformed into GFY256 to generate GFY300.  
GFY308 was constructed by first tagging VPH1::2xHA (pSKN12; Kawasaki-Nishi et al., 
2001) with a GFP::ADH::HygR cassette using in vivo ligation to create pGF336.  The 
VPH1 promoter, coding sequence and GFP::HygR cassette were amplified and 
transformed into vph1!::KanR yeast (LGY120) as previously described to create 
GFY308.  For GFY310, STV1 (from pJG2) was tagged with GFP::ADH::NatR (amplified 
from pGF02) using in vivo ligation.  STV1::GFP::NatR was then integrated into 
stv1!::Kan
R yeast (KEBY4).  For GFY307, VPH1::GFP::HygR was amplified without 
any promoter sequence from pGF336 and in vivo ligated downstream of the STV1 
promoter to create pGF332.  Finally, the VPH1 locus including the GFP tag and drug 
cassette were amplified and integrated at the STV1 locus in LGY120 yeast.  For 
construction of GFY314, the sequence of mDsRed was amplified from pERGmDsRed 
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(Binns et al., 2006), propagated into TOPO, subcloned to pRS316, and tagged with 
ADH::Nat
R.  A PCR fragment of mDsRed::ADH::NatR was then generated with a 
forward primer containing homology to the coding region of Anc.a and the product was 
transformed into GFY255 to exchange the GFP tag for mDsRed.  For GFY315-317, the 
drug marker in GFY310 was first switched to KanR.  Next, VPH1 was deleted with the 
Hyg
R
 cassette (using genomic DNA from GFY270).  Finally, VPH1::2xHA::ADH::NatR 
(from pGF339), STV1::2xH::ADH::NatR (from pGF337), and Anc.a::2xHA::ADH::NatR 
(from pGF245) were PCR amplified and integrated at the VPH1 locus to create GFY315, 
GFY316, and GFY317, respectively.  Strains were confirmed by diagnostic PCR, 
Western blots (when applicable), and growth tests.  
 Culture conditions:  Yeast were cultured in YEPD (1% yeast extract, 2% 
peptone, and 2% dextrose), YEPD pH 5.0 buffered using 50 mM succinate/phosphate 
plus 0.01% adenine, or synthetic drop-out media containing dextrose (SD) and 
supplemented with amino acids.  Growth assays were performed by spotting 3-5 !L of 
exponentially growing cells onto agar media.  Five-fold serial dilutions were used; the 
first spot corresponds to an OD600 of approximately 0.8-1.0.  For growth tests on media 
containing bathophenanthrolinedisulfonic acid (BPS; Sigma-Aldrich, USA), cells were 
grown overnight to saturation in YEPD pH 5.0 plus 25 !M BPS.  Cultures were back-
diluted to an OD600 of 0.25-0.30 in YEPD pH 5.0 plus 100 !M BPS for 6 hours before 
being spotted (2-3 !L) onto agar media.  Conditions used include YEPD pH 5.0, YEPD + 
100 mM Ca2+, YEPD + 3.5 mM Zn2+, and YEPD + 95 !M BPS.  Plates were incubated 
at 30˚C for 2-5 days. 
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Table 2.  Yeast strains used in this study. 
 
Strain Description Reference 
SF838-
1D! 
MAT! ura3-52 leu2-3,112 his4-519 ade6 pep4-3 
gal2 
Rothman and 
Stevens (1986) 
KEBY4 SF838-1D! stv1"::KanR 
Kawasaki-Nishi et 
al. (2001a) 
LGY120 SF838-1D! vph1"::KanR 
Davis-Kaplan et al. 
(2006) 
GFY270 SF838-1D! vph1"::HygR stv1"::KanR This study 
GFY271 SF838-1D! vph1"::NatR stv1"::KanR This study 
GFY251 
SF838-1D! vph1"::HygR 
PrSTV1::Anc.a::2xHA::ADH::Nat
R This study 
GFY250 
SF838-1D! PrVPH1::Anc.a::2xHA::ADH::Nat
R
 
stv1"::Kan
R This study 
GFY253 
SF838-1D! vph1"::NatR 
PrSTV1::Anc.a::2xHA::GFP::ADH::Hyg
R This study 
GFY255 
SF838-1D! 
PrVPH1::Anc.a::2xHA::GFP::ADH::Hyg
R
 
stv1"::Kan
R This study 
GFY308 SF838-1D! VPH1::2xHA::GFP::ADH::HygR This study 
GFY310 SF838-1D! STV1::GFP::ADH::NatR This study 
GFY310 SF838-1D! STV1::GFP::ADH::NatR This study 
GFY307 SF838-1D! PrSTV1::VPH1::GFP::ADH::Hyg
R This study 
GFY314 
SF838-1D! stv1"::KanR 
PrVPH1::Anc.a::2xHA::mDsRed::ADH::Nat
R This study 
GFY315 
SF838-1D! STV1::GFP::KanR 
VPH1::2xHA::ADH::Nat
R This study 
GFY316 
SF838-1D! STV1::GFP::KanR 
PrVPH1::STV1::2xHA::ADH::Nat
R This study 
GFY317 
SF838-1D! STV1::GFP::KanR 
PrVPH1::Anc.a::2xHA::ADH::Nat
R This study 
GFY256 
SF838-1D! 
PrVPH1::Anc.a::2xHA::GFP::ADH::Hyg
R
  This study 
GFY300 
SF838-1D! 
PrVPH1::Anc.a::2xHA::GFP::ADH::Hyg
R
 
vma21"::Kan
R This study 
 
 Whole cell extract preparation and immunoblotting:  Extracts from yeast cells 
were harvested as previously described (Ryan et al., 2008).  Briefly, cultures were growth 
to saturation overnight in rich media, diluted to an OD600 of 0.25, and grown for an 
additional 4-6 hours to an optical density of 1.0.  Cells from 10 mL of this culture were 
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harvested, resuspended into Thorner buffer (8M urea, 5% SDS, and 50 mM TRIS pH 
6.8), and vortexed with glass beads for 8-10 minutes.  A modified Lowry assay was used 
to determine the amount of protein within each extract (Markwell et al., 1978).  Equal 
loads of protein were probed by SDS-PAGE, moved to nitrocellulose, and incubated with 
antibodies.  Antibodies included monoclonal anti-HA (Sigma-Aldrich), anti-Vma2p 
(13D11B2; Molecular Probes, Inc.), anti-Dpm1p (5C5; Invitrogen), and secondary 
horseradish peroxidase-conjugated anti-mouse antibody (Jackson ImmunoResearch 
Laboratories, West Grove, PA).  Western blots were visualized using ECL detection. 
 Fluorescence microscopy:  Cells were stained with quinacrine as previously 
described (Flannery et al., 2004).  Briefly, cells were grown overnight in YEPD pH 5.0 + 
adenine and then back-diluted to an OD600 of 0.25 in YEPD (unbuffered) for 4-6 hours.  1 
mL of exponentially growing yeast was harvested, incubated on ice for 5 minutes, and 
resuspended in 200 !M quinacrine, 100 mM HEPES pH 7.6, and 50 !g/mL of 
concanavalin A tetramethylrhodamine (Invitrogen) in YEPD for 10 minutes at 30˚C.  
Cells were washed 3-4 times in 100 mM HEPES plus 2% glucose (on ice) and then 
visualized by fluorescent microscopy within 30 minutes of quinacrine treatment.   
 For visualization of fluorescently-tagged proteins (GFP, mcherry, mDsRed), 
strains were grown overnight in the appropriate media (minimal media if containing a 
vector) and then back-diluted to an OD600 of 0.25 in rich media at pH 5.0.  Exponentially 
growing cells were harvested by centrifugation, washed once with water, and visualized 
by fluorescent and DIC microscopy.   
 For yeast treated with cycloheximide, cultures were grown overnight in rich 
media, back-diluted to an OD600 of 0.25, and grown at 30˚C for 4 hours to a density of 
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approximately 0.7-0.8.  10 mL of samples were treated with 20 !g/mL cycloheximide 
(Sigma-Aldrich, USA) or 0.02% DMSO (mock treatments) and incubated at 30˚C for 0-2 
hours.  At specific time points, 1 mL of cells was centrifuged, washed with water, and 
visualized on the microscope.  Cycloheximide-treated cells were quantified by scoring 
the subcellular localization for 150-400 cells for control strains (Vph1p-GFP, Vph1p-
GFP under control of the STV1 promoter, Stv1p-GFP, GFP-ALP, or Vps10p-GFP) and 
400-600 cells for experimental strains (Anc.a-GFP under control of either the VPH1 or 
STV1 promoter).  Experiments were performed in triplicate.  Error is expressed as the 
standard deviation. 
 All images were taken using a 100x objective on an Axioplan 2 fluorescence 
microscope (Carl Zeiss, Thornwood, NY) and analyzed using Axiovision software (Car 
Zeiss) and Adobe Photoshop CS (v. 8.0). 
 
3. Results 
 Anc.a functions in extant S. cerevisiae as part of a hybrid V-ATPase complex:  
It is likely the two subunit a isoforms in yeast (Vph1p and Stv1p; Figure 1, Chapter II) 
evolved from a gene duplication event within the fungal clade (Figure 1).  We tested the 
function of most recent common ancestor of Vph1p and Stv1p (referred to as “Anc.a”) in 
extant S. cerevisiae.  The sequence of this ancient protein was determined by calculating 
the maximum likelihood sequence from the phylogeny of a large set of subunit a isoforms 
from modern species (Supplemental Table S1, see Appendix B).  Anc.a shares a high 
degree of sequence identity to the C-termini of both Stv1p and Vph1p (Figure 2A).  
However, Anc.a is only 38% and 53% identical to the N-termini of Stv1p and Vph1p, 
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respectively (Figure 2A).  Secondary structure predictions of the N-terminal, cytosolic 
domains of Vph1p, Stv1p, and Anc.a revealed a very similar overall structure of the three 
proteins (Figure 2B).  
 
Figure 1.  The maximum likelihood phylogeny of fungal V-ATPase subunit a.  The tree 
was rooted using subunit a sequences from D. discoideum (Amoebozoa) and A. thaliana 
(Plantae) as outgroups.  The position of the reconstructed fungal ancestral subunit a 
protein is labeled as “Anc.a.”  Extant taxa marked with « indicate predicted subunit a 
sequences according to GenBank annotations, whereas all other sequences have been 
functionally assayed.  Branch support values are approximate-likelihood ratio test values 
based on a Shimodaira-Hasegawa-like procedure.  Statistical support for the Anc.a 
sequence can be found in Supplemental Figure S1 (see Appendix B). 
 
! 58!
 
Figure 2.  Alignment of S. cerevisiae Stv1p, Vph1p, and Anc.a amino acid sequences. 
(A) Identical residues between all three proteins are shown against a black background.  
Residues identical between only Vph1p and Anc.a are shown against a magenta 
background.  Residues identical between Stv1p and Anc.a are shown against a green 
background.  The alignment was performed using the CLUSTALW program (Thompson 
et al., 1994).  Potential transmembrane domains are marked with black bars above the 
alignment (modeled from Wang et al., 2008).  The critical arginine residues (Stv1p R795, 
Vph1p R735, and Anc.a R737) are marked against a yellow background.  The position of 
the double HA epitope tag is indicated by a triangle (beginning after residue 171 for 
Vph1p, 227 for Stv1p, and 185 for Anc.a).  (B) Secondary structure prediction of the N-
termini of Stv1p, Vph1p, and Anc.a by the PSIPRED program (University College 
London). !-helices are shown as cylinders, ß-sheets are shown as black arrows, and 
coiled-coil regions are shown as black lines.  The breaks in the lines represent short 
insertions that have no predicted structure.   
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 Since the expression level of the ancestral subunit a is unknown, we chose to test 
the expression of an integrated copy of Anc.a under control of either the STV1 or VPH1 
promoter; the coding region of Anc.a replaced the entire coding region of either yeast 
gene.  We assayed the ancestral isoform in yeast lacking both contemporary Vph1p and 
Stv1p on media buffered with either excess calcium or zinc (Figure 3A).  Yeast deleted 
for both isoforms do not acidify their vacuoles and are unable to survive on media 
containing excess metals (Manolson et al., 1994).  Cells deleted for STV1 (stv1!) are not 
sensitive to either calcium or zinc as they still contain a functioning vacuolar isoform.  
However, yeast lacking VPH1 (vph1!) grow in the presence of 100 mM Ca2+ but cannot 
survive on media containing 3.5 mM Zn2+.  Resistance to calcium depends on proton 
antiporters present on both the vacuole and Golgi apparatus; cells containing an acidified 
Golgi/endosome are therefore able to survive on excess calcium (Rudolph et al., 1989; 
Miseta et al., 1999).  Resistance to zinc depends on the presence of proton/zinc 
antiporters present on the vacuolar membrane (MacDiarmid et al., 2000).  Expression of 
Anc.a under control of either promoter that replaced the endogenous integrated copy of 
either STV1 or VPH1 was sufficient to promote growth on toxic levels of calcium or zinc 
(Figure 3A).  Western blots to the HA epitope tag revealed the difference in steady-state 
levels of Anc.a under control of either the STV1 or VPH1 promoters; strains differed in 
levels of Anc.a protein by approximately 20-fold (Figure 3B).  The levels of the V1 
subunit Vma2p did not change in either of these strains.  These results indicate that Anc.a 
allows for V-ATPase function on the yeast vacuole. 
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Figure 3.  Ancestral subunit a complements a loss of both VPH1 and STV1.  (A) 
Exponentially growing cultures of wild-type (WT; SF838-1D!), vph1! stv1! (GFY271), 
stv1! (KEBY4), vph1! (LGY120), vph1! PrSTV1-Anc.a (GFY251), and PrVPH1-Anc.a 
stv1! (GFY250) were spotted onto rich media and media containing either 100 mM 
calcium or 3.5 mM zinc.  (B) Western blot analysis of strains (vph1! stv1!) expressing 
epitope-tagged Anc.a protein (GFY250 and GFY251).  Samples were separated by SDS-
PAGE, transferred to nitrocellulose, and probed with antibodies to the HA epitope tag 
and V1 subunit, Vma2p.  Antibodies to Dpm1p served as a loading control.  The position 
of the closest molecular marker is indicated.  (C) Yeast deleted for VPH1 and STV1 
(GFY271) were transformed with vectors expressing Anc.a (pGF245), Anc.a R737Q 
(pGF342), or Anc.a R737A (pGF341) and tested on media containing calcium and zinc 
as described in Part A.  Vectors used were under control of the VPH1 promoter. 
 
 Our ancestral reconstruction included 134 residues that were poorly supported by 
our maximum likelihood phylogenetic algorithm (with posterior probability < 0.8) and 
had plausible secondary alternate states (with posterior probability > 0.2).  Posterior 
probability (PP) is a measure of the confidence of each ancestral state expressed as a 
probability (Hanson-Smith et al., 2010).  Given the statistical support for alternative 
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amino acids within the Anc.a sequence, we sampled 50 independent, single amino acid 
substitutions to Anc.a; sites were chosen randomly across the entire protein sequence.  
Point mutations were introduced into the protein sequence of Anc.a and each alternative 
state was tested in vph1! stv1! yeast by growth assays on calcium and zinc.  We 
determined that our reconstruction was robust to uncertainty as all changes to Anc.a still 
allowed for full complementation (Supplemental Table S2, see Appendix B). 
 Previous work has highlighted the importance of the arginine residue at site 735 
in Vph1p and the corresponding arginine at site 795 in Stv1p (Kawasaki-Nishi et al., 
2001c).  This amino acid is essential for proton translocation and it is highly conserved in 
eukaryotic sequences.  Complementation by Anc.a in vph1! stv1! yeast was fully 
dependent on the presence of this critical arginine residue within the C-terminus.  It is 
also strongly supported in our reconstruction with a posterior probability of 1.0.  
Substitution of Vph1p arginine 735 for glutamine (which allows for V0 assembly) or 
alanine (which disrupts V0 assembly) has been shown to completely abolish V-ATPase 
activity (Kawasaki-Nishi et al., 2001c).  When these mutational changes were introduced 
into Anc.a in cells lacking VPH1 and STV1 we observed no complementation on media 
containing either calcium or zinc (Figure 3C) yet Western blots revealed that the Anc.a 
R737Q mutant protein was stable (unpublished results).  This demonstrates that Anc.a 
functions within a hybrid V-ATPase complex and is required for proton translocation. 
 The yeast isoforms of subunit a are subject to degradation upon loss of Vma21p 
or any of the other essential assembly factors (Graham et al., 1998; Hill and Cooper, 
2000).  Stability of the Anc.a protein was also fully dependent on the presence of the 
dedicated V-ATPase assembly factor, Vma21p (Supplemental Figure S2, see Appendix 
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B).  These data demonstrate that assembly of the hybrid ancestral V-ATPase complex 
requires the modern-day yeast assembly machinery. 
 Anc.a functionally replaces yeast Stv1p and Vph1p:  We assayed whether 
expression of Anc.a properly acidified the yeast vacuole by staining with the dye 
quinacrine.  Quinacrine is a weakly basic, fluorescent dye that accumulates within 
acidified compartments.  Staining of vph1! or vph1! stv1! mutants showed that these 
cells do not acidify their vacuoles (Figure 4).   
 
Figure 4.  Expression of Anc.a results in acidification of the yeast vacuole.  Cultures of 
wild-type (WT; SF838-1D!), vph1! stv1! (GFY271), vph1! (LGY120), stv1! 
(KEBY4), vph1! PrSTV1-Anc.a (GFY251), and PrVPH1-Anc.a stv1! (GFY250) were 
stained with quinacrine (green; acidified compartments) and concanavalin A-
tetramethylrhodamine (red; stains the yeast cell wall) and viewed by fluorescent or DIC 
microscopy. 
 
 Yeast lacking the Golgi-isoform, Stv1p properly acidify their vacuoles as they 
contain the vacuolar isoform, Vph1p.  Expression of Anc.a was sufficient to confer wild-
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type levels of acidification in cells lacking both STV1 and VPH1 (Figure 4).  These data 
suggest that the ancestral protein can function in place of the vacuolar isoform. 
 Quinacrine staining is not sensitive enough to visualize Golgi/endosomal 
acidification in yeast.  Also, conventional growth assays (on elevated calcium or zinc) do 
not differentiate between wild-type yeast and yeast lacking STV1, as the vacuolar isoform 
compensates for a loss of the Stv1p-containing complex (Figure 3A).  However, a recent 
report described a phenotypic difference between wild-type yeast and the stv1! mutant 
on media containing the iron chelator, BPS (Jo et al., 2009).  Acidification of the 
Golgi/endosomal network is critical for iron metabolism/homeostasis (Philpott and 
Protchenko, 2008).  We utilized low iron conditions to determine if Anc.a could 
functionally substitute for Stv1p in vivo.  Cells lacking the V-ATPase (vph1! stv1!) were 
fully sensitive to media containing 95 !M BPS (Figure 5).  While yeast lacking Vph1p 
survived under these conditions, cells lacking the Golgi isoform, Stv1p, were fully 
sensitive.  Expression of Anc.a under control of the STV1 promoter was not sufficient to 
promote growth on media buffered with BPS.  However, expression of Anc.a under 
control of the VPH1 promoter conferred growth under these low iron conditions (Figure 
5).  These results demonstrate that Anc.a is also sufficient to substitute for the Golgi 
isoform, Stv1p. 
 Anc.a localizes to both the Golgi/endosome and vacuole in yeast:  Since Anc.a 
could complement the loss of either Stv1p or Vph1p, we assayed the cellular localization 
of the ancestral V-ATPase complex in yeast.  Tagging of subunit a isoforms with GFP at 
the C-terminus did not compromise V-ATPase function (our unpublished results).   
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Figure 5.  Expression of Anc.a complements the low iron growth defect of stv1! yeast.  
Cultures of wild-type (WT; SF838-1D!), vph1! stv1! (GFY271), vph1! (LGY120), 
stv1! (KEBY4), vph1! PrSTV1-Anc.a (GFY251), and PrVPH1-Anc.a stv1! (GFY250) were 
grown to saturation in YEPD pH 5.0 plus 25 "M BPS, back diluted into YEPD pH 5.0 
plus 100 "M BPS, and grown for 6 hours before being spotted onto rich media or media 
containing 95 "M BPS. 
 
 Vph1p-GFP localized to the limiting membrane of the vacuole whereas Stv1p-
GFP localized to punctate structures (Figure 6A).  Stv1p co-localizes with the late-Golgi 
marker, A-ALP, and, to a lesser extent, the endosomal marker, Pep12p (Kawasaki-Nishi 
et al., 2001a).  A-ALP is a reporter protein containing a fusion between the cytosolic 
portion of Ste13p and alkaline phosphatase (Nothwehr et al., 1997).  The majority of 
Stv1p resides within the late Golgi although it has previously been shown to cycle 
through the endosome (Kawasaki-Nishi et al., 2001a).  Overexpression of Stv1p results 
in its missorting to the vacuolar membrane (Manolson et al., 1994).  Since the ancient 
expression level of the ancestral isoform is unknown, we tested whether altering the 
expression level of the contemporary yeast subunit Vph1p would result in a different 
localization pattern.  We tested the localization of Vph1p-GFP under control of the 
weaker STV1 promoter.  Whereas the intensity of the fluorescent signal was greatly 
decreased, we found no difference in the localization of Vph1p-containing V-ATPase 
complex, as it was still present on the vacuolar membrane.  Interestingly, Anc.a localized 
to both punctate stuctures and the vacuolar membrane (Figure 6A).  The localization 
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pattern did not change when Anc.a was expressed under either the STV1 or VPH1 
promoters suggesting that localization is not dependent on expression levels for this 
isoform. 
 
Figure 6.  Anc.a localizes to the vacuole membrane and Golgi/endosomal network.  (A) 
Yeast cultures expressing Vph1p-GFP (GFY308), Stv1p-GFP (GFY310), Vph1p-GFP at 
the STV1 locus (GFY307), vph1! PrSTV1-Anc.a-GFP (GFY253), and PrVPH1-Anc.a-GFP 
stv1! (GFY255) were visualized by fluorescent or DIC microscopy.  White arrows label 
several of the punctate structures seen in strains expressing Anc.a protein.  (B) Cultures 
of PrVPH1-Anc.a-GFP stv1! (GFY255) were transformed with a vector expressing 
mCherry-ALP and visualized by fluorescent microscopy.  The merged image shows the 
overlay of the GFP (green) and mCherry (magenta) channels as a white signal.  Cultures 
of stv1! PrVPH1-Anc.a-mDsRed (GFY314) were transformed with a CEN-based plasmid 
expressing Vps10p-GFP (under control of the VPS10 promoter) and visualized by 
fluorescent microscopy.  The merged image between the mDsRed (magenta) and GFP 
(green) channels presents overlap as a white color.  White arrows indicate the presence of 
several distinct, punctate structures in the merged image. 
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 We next determined the precise cellular compartments that contained the ancestral 
V-ATPase.  Alkaline phosphatase (ALP) served as a marker for the vacuolar membrane.  
ALP traffics to the vacuole using a different route (ALP pathway) than the V-ATPase 
(CPY pathway) (Raymond et al., 1992; Cowles et al., 1997; Piper et al., 1997; Stepp et 
al., 1997).  In Figure 6B we show colocalization of mCherry-tagged ALP with Anc.a-
GFP on the limiting membrane of the vacuole.  Vps10p, the receptor for 
carboxypeptidase Y (CPY), cycles between the late Golgi and endosome and served as a 
marker for the late Golgi (Marcusson et al., 1994; Cooper and Stevens, 1996).  We 
assayed the localization of Anc.a-mDsRed in yeast also expressing Vps10p-GFP (Figure 
6B).  Vps10p-GFP localized to punctate structures as expected and the punctate 
structures containing Anc.a colocalized with Vps10p.  These data demonstrate that the 
Anc.a-containing V-ATPase complex is localized to both the trans-Golgi network as well 
as the vacuolar membrane. 
 The Anc.a V-ATPase complex utilizes slowed anterograde trafficking to the 
vacuole membrane:  We investigated the different trafficking mechanisms that might 
describe the dual localization pattern of Anc.a.  It is possible that Anc.a could be 
retrieved from the endosome back to the Golgi (similar to yeast Stv1p).  Alternatively, 
rather than retrograde transport, Anc.a could utilize slowed anterograde transport en route 
to the vacuole.  Either of these models would account for the steady-state localization of 
Anc.a to both vacuolar and Golgi/endosomal compartments. 
 To differentiate between these models, we treated cells expressing Anc.a-GFP 
with cycloheximide to inhibit protein synthesis yet still allow for continued vesicular 
transport of cargo proteins.  Cargo that is actively retrieved from the endosome to the 
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Golgi should continue to localize to the Golgi/endosome upon treatment with 
cycloheximide.  However, proteins lacking a retrieval signal should be transported to the 
vacuole after protein synthesis is inhibited.  Yeast treated with cycloheximide showed a 
dramatic shift in the localization pattern of Anc.a-GFP (Figure 7A).  While the mock 
treatment displayed dual localization to both the vacuolar membrane and punctate 
structures, cells treated with cycloheximide only showed strong GFP signal on the 
vacuolar membrane.  Control treatments did not show any detectible difference in 
localization pattern.  We also tested to ensure that the shift in localization was not due to 
a decrease in steady-state protein levels of Anc.a-GFP. Western blots demonstrated that 
there was no significant change in Anc.a protein levels during the cycloheximide 
treatment compared with control samples (Figure 7B).  Finally, we quantified the 
localization of Anc.a-GFP compared to a number of other resident Golgi proteins (Stv1p 
and Vps10p) or resident vacuolar proteins (Vph1p and ALP) upon treatment with 
cycloheximide (Figure 7C).  Cells were scored for the presence of the fluorescent 
proteins in punctate structures.  Upon drug treatment, ALP, Vph1p, or Vph1p expressed 
from the STV1 locus did not show any shift in the percentage of cells containing puncta 
(Figure 7C).  Similarly, we did not see any shift in the localization pattern for the late-
Golgi membrane proteins Stv1p and Vps10p.  However, there was a dramatic difference 
in the localization pattern of Anc.a-GFP under either the VPH1 (50% reduction) or STV1 
(61% reduction) promoters.  In addition, the fluorescence intensity of the remaining 
puncta was also decreased (data not shown).  These experiments indicate that the 
trafficking of Anc.a likely involves slow, anterograde transport en route to the vacuole 
and is likely not to involve active retrieval/retention within the Golgi/endosome. 
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Figure 7.  Anc.a localization shifts to the vacuole membrane after treatment with 
cycloheximide.  (A) An exponentially growing culture of PrSTV1-Anc.a-GFP vph1! 
(GFY253) was treated with either 0.02% DMSO (mock) or 20 !g/mL cycloheximide.  
Cells were visualized immediately after treatment and two hours following treatment by 
fluorescent and DIC microscopy.  White arrows indicate the presence of multiple puncta.  
(B) Cultures of PrSTV1-Anc.a-GFP vph1! (GFY253) were treated with DMSO or 
cycloheximide as described in Part A.  Whole cell extracts were prepared at 30-minute 
intervals, separated by SDS-PAGE and probed with anti-HA, Vma2p, and Dpm1p 
antibodies.  (C) Strains containing the following GFP-tagged constructs were treated with 
DMSO or cycloheximide: Vph1p-GFP (GFY308), Stv1p-GFP (GFY310), Vph1p-GFP at 
the STV1 locus (GFY307), wild-type yeast expressing GFP-ALP, or Vps10p-GFP 
(pGF35), vph1! PrSTV1-Anc.a-GFP (GFY253), and PrVPH1-Anc.a-GFP stv1! (GFY255).  
The percentage of cells showing punctate fluorescent staining was quantified.  Between 
150-400 cells were counted for each control strain and the 400-600 cells were counted for 
stains containing Anc.a.  Experiments were performed in triplicate and the error is 
expressed as the standard deviation. 
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 Finally, since Anc.a also localizes to the Golgi/endosomal network, we tested 
whether Anc.a would utilize the same sorting machinery as the Stv1p isoform.  The 
retrieval machinery that sorts the Stv1p-containing V-ATPase is saturable; 
overexpression of Stv1p results in its mislocalization to the yeast vacuole (Manolson et 
al., 1994).  Therefore, we tested whether expression of Anc.a would saturate the Stv1p-
sorting machinery and cause endogenous levels of Stv1p to be missorted to the vacuolar 
membrane.  Stv1p-GFP localized to punctate structures when VPH1 was also present 
(Figure 8, row 1).  When VPH1 was replaced with an untagged copy of STV1 (resulting 
in overexpression of Stv1p), the endogenous copy of Stv1p-GFP was mislocalized to the 
vacuole (Figure 8, row 2).  Finally, high-level expression of Anc.a did not cause a shift in 
the localization of endogenous Stv1p-GFP (Figure 8, row 3).  These data imply that 
trafficking of Anc.a does not utilize the same sorting machinery as the Stv1p isoform. 
 
Figure 8:  Anc.a does not perturb Stv1p sorting in budding yeast.  Strains expressing 
Stv1p-GFP that contained either VPH1 (GFY315), STV1, (GFY316), or Anc.a (GFY317) 
integrated at the VPH1 locus were visualized by fluorescent and DIC microscopy. 
 
4. Discussion  
 Like other large, multiprotein complexes, the V-ATPase enzyme has undergone 
radical architectural changes through evolutionary time while maintaining a conserved 
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enzymatic function.  The high degree of homology between specific V-ATPase subunit 
pairs such as V1 subunits A and B, V0 subunit a isoforms, and V0 proteolipid ring 
subunits c, c’, and c” across all eukaryotes suggest that gene duplication events have 
played a significant role in the increasing complexity of this multiprotein enzyme (Müller 
and Grüber, 2003; Cross and Müller, 2004).  Within the V0 subdomain, subunit a is 
unique within budding yeast because it is the only complex-specific subunit isoform of 
the V-ATPase.  Within S. cerevisiae, Stv1p and Vph1p are solely responsible for the 
phenotypic differences seen between the two isoforms of the V-ATPase.  One of the most 
dramatic differences can be seen in the distinct subcellular localizations of Stv1p-
complex (Golgi/endosome) and Vph1p-complex (vacuole). 
 We sought to describe the evolutionary origins of the Stv1p and Vph1p isoforms 
in budding yeast using ancestral gene reconstruction.  Previous work has been 
unsuccessful at characterizing other V-ATPase subunit a isoforms from various 
eukaryotes within budding yeast (Aviezer-Hagai et al., 2000; unpublished results).  This 
type of horizontal approach fails to provide the specific genetic background for 
mutational changes that have accumulated within extant nodes along different 
evolutionary trajectories.  Ancestral reconstruction incorporates mutational information 
from modern sequences to infer the most probable ancestral state of a gene.   
 Several evolutionary models of gene duplication events followed by 
subfunctionalization might describe the phenotypes of contemporary subunits Stv1p and 
Vph1p (Innan and Kondrashov, 2010).  For instance, it is possible that the ancestral 
subunit a was exclusively localized to either the vacuole or the Golgi apparatus and that 
the derived function of the duplicated subunit was to occupy a second compartment.  Our 
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in vivo analysis of Anc.a in S. cerevisiase suggest that the pre-duplicated subunit a 
functioned on both the Golgi/endosomal and vacuolar compartments.  Surprisingly, 
extant yeast are able to properly assemble the ancestral subunit as part of a hybrid V-
ATPase complex.  Furthermore, yeast allow for efficient transport of the V-ATPase and 
in vivo acidification despite differences in the primary amino acid sequence between 
Anc.a, Stv1p, and Vph1p.  These results highlight the conservation of overall structural 
identity of subunit a, which makes contacts with a number of both V0 and V1 subunits 
and interacts with various assembly factors in yeast (Landolt-Marticorena et al., 2000; 
Wilkens et al., 2004; Zhang et al., 2008; Qi and Forgac, 2008; Ediger et al., 2009).  This 
is also evident when examining the support values for the Anc.a reconstruction; despite 
23.9% of all sites having less than 80% posterior probability, our reconstruction resulted 
in a high degree of complementation and function in vivo. 
 Interestingly, trafficking of the Anc.a-containing V-ATPase does not utilize the 
extant, Stv1p-sorting machinery.  Therefore, rather than being specifically targeted for 
retrieval from the endosome back to the trans-Golgi, Anc.a is likely being slowed en 
route to the vacuole through these compartments.  Also, contemporary yeast contain the 
necessary machinery required to cause slowed anterograde trafficking of Anc.a.  Many of 
the components of vesicular trafficking pathways (including the TRAPP, COG, ESCRT, 
and GARP complexes) are highly conserved among eukaryotes including humans (Field 
and Dacks, 2009; Bonifacino and Hierro, 2010; Reynders et al., 2010; Barrowman et al., 
2010).  We have described a unique mechanism for localization of the hybrid Anc.a-
containing V-ATPase enzyme in budding yeast to two different cellular compartments. 
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 Given the localization of Anc.a in yeast as well as previous insights into the 
biochemical differences between the contemporary yeast subunits, we propose a model of 
subfunctionalization for subunit a following the gene duplication event that took place 
within the fungal lineage.  A number of other factors have contributed to the evolution of 
Stv1p and Vph1p that have allowed for the shift in V-ATPase localization.  A common 
evolutionary trend following subfunctionalization is the difference in gene expression of 
the two duplicated genes (Force et al., 1999).  Differences in the relative levels of 
transcript and/or differential regulation can lead to alterations in spatial and temporal 
control of the two genes following the duplication event.  In the case of Stv1p and 
Vph1p, previous work has determined the difference in mRNA transcripts (5 fold) 
between the two genes (Manolson et al., 1994).  However, this is not sufficient to 
completely explain the difference in steady-state levels between yeast Stv1p and Vph1p 
(Vph1p ~20 fold higher).  One possibility includes differences in V0 assembly between 
the two isoforms.  Upon a loss of Vph1p, there is a reproducible increase in the levels of 
Stv1p protein (Perzov et al., 2002; data not shown).  Additionally, preliminary results 
have shown that there is a difference in the steady-state levels between Anc.a and Stv1p 
protein when under the control of the STV1 promoter; Anc.a shows a higher protein level 
(unpublished results).  This suggests a possible reduction in assembly for the Stv1p 
isoform following the duplication event from Anc.a.  Since our results demonstrate that 
Anc.a functions on the vacuole, it is possible that the expression of Anc.a was similar to 
modern VPH1.  Therefore, a reduction in the levels of Stv1p protein had to accompany a 
shift in the localization of the evolving Stv1p isoform to the Golgi/endosome because the 
modern Stv1p-sorting machinery is saturable (Manolson et al., 1994).   
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 It is unknown why the two post-duplication gene products were maintained in 
budding yeast while other fungi contain only a single subunit a isoform.  However, work 
on other eukaryotes has provided insight into the importance of V-ATPase specialization 
using subunit a.  This involves both the localization of this critical enzyme to specific 
subcellular compartments (including the plasma membrane) and a variety of additional 
functional roles for subunit a including membrane fusion, pH sensing, development, and 
V-ATPase regulation (Adams et al., 2006; Marshansky, 2007; Baars et al., 2007; Forgac, 
2007).  There may have been a selective fitness advantage to evolving a dedicated 
Golgi/endosomal isoform of the V-ATPase in budding yeast.  The importance of iron 
uptake and metabolism under varying environmental conditions is evident in almost 
every organism (Philpott and Protchenko, 2008).  Yeast may have evolved the Stv1p 
isoform to specifically acidify the Golgi and endosomal compartments to allow for 
essential processes including iron homeostasis that utilize an acidified endosomal 
network. 
 The process of ancestral gene reconstruction has been a powerful tool providing 
insight into the evolution of enzyme-substrate specificity and the directionality of 
evolutionary change (Ortlund et al., 2007; Dean and Thornton, 2007; Bridgham et al., 
2009).  Anc.a serves as a useful platform to perform future structural and mutational 
analyses to address questions regarding other biochemical differences between Stv1p and 
Vph1p including assembly, coupling efficiency, and in vivo dissociation.  Further 
experiments will also characterize the evolutionary trajectory of the Stv1p-dependent 
sorting signal(s).  Preliminary analyses have found that residues necessary for Stv1p 
trafficking are not found within the Anc.a N-terminus (Cronan and Stevens, unpublished 
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results).  Anc.a also provides a scenario where it is the sole V-ATPase isoform, similar to 
other fungal species such as N. crassa and S. pombe.  Additional experimentation will 
provide insight into how organisms with a single isoform are able to efficiently traffic the 
V-ATPase to multiple cellular compartments.  Anc.a has provided a model for the 
evolutionary origins of the two yeast isoforms.  Future ancestral reconstructions will 
allow for a more complete understanding of the molecular mechanisms responsible for 
the diverse set of V-ATPase isoforms seen in many eukaryotes. 
 
 The use of ancestral reconstruction has been a powerful tool allowing for an 
evolutionary analysis of the two yeast V-ATPase isoforms.  This type of work will allow 
for a plethora of additional experiments that utilize a historical perspective to classical 
molecular techniques.  Future studies could aid in characterizing the regulation, coupling 
efficiency, and trafficking signal(s) within subunit a in yeast or other organisms.  
Additionally, other subunits of the V-ATPase might be interesting candidates for 
ancestral reconstructions.  One obvious and intriguing target is the protolipid ring of the 
V0 subdomain. 
 The mechanism of the proteolipid ring is highly conserved across all lineages 
within both the V-type ATPase enzymes as well as the distantly related F-type and A-
type ATPase complexes.  However, given the restrictions on the overall enzymatic 
function of this subdomain, there is great diversity in the number, composition, and 
stoichiometry of the subunits that make up the proteolipid ring across the three domains 
of life.  We chose to explore evolutionary questions regarding the origins of the three-
subunit ring found in fungi with respect to the two proteolipid system used in metazoans.  
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This work uses the V-ATPase as a model protein complex to examine how increasing 
protein complexity might arise while conserving overall enzyme function. While the data 
presented in Chapter III examines a fungal-specific duplication event, we chose to 
characterize ancestral subunits that existed at the split between fungi and metazoans. 
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CHAPTER IV 
THE EVOLUTION OF MULTI-PARALOG PROTEIN COMPLEXITY IN THE 
VACUOLAR H+-ATPASE V0 PROTEOLIPID RING 
 This work was done in collaboration with several co-authors.  G. C. Finnigan, T. 
H. Stevens, and V. Hanson-Smith conceived the experiments.  V. Hanson-Smith 
performed the phylogenetic analysis and statistical ancestral reconstructions.  G. C. 
Finnigan performed all functional experiments.  G. C. Finnigan, T. H. Stevens, V. 
Hanson-Smith, and J. W. Thornton interpreted the results, wrote, and edited the 
manuscript.  V. Hanson-Smith is affiliated with the Center for Ecology and Evolutionary 
Biology and Department of Computer Science at the University of Oregon (Eugene, OR, 
97403).  J. W. Thornton is affiliated with the Center for Ecology and Evolutionary 
Biology at the University of Oregon (Eugene, OR, 97403) and the Howard Hughes 
Medical Institute.  G. C. Finnigan and T. H. Stevens are affiliated with the Institute of 
Molecular Biology at the University of Oregon (Eugene, OR, 97403). 
 
1. Introduction  
 A central challenge of evolutionary biology is to understand the relationship 
between genotypes and physiological phenotypes.  A growing body of investigation has 
articulated precise molecular and evolutionary mechanisms for several cases in which 
gene duplications followed by amino acid substitutions gave rise to contemporary 
phenotypic diversity1-6.  However, there is a relative paucity of evidence demonstrating 
the molecular mechanisms of the converse situation, in which duplicated genes were 
conserved without significantly changing their concomitant phenotype from its pre-
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duplicated---ancestral---state.  The V-ATPase illustrates this puzzle.  The V-ATPase is a 
multi-subunit protein complex that acidifies cellular organelles by coupling ATP 
hydrolysis with proton translocation across membranes; this enzymatic function is 
required for intracellular protein trafficking, coupled transport of small molecules, and 
receptor-mediated endocytosis3.  The V-ATPase V0 subdomain contains a hexameric 
proteolipid ring that functions through a rotary mechanism7,8 (Figure 1, see Chapter I).  
Although the V-ATPase is found in species across the Eukaryote domain, the V0 
proteolipid ring varies in subunit composition among lineages: Fungi use three different 
proteolipid subunits (designated c, c’, and c”) whereas other Eukaryotes---including 
metazoans---use only two subunits3 (c and c”) (Figure 1).  Contemporary yeast build 
proteolipid rings using one copy of c”, one c’, and multiple copies of c9.  Although all 
three subunits are required for the V-ATPase to function in Fungi, the evolutionary 
processes and underlying molecular mechanisms that led to a fungal preservation of 
duplicated subunit c’ are unknown99-11.  Understanding the evolutionary history of the V-
ATPase is of biomedical importance: V-ATPase been implicated in human osteopetrosis, 
multidrug resistance in squamous cell carcinoma, and virulence strategies in Legionella 
pneumophila
12-14.  
 In order to determine why the duplicated gene was preserved in Fungi---rather 
than accumulating deleterious mutations and psuedogenizing---we functionally compared 
the pre-duplicated Opisthokont ancestral V-ATPase proteolipid ring with a contemporary 
post-duplication fungal proteolipid ring. 
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Figure 1.  Evolution of the V-ATPase proteolipid ring.  The maximum likelihood 
phylogeny of V-ATPase subunits c, c’, and c”.  Amoebozoa, Apicomplexa, Animals, and 
Choanoflagellates contain subunits c-c’ (typically labelled as just c in most V-ATPase 
literature) and c”, whereas Fungi contain subunits c, c’, and c”.  The positions of the four 
reconstructed ancestral proteins are labeled as Opisthokont Anc.c”, Anc.c-c’, Anc.c, and 
Anc.c’.  A more comprehensive phylogeny with support values for ancestral nodes and 
ancestral state reconstructions is found in Figure 2.  A comparison of ancestral protein 
sequences to extant sequences is found in Figure 3 and Figure 7. 
 
 First, we reconstructed the maximum likelihood phylogeny of all known 
eukaryotic proteolipid subunits c, c’, and c” (Figure 2), and then we resurrected the 
ancestral Anc.c-c’ (the most-recent shared ancestral protein of Opisthokont proteolipid 
subunits c and c’) and Anc.c” (the most-recent-common shared ancestral protein of 
Opishthokont subunit c”) (Figure 3).  We assayed the function of the reconstructed 
ancestral proteins in vivo using extant yeast S. cerevisiae. 
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Figure 2.  Maximum likelihood phylogeny of V-ATPase subunits c, c’, and c” protein 
sequences.  Decimals on internal nodes are approximate likelihood ratio support for the 
monophyly of the clade.  The inset bar graphs show support for ancestral reconstructions.  
The locations of Anc.c-c’, Anc.c”, Anc.c, and Anc.c’ are noted. 
 
 
2. Methods summary 
 Protein sequences of the Anc.c-c’ and Anc.c” were inferred using maximum-
likelihood phylogenetics from an alignment of 139 protein sequences of extant c, c’, and 
c” from Amobebozoa, Apicomplexa, Metazoa, Choanoflagellates, and Fungi. 
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Figure 3.  Protein sequence alignment of the S. cerevisiae proteolipids Vma3, Vma11, 
and Vma16 to the Anc.c-c’ and Anc.c” subunits.  Alignments were performed using 
CLUSTAL15.  Potential transmembrane domains are marked with black bars above the 
protein sequences according to SOSUI16.  (A) Identical residues between all three 
proteins are shown against a black background.  Residues identical between only Vma3 
and Anc.c-c’ are shown against a magenta background.  Residues identical between only 
Vma11 and Anc.c-c’ are shown against a green background.  Glutamic acid residues 
critical for V-ATPase enzyme function are highlighted in yellow (Vma3 E137, Vma11 
E145, Anc.c-c’ E139).  A blue arrow indicates the position of Vma3 I21 and Anc.c-c’ 
M22.  A red arrow indicates the position of Vma11 F20 and Anc.c-c’ V15.  (B) Identical 
residues between Vma16 and Anc.c” are shown against a black background.  The critical 
glutamic acid residues (Vma16 E108 and Anc.16 E98) are highlighted in yellow. 
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 Ancestral genes were synthesized, cloned into yeast expression vectors, and tested 
for complementation in various S. cerevisiae mutants.  V-ATPase function was assayed 
by growth tests on media buffered with CaCl2 (as described by previously
17).  Steady-
state levels of Vph1 were determined by Western blotting17.  Quinacrine staining and 
Vph1-GFP fusion constructs were visualized by fluorescent microscopy17. 
 
3. Expanded methods 
 In silico reconstruction of ancestral protein sequences:  We queried GenBank 
for all Eukaryote V-ATPase V0 proteolipid sequences.  Our query returned c, c’, and c” 
protein sequences for twenty-six species in Fungi, and c and c’ sequences for thirty-five 
species in Metazoa, Amoebozoa, and Apicomplexa. We aligned the sequences using 
PRANK v0.08120218,19.  This alignment is best-fit by the Whelan-Goldman matrix 
(WAG) with gamma-distributed rate variation (+G) and proportion of invariant sites (+I), 
according to the Akaike Information Criterion as implemented in PROTTEST20,21.  Using 
WAG+G+I, we used PhyML v3.0 to infer the maximum likelihood (ML) topology, 
branch lengths, and model parameters22.  We optimized the topology using the best result 
from Nearest-Neighbor-Interchange and Subtree Pruning and Regrafting; we optimized 
all other free parameters using the default hill-climbing algorithm in PhyML. 
Phylogenetic support was calculated as the approximate likelihood ratio23.  Our ML 
analysis inferred the Nematoda c and c’ sequences to be basal to the Chromalveolata 
lineages; this result is inconsistent with our expectation that Nematoda are animals24 and 
we therefore excluded Nematoda data from further downstream analysis. 
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 We reconstructed ML ancestral states at each site for all ancestral nodes in our 
ML phylogeny using our own set of Python scripts, called Lazarus, which wraps PAML 
version 4.125.  Lazarus parsimoniously places ancestral gap characters according to 
Fitch’s algorithm26.  We characterized the overall support for Anc.c-c’ and Anc.c” by 
binning the posterior probability of the ML state at each site into 5%-sized bins and then 
counting the proportion of total sites within each bin (Figure 2). 
 Robustness to alignment uncertainty:  In order to assess if our ancestral 
reconstructions are robust to alignment uncertainty, we aligned our proteolipid protein 
sequences using four different alignment algorithms: CLUSTAL version 2.0.1015 
MUSCLE v3.727, AMAP v2.228, and PRANK v0.08120218.  We then inferred the ML 
phylogeny and branch lengths for each alignment, using the methods described above. 
The resultant alignments varied in length from 347 sites (using CLUSTAL) to 683 sites 
(using PRANK), but all four alignments yielded the same ML topology with nearly 
identical ML branch lengths. 
 In order to determine which alignment algorithm yields the most accurate 
ancestral inferences under V-ATPase phylogenetic conditions, we simulated sequences 
across the V-ATPase ML phylogeny using insertion and deletion rates ranging from 0.0 
to 0.1 indels per site. For each indel rate, we generated ten random unique indel-free 
ancestral sequences 400 amino acids in length and then used INdelible29 to simulate the 
ancestral sequence evolving along the branches of our ML phylogeny under the 
conditions of WAG+I+G model with indel events randomly injected according to the 
specified indel rate. The size of each indel event was drawn from a Zipfian distribution 
with coefficient equal to 1.1 and the maximum length limited to 10 amino acids.  We 
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aligned each replicate’s descendant sequences using AMAP, CLUSTAL, MUSCLEs, and 
PRANK; for each alignment, we inferred the ML topology, branch lengths, and model 
parameters using the methods described above.  We used Lazarus to reconstruct all 
ancestral states, and queried Lazarus for the most-recent shared ancestor for Opisthokont 
c/c’ and Opisthokont c” sequences. We measured the error of ancestral reconstructions as 
the proportion of ancestral sites that incorrectly contained an indel character (Figure 4). 
! 
Figure 4.  Ancestral sequence reconstruction (ASR) error as a function of insertion-
deletion rate.  Replicate sequences were simulated on the phylogeny shown in Figure 1B, 
and aligned using four different algorithms (AMAP, Clustal, MUSCLE, and Prank).  We 
reconstructed the most-recent shared ancestors for the Opishtokont c-c’ sequences and 
Opishtokont c” sequences.  Ancestral sequence reconstruction was measured as the 
proportion of sites that incorrectly contained an indel character. 
 
 Plasmids and yeast strains:  Bacterial and yeast manipulations were performed 
using standard laboratory protocols for molecular biology30.  Plasmids used can be found 
in Table 1.  Ancestral sequences (pGF140, pGF139, pGF506, and pGF508) were 
synthesized by GenScript (Piscataway, NJ) with a yeast codon bias.  Triple 
hemagglutinin (HA) epitope tags were included prior to each stop codon.  The Anc.c-c’, 
Anc.c”, Anc.c, and Anc.c’ genes were subcloned to single-copy, CEN-based yeast 
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vectors.  The ADH terminator sequence (247 base pairs) and NatR drug resistance 
marker31 were polymerase chain reaction (PCR) amplified with 40 bp tails homologous to 
the 3' end of each coding region and vector sequence.  Vectors were gapped, co-
transformed into SF838-1D! yeast with PCR fragments, and cells were selected for NatR.  
A second round of in vivo ligation was used to place the ancestral genes under 500 bps of 
the VMA3 or VMA16 promoters to create pGF140 and pGF139, respectively.  pGF141 
was created using in vivo ligation to move VPH1::GFP::HIS3 (from pGF06) to pRS415.  
The following vectors all used a similar cloning strategy:  pGF213, pGF240 - pGF41, 
pGF252 - pGF254, pGF499 - pGF501, pGF503 - pGF508, pGF510, pGF512 - pGF515, 
pGF517 - pGF519, pGF521, pGF523, pGF525, pGF528, pGF529, pGF531, pGF534 - 
pGF537, and pGF542.  Briefly, the relevant locus (VMA21, VMA3, VMA11, Anc.c-c’, 
Anc.c”, or Anc.c) was PCR amplified with 5' and 3' untranslated flanking sequence and 
cloned into pCR4Blunt-TOPO (Invitrogen, Carlsbad, CA).  If necessary, a modified 
Quikchange protocol32 was used to introduce point mutations before the gene was 
subcloned into a yeast vector (pRS316, pRS415, or the high-copy vector, YEp351).  To 
generate pGF502, codon 31 through the stop codon of Anc.c” were amplified with the 
ADH::Nat
R cassette from pGF139, cloned into TOPO, and in vivo ligated downstream of 
the VMA16 promoter (including a start codon) in pRS415. 
 A triple-fragment in vivo ligation was used to generate pGF646 - pGF651.  
Gapped vector containing the VMA16 promoter was transformed into yeast with two PCR 
fragments of the proteolipid genes to be fused.  For pGF646, the coding region of (i) 
VMA16 (without codons 2-41) and (ii) the coding region of Anc.c’ (without codons 2-5) 
were amplified by PCR.   
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Table 1.  Yeast strains and plasmids in this study. 
!
Strain Genotype Reference 
SF838-
1D! MAT! ura3-52 leu2-3,112 his4-519 ade6 pep4-3 gal2 33 
LGY113 SF838-1D!; vma3"::KanR 17 
LGY114 SF838-1D!; vma11"::KanR 17 
LGY115 SF838-1D!; vma16"::KanR 17 
LGY125 SF838-1D!; vma3"::KanR  vma11"::HygR This study 
LGY143 
SF838-1D!; vma3"::KanR  vma11"::HygR 
vma16"::Nat
R This study 
LGY124 SF838-1D!; vma11"::KanR vma16"::NatR This study 
LGY139 SF838-1D!; vma3"::KanR vma16"::NatR This study 
   
Plasmid Description Reference 
pRS415 CEN, LEU2 34 
pRS316 CEN, URA3 35 
pYEP351 2µ, LEU2 36 
pGF06 pRS316 VPH1::GFP::HIS5 17 
pGF141 pRS415 VPH1::GFP::HIS5 This study 
pGF140 pRS316 prVMA3::Anc.c-c’::3xHA::ADH::NatR This study 
pGF139 pRS415 prVMA16::Anc.c”::3xHA::ADH::NatR This study 
pGF252 
pRS316 prVMA3::Anc.c-c’::3xHA::ADH A41C, 
E139Q This study 
pGF253 pRS316 prVMA16::Anc.c”::3xHA::ADH E98Q This study 
pGF254 pRS316 VMA3 This study 
pGF499 pRS316 VMA3 I21A This study 
pGF500 pRS316 VMA11 This study 
pGF501 pRS316 VMA11 F20A This study 
pGF241 pRS316 prVMA3::Anc.c-c’::3xHA::ADH V15F This study 
pGF239 pRS316 prVMA3::Anc.c-c’::3xHA::ADH A41S This study 
pGF240 pRS316 prVMA3::Anc.c-c’::3xHA::ADH A120G This study 
pGF502 
pRS415 prVMA16::Anc.c”(2-
30")::3xHA::ADH::Nat
R This study 
pGF503 pRS316 prVMA16::Anc.c”::3xHA::ADH I58L This study 
pGF504 pRS316 prVMA16::Anc.c”::3xHA::ADH M77I This study 
pGF505 pRS316 prVMA16::Anc.c”::3xHA::ADH K87R This study 
pGF213 pYEP351 VMA21 This study 
pGF506 pRS316 prVMA3::Anc.c::3xHA::ADH::NatR  This study 
pGF507 pRS415 prVMA3::Anc.c::3xHA::ADH::NatR  This study 
pGF508 pRS316 prVMA3::Anc.c’::3xHA::ADH::NatR  This study 
pGF510 pRS316 prVMA3::Anc.c-c’::3xHA::ADH V15A This study 
pGF512 pRS316 prVMA3::Anc.c-c’::3xHA::ADH M22I This study 
pGF513 pRS316 prVMA3::Anc.c-c’::3xHA::ADH S25T This study 
pGF514 pRS316 prVMA3::Anc.c-c’::3xHA::ADH V38I This study 
pGF515 pRS316 prVMA3::Anc.c-c’::3xHA::ADH A42G This study 
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Table 1.  (continued). 
!
Plasmid Description Reference 
pGF517 pRS316 prVMA3::Anc.c-c’::3xHA::ADH V45T This study 
pGF518 pRS316 prVMA3::Anc.c-c’::3xHA::ADH M46L This study 
pGF519 pRS316 prVMA3::Anc.c-c’::3xHA::ADH M46F This study 
pGF521 pRS316 prVMA3::Anc.c-c’::3xHA::ADH I55L This study 
pGF523 pRS316 prVMA3::Anc.c-c’::3xHA::ADH A61S This study 
pGF525 pRS316 prVMA3::Anc.c-c’::3xHA::ADH K79L This study 
pGF528 pRS316 prVMA3::Anc.c-c’::3xHA::ADH Y87F This study 
pGF529 pRS316 prVMA3::Anc.c-c’::3xHA::ADH N88T This study 
pGF531 pRS316 prVMA3::Anc.c-c’::3xHA::ADH H92Q This study 
pGF534 pRS316 prVMA3::Anc.c-c’::3xHA::ADH F108Y This study 
pGF535 pRS316 prVMA3::Anc.c-c’::3xHA::ADH T121Y This study 
pGF536 pRS316 prVMA3::Anc.c-c’::3xHA::ADH A122M This study 
pGF537 pRS316 prVMA3::Anc.c-c’::3xHA::ADH I132V This study 
pGF542 pRS316 prVMA3::Anc.c-c’::3xHA::ADH N159D This study 
pGF646 
pRS415 prVMA16::VMA16(2-41!)::Anc.c’(2-
5!)::3xHA::ADH::Nat
R This study 
pGF647 
pRS415 prVMA16::Anc.c’(162-164!)::VMA16(1-
41!)::3xHA::ADH::Nat
R This study 
pGF648 
pRS415 prVMA16::VMA16(2-41!)::Anc.c-c’(1-
2!)::3xHA::Nat
R
 This study 
pGF649 
pRS415 prVMA16::Anc.c-c’(162!)::VMA16(1-
49!)::3xHA::Nat
R
 This study 
pGF650 
pRS415 prVMA16::VMA16(2-41!)::Anc.c(1-
2!)::3xHA::Nat
R This study 
pGF651 
pRS415 prVMA16::Anc.c(161-162!)::VMA16(1-
49!)::3xHA::Nat
R This study 
  
 The proteolipid on the C-terminal portion of the gene fusion also contained the 
ADH terminator and NatR cassette; the amplified products contained PCR tails with 
homology to link the genes to both the gapped vector and to each other.  Gene fusions 
were modeled after a previous experimental design37 where the lumenal protein sequence 
linking the two proteolipids was designed to be exactly 14 amino acids.  To meet these 
criteria, additional amino acids were inserted in the following vectors linking the two 
subunits:  pGF646 (TRVD), pGF648, pGF650 (TR), pGF649, pGF651 (GS). 
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 Yeast strains used can be found in Table 1.  Strains containing deletion cassettes 
other than Kan31 were constructed by PCR amplifying the HygR or NatR cassette from 
pAG32 or pAG25, respectively, with primer tails with homology to flanking sequences to 
the VMA11 or VMA16 loci.  11!::KanR and 16!::KanR strains (SF838-1D!) were 
transformed with the HygR and NatR PCR fragments, respectively, and selected for drug 
resistance.  The 11!::HygR locus was amplified and transformed into LGY113 (to create 
LGY125) and LGY115 (to create LGY124).  This was repeated with the 16!::NatR locus 
to create LGY139 and LGY143. 
 Yeast growth assays:  Yeast were grown in liquid culture, diluted five-fold, and 
spotted onto YEPD media buffered to pH 5.0 or media containing 25 mM or 30 mM 
CaCl2 (as previously described
17). 
 Whole cell extract preparation and immunoblotting:  Yeast extracts and 
Western blotting were performed as previously described17.  Antibodies used in this study 
included monoclonal primary anti-Vph1 (10D7; Invitrogen), anti-Vma1 (8B1; 
Invitrogen), and anti-Dpm1 (5C5; Invitrogen), and secondary horseradish-conjugated 
anti-mouse antibody (Jackson ImmunoResearch Laboratory, West Grove, PA). 
 Fluorescence microscopy:  Staining with quinacrine was performed as 
previously described17,38,39.  Visualization of GFP-tagged proteins was conducted as 
previously described17.  Microscopy images were obtained using an Axioplan 2 
fluorescence microscope (Carl Zeiss, Thornwood, NY).  A 100x objective was used as 
well as AxioVision software (Carl Zeiss). 
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4. Results 
 The reconstruction ancestor functions as subunit c, c’ or both c and c’ in 
extant budding yeast:  Our reconstructions show that V-ATPase’s function of vacuolar 
acidification was indeed conserved over evolutionary time, despite the Fungi-specific 
conservation of the duplicated proteolipid gene.  In our growth assays, the reconstructed 
Anc.c-c’ functionally substituted for the S.cerevisiae ortholog of subunit c (Vma3), the 
ortholog of subunit c’ (Vma11), and both Vma3 and Vma11 (Figure 5A).  Yeast cells 
lacking Vma3 (designated as 3!) or lacking Vma11 (designated as 11!) were unable to 
grow in the presence of elevated CaCl2 because they lack a functional V-ATPase 
necessary for vacuolar acidification, but they were able to survive on permissive media.  
Expressing Anc.c-c’ in 3! rescued cellular growth; these cells were only partially 
sensitive to CaCl2.  Expressing Anc.c-c’ in 11! also rescued growth, as well as in double-
delete 3!11!.  The reconstructed Anc.c” functionally substituted for S. cerevisiae subunit 
c” (Vma16) (Figure 5B).  Furthermore, co-expression of Anc.c-c’ and Anc.c” permitted 
cell growth in yeast lacking all three proteolipid subunits Vma3, Vma11, and Vma16 
(Figure 5C).  We stained cells with the dye quinacrine and observed that yeast expressing 
Anc.c-c’ and Anc.c” properly acidified the vacuolar lumen---as is expected of a properly 
functioning yeast V-ATPase complex---while cells lacking the V-ATPase failed to show 
any staining (Figure 5D). 
 Previous observations showed that V-ATPase function requires the presence of 
critical glutamic acid residues at specific sites9,40; these residues are strongly supported in 
our reconstructions with 1.0 posterior probability at sites 139 in Anc.c-c’ and 98 in 
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Anc.c”.  Mutating these glutamic acids to glutamines (E139Q and E98Q) destroyed 
ancestral function, thus demonstrating the necessity of E139 and E98 (Figure 6). 
 
Figure 5.  Functional growth assays of ancestral V-ATPase subunits expressed in 
contemporary S. cerevisiae mutants.  Yeast were plated on permissive media (YEPD) and 
media buffered with 25 mM Ca2+. (A) Anc.c-c’ was expressed in yeast lacking Vma3 
(3!), Vma11 (11!), and both Vma3 and Vma11 (3!11!).  Growth was compared with 
wild-type (WT) and 3! yeast.  (B) Anc.c” was expressed in yeast lacking Vma16 (16!) 
and growth was compared to the appropriate controls.  (C) Dual-expression of Anc.c-c’ 
and Anc.c” in 3!11!16! yeast was compared with controls.  (D) Anc.c-c’ in 3! yeast 
and Anc.c” in 16! yeast were stained with quinacrine (green; acidified compartments) 
and concanvalin A-tatramethylrhodamine (red; binds to yeast cell wall) and viewed by 
either fluorescent or DIC microscopy.  Wild-type (WT) and 3! yeast serve as controls.  
Variable levels of quinacrine staining were observed for 3! yeast containing Anc.c-c’. 
 
 The observed functions of Anc.c-c’ and Anc.c” are robust to uncertainty about the 
inferred ancestral sequences; we reconstructed alternate versions of Anc.c-c’ and Anc” 
using secondary amino acid states with support greater than 0.2 posterior probability and 
we observed no qualitative difference in function compared to the ML reconstruction 
(Table 2). 
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Figure 6.  Functional growth assays of Anc.c-c’ and Anc.c” lacking critical glutamic acid 
residues in contemporary S. cerevisiae.  Yeast were plated on permissive media (YEPD) 
and media buffered with 25 mM Ca2+.  (A) A particular allele of Anc.c-c’ (A41C) was 
used to illustrate the dramatic growth difference when the E139Q mutation is introduced.  
Anc.c-c’ A41C, and Anc.c-c’ A41C E139Q, were expressed in yeast lacking Vma3 (3!). 
(B) Anc.c” and Anc.c” E98Q, were expressed in yeast lacking Vma16 (16!) and tested 
under similar conditions. 
 
 Intermediate ancestors Anc.c and Anc.c’ function as subunit c and c’, 
respectively:  We next reconstructed intermediate ancestral protelipid subunits (Figure 
7), and observed that the subunit identities of c and c’ diverged very soon after the Anc.c-
c’ gene duplication event.  Specifically, we reconstructed Anc.c (the most-recent-shared 
ancestor of all Fungi subunit c) and Anc.c’ (the most-recent-shared ancestor of all Fungi 
subunit c’), and tested their function in extant yeast. 
 Anc.c identified as subunit c while Anc.c’ identified as subunit c’ (Figure 8).  
Anc.c’ functioned in place of extant yeast Vma11, and did not function as yeast Vma3 
(Figure 8A).  Anc.c functioned in place of yeast Vma3, and very poorly functioned as 
Vma11 (Figure 8B).  Co-expression of both Anc.c and Anc.c’ in 3! 11! increased the V-
ATPase function as compared to the single ancestral chimeras  (Figure 8C).  Anc.c’ in 
11! yeast and Anc.c in 3! yeast properly acidified the vacuole (Figure 8D).   
! 91!
Table 2.  Robustness to uncertainty for Anc.c-c’ and Anc.c” sequences.  The following 
residues were chosen from Anc.c-c’ and Anc.c” that had a posterior probability of less 
than 80%.  Regions corresponding to lumenal portions of either ancestral proteolipid (as 
predicted by SOSUI, Figure 3) were excluded from this analysis.  The Anc.c” 2-30! 
mutant contained 23 residues that had a posterior probability of less than 80%.  These 
alternate reconstructions were transformed into vma3!, vma11!, and vma3! vma11! 
strains (for Anc.c-c’) and vma16! yeast (for Anc.c”) and tested for growth on rich media 
and media containing 25 mM Ca2+.  Wild-type yeast scored five pluses and any yeast 
strain lacking a proteolipid subunit (3!, 11!, 3!11!, or 16!) all scored zero under these 
conditions. 
 
Proteolipid  Genotype     
      vma3! 
  vma3! vma11! vma11! 
Anc.c-c’  +++ ++ +++ 
Anc.c-c’ V15F  ++ ++++ ++ 
Anc.c-c’ A41S  ++ + ++ 
Anc.c-c’ A120G  ++ +  ++ 
       
  vma16!    
Anc.c”  +++++    
Anc.c” I58L  +++++    
Anc.c” M77I  +++++    
Anc.c” K87R  +++++    
Anc.c” 2-30!  +++++     
 
 Also, the hybrid V-ATPase complexes containing either Anc.c or Anc.c’ properly 
localized to the vacuole membrane (Figure 8E).  The two phylogenetic branches leading 
to Anc.c and Anc.c’ contain 25 and 31 mutations, respectively.  Although it is impractical 
to characterize the function of all 2025 (=1.55x1025) and 2031 (=8.22x1033) possible 
substitution combinations, we can conclude that the substitutions necessary for c and c’ 
subunit identities are included in these sets. 
 Single amino acid substitutions affect the evolutionary trajectory of the c and 
c’ subunits:  We further analyzed the amino acid substitutions leading to Anc.c and 
Anc.c’ and observed that no single substitution completely shifted the identify of Anc.c-
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c’ into either subunit c or c’, but a small subset of substitutions individually affected a 
strong---but not complete---change. 
 
Figure 7.  Protein sequence alignment of Anc.c-c’, Anc.c, Anc.c’ and yeast Vma3 and 
Vma11 subunits using CLUSTAL15.  Potential transmembrane domains are indicated.  A) 
Identical residues between all three proteins are shown against a black background.  
Residues identical between Anc.c’ and S. cerevisiae Vma11 are shown against a green 
background.  B) Identical residues between all three proteins are shown against a black 
background.  Residues identical between Anc.c and yeast Vma3 are highlighted against a 
magenta background. 
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Figure 8.  Functional growth assays of intermediate ancestors Anc.c and Anc.c’.  Yeast 
were plated on permissive media (YEPD) and media buffered with 25 mM or 30 mM 
Ca2+.  (A) Anc.c-c’ and Anc.c’ were expressed in yeast lacking Vma3 (3!) or Vma11 
(11!) and tested with controls; (B) we performed an identical analysis using Anc.c rather 
than Anc.c’.  (C) Anc.c, Anc.c’ or the combination of both Anc.c and Anc.c’ were 
expressed in yeast lacking both Vma3 and Vma11 (3! 11!) and plated with controls.  (D) 
Yeast lacking Vma11 (11!) expressing Anc.c’ and yeast lacking Vma3 (3!) expressing 
Anc.c were stained with quinacrine.  Controls were as described in Figure 2.  (E) Yeast 
deleted for Vma3 expressing Anc.c-c’, 16! yeast expressing Anc.c”, 11! yeast 
expressing Anc.c’, and 3! yeast expressing Anc.c were transformed with a vector 
containing Vph1-GFP.  Controls incuded a wild-type strain and 3! mutant.  Strains were 
treated with the DNA-binding dye Hoechst 33342 (shown as magenta) and viewed by 
fluorescent or DIC microscopy.  Merged images show the localization of Vph1-GFP 
(green) to either the ER perinuclear and cortical membranes (3! and 3! yeast expressing 
Anc.c-c’) or to the limiting membrane of the vacuole (16! expressing Anc.c”, 11! 
expressing Anc.c’, and 3! expressing Anc.c). 
 
 We selected diagnostic residues that are highly conserved in either---but not both-
--of the contemporary Fungi proteolipid subunit c and c’ sequences, and we tested the 
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functional effect of introducing each residue as a single substitution into the sequence of 
Anc.c-c’ (Table 3).     
Table 3.  All single amino acid changes made to Anc.c-c’.  These were tested in yeast 
lacking either Vma3 or Vma11.  Growth was assayed on rich media buffered with 25 mM 
Ca2+.  The predicted identity of each residue (based on the high conservation within 
sampled fungal subunits) is listed.  K79L is predicted to contribute to both yeast Vma3 
and Vma11 identity as it is identical between these extant subunits.  The wild-type strain 
scored five pluses under these conditions.  Yeast lacking either Vma3 or Vma11 (not 
containing any ancestral proteolipid) scored zero.  Residues that were tested were 
restricted to those present within either Anc.c or Anc.c’.  M22I and V15F are noted in 
bold and were chosen for further characterization. 
 
   Predicted Found in 
Proteolipid Genotype 3 and/or 11 Either Anc.c 
 3! 11! “identity” or Anc.c’ 
Anc.c-c’ ++++ ++ N/A N/A 
- 0 0 N/A N/A 
Anc.c ++++++ 0/+ 3 N/A 
Anc.c’ 0 ++++++ 11 N/A 
V15A + +++ 3 Anc.c 
M22I* +++++ + 3 Anc.c 
S25T +++ ++ 3 Anc.c 
M46L +++ ++ 3 Anc.c 
K79L ++++++ ++++ 3 & 11 Anc.c 
N88T ++ + 3 Anc.c 
H92Q ++ ++ 3 Anc.c 
A120G ++ ++ 3 Anc.c 
N159D ++ ++ 3 Anc.c 
V15F* ++ ++++ 11 Anc.c’ 
M16A ++ ++ 11 Anc.c’ 
V38I ++++ ++ 11 Anc.c’ 
A42G +++ ++ 11 Anc.c’ 
V45T ++ ++ 11 Anc.c’ 
M46F ++ ++ 11 Anc.c’ 
I55L +++++ +++ 11 Anc.c’ 
A61S ++++ ++ 11 Anc.c’ 
Y87F ++ ++ 11 Anc.c’ 
F108Y + ++ 11 Anc.c’ 
T121Y ++++ ++ 11 Anc.c’ 
A122M + ++ 11 Anc.c’ 
I132V +++++ ++ 11 Anc.c’ 
 
 Two noteworthy substitutions are Val to Phe at site 15 (V15F), and Met to an Iso 
at site 22 (M22I).  V15F partially shifted ancestral identity towards subunit c’ while 
compromising c identity.  M22I partially shifted identity towards subunit c while partially 
destroying c’ identity (Figure 9).  Interestingly, Phe at site 15 is not necessary in extant 
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yeast subunit c’, and Iso at site 21 is not necessary in extant subunit c (Figure 9 B,F); this 
observation suggests that genetic background and epistasis play crucial roles in protein 
evolution, consistent with previous findings in other protein families41. 
 
Figure 9.  Two single amino acid changes contribute towards subunit c and c’ identity.  
Introduction of V15F in to the Anc.c-c’ increases function in vma11! yeast and Anc.c-c’ 
with M22I increases complementation in vma3! yeast.  (A) Growth tests were performed 
with Anc.c-c’ and Anc.c-c’ V15F in yeast lacking either Vma3 or Vma11.  (B) Growth 
assays of extant yeast Vma11 and Vma11 containing F20A mutation were performed on 
rich media containing 100 mM Ca2+.  (C) Quinacrine staining was performed on vma11! 
yeast expressing Anc.c-c’ V15F.  (D) The localization of Vph1-GFP was assayed by 
fluorescence microscopy in cells expressing Anc.c-c’ V15F.  The nucleus was stained 
with DAPI.  (E through H) We performed an identical analysis of the Anc.c-c’ subunit 
containing the M22I substitution as the V15F mutant. 
 
5. Discussion  
 Our ancestral reconstructions---combined with previous results---support a model 
of subfunctionalization following the gene duplication of Anc.c-c’.  Subfunctionalization 
is strongly suggested by the fact that Anc.c-c’ can function as either subunit c or c’ 
(Figure 5), but Anc.c’ cannot function as c and Anc.c functions very poorly as c’ (Figure 
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8).  Previous observations show the complementarity of these two subunits is conserved 
in contemporary yeast, as extant subunits c and c’ cannot be functionally interchanged9-11.  
Furthermore, previous observations showed that yeast subunits are confined in their ring 
arrangement such that c’ cannot interface with the clockwise side of c”, c cannot interface 
with the counterclockwise side of c”, and c’ cannot interface with itself37.  A synthesis of 
these two ideas---functional complementarity and structural specificity---implies an 
evolutionary model in which Anc.c-c’ subfunctionalized its ability to interface with itself 
and with Anc.c”.  The structural model in Wang et al. (2007 implies the proteolipid ring 
is assembled using three interfaces, which we designate P, Q, and R (Figure 10A,B).   
 In this model, every subunit participates in at least two interfaces: one on its 
clockwise side and another on its counterclockwise side.  Subunit Anc.c”, for example, 
participated in interface Q clockwise and interface R counterclockwise (when viewed 
from the luminal side of the membrane).  We tested this model using the intermediate 
ancestral ring containing Anc.c’ (immediately following the duplication of Anc.c-c’).  
We created two reciprocal gene fusions between yeast subunit c” and Anc.c’---using an 
experimental strategy developed by Wang et al. (2007)---that constrains the ring position 
of Anc.c’ to be either immediately clockwise or counterclockwise to subunit c”.  We 
observed that Anc.c’ only functioned on the counterclockwise side of subunit c”; V-
ATPase was nonfunctional when Anc.c’ is forced to occupy the clockwise side (Figure 
11).   
 The following evolutionary history emerges: immediately after Anc.c-c’ 
duplicated, the two descendant subunits were functionally identical and we presume the 
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proteolipid ring could be formed from many possible combinations of the two 
descendants (i.e., one and four copies, two and three copies, etc.). 
 
Figure 10.  A model of subfunctionalization in the fungal V0 proteolipid ring.  (A) The 
pre-duplicated ring included two subunits: Anc.c-c’ and Anc.c”.  The roman numerals 
indicate putative placement of transmembrane helices (numbered I through V) as 
predicted (Figure 3).  Intersubunit interfaces are labeled P, Q, and R.  (B) After 
duplication of Anc.c-c’ and subfunctionalization, the proteolipid ring included three 
subunits arranged according to a previous model37.  (C) All predicted intersubunit 
interfaces are described in tabular form.  Red Xs indicate lost interfaces. (D) Anc.c-c’ 
participated in interfaces P and R on its I/II side and interfaces P and Q on its III/IV side.  
Participation in R (I/II) was lost along the lineage leading to Anc.c; participation in P 
(I/II) and Q (III/IV) was lost along the lineage leading to Anc.c’.  
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Figure 11.  Translation fusions between contemporary yeast c” and Anc.c’ demonstrate 
the positioning of these two subunits within the V-ATPase proteolipid ring.  (A) Yeast 
deleted for VMA11 and VMA16 (11! 16!) were transformed with vectors containing a 
gene fusion between yeast c” lacking the first transmembrane domain followed by Anc.c’ 
(Sc.c”-Anc.c’) or a gene fusion between Anc.c’ followed by yeast c” lacking the first 
transmembrane domain (Anc.c’-Sc.c”) and tested on permissive media and media 
containing 25 mM Ca2+.  (B) Whole cell extracts were prepared from strains expressing 
either gene fusion construct and probed using anti-HA antibodies or anti-Dpm1 
antibodies (loading control).  Extracts from wild-type yeast served as a negative control.  
(C) Construction of the proteolipid gene fusions followed a similar strategy performed by 
Wang et al. (2007).  The first transmembrane domain of yeast subunit c” was deleted in 
both gene fusions.  Constructs contained a C-terminal, triple HA epitope tag and were 
expressed under control of the yeast VMA16 promoter.  Both constructs are fused using a 
14 amino acid linker region. 
 
 
 This arrangement flexibility was lost over evolutionary time: Anc.c’ lost the 
ability to participate in interface P on its clockwise side, while the ability of Anc.c to 
participate in interface R has been eroded (Figure 10C,D).   
 The pairwise loss of participation in interface R (in Anc.c) and P (in Anc.c’) is 
sufficient to explain the specific arrangement of proteolipid subunits.  The loss of R on 
the clockwise side of Anc.c prevented Anc.c from occupying the 6:00 ring position 
adjacent to Anc.c”, while the loss of P on the clockwise side of Anc.c’ prevented Anc.c’ 
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from occupying any position except at 6:00.  These complementary losses created a 
structural sitution in which both subunits c and c’ are necessary for proteolipid assembly 
and function.  In addition to losing P participation, Anc.c’ also lost the ability to 
participate in Q (on its counterclockwise side).  The most parsimonious hypothesis is that 
Anc.c’ lost Q as a neutral consequence of its forced confinement to the 6:00 ring position.  
A less parsimonious hypothesis is that Q was lost prior to the complementary losses of P 
and R, but this alternative explanation raises the question of why Anc.c’ was conserved 
rather than psuedogenized. 
 The results of our diagnostic single-state mutation experiments are congruent with 
our model of subfunctionalization (Table 3).  Two of the mutations with strongest effect, 
V15F and M22I, occurred within transmembrane domain 1 (TM1) of Anc.c and Anc.c’; 
this is consistent with our hypothesis that loss of participation in interfaces P and R 
primarily resulted from amino acid substitutions to the TM1/TM2 side of the duplicated 
subunits.  However, correlations between functional effect and transmembrane location 
can be meretricious because the precise order of evolutionary appearance and epistatic 
interactions of the single amino acid mutations is unknown. 
 Our results also suggest a strong correlation between the evolution of subunit 
identity and assembly of the V0 complex.  Previous work has shown that assembly 
defects in the V-ATPase V0 subdomain cause the stator subunit Vph1 to be rapidly 
degraded42,43.  However, overexpression of the dedicated V-ATPase assembly factor 
Vma21 is able to suppress particular V0 assembly defects
44.  Consistent with these 
findings, we observed that steady-state levels of Vph1 were reduced in 3! or 11! yeast 
expressing Anc.c-c’, and that overexpression of Vma21 improved the growth of Anc.c-c’ 
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in 3! yeast (Figure 12).  Furthermore, assembly defects were overcome by expression of 
either Anc.c or Anc.c’ in place of Anc.c-c’ (Figure 12).  Lacking a crystal structure of the 
V-ATPase, the precise contribution of the residues present within Anc.c and Anc.c’ will 
require further study.!
 It is also unknown if the incorporation of subunit c’ conferred a fitness advantage 
within Fungi, or if the increased subunit complexity was preserved via neutral processes.  
The subfunctionalization model of duplication-degeneration-complementation suggests 
that multi-subunit complexity can evolve neutrally45.  On the other hand, previous work 
suggests two possible molecular mechanisms by which proteolipid ring complexity could 
confer a fitness advantage.  First, the V-ATPase does not form a passive channel for 
protons when the V1 subdomain is removed
46,47 and hence proteolipid rings with two 
subunits are more efficient than rings with a single subunit.  Extending this logic, a 
compelling hypothesis is that three subunits are more efficient than two.  Second, ring 
asymmetry conferred by additional subunits could have allowed the V-ATPase to more 
efficiently avoid thermodynamic equilibrium (termed “proton slippage”) and continue 
pumping protons under varying environmental conditions48,49. 
 We presume that our subfunctionalization model applies to all fungal V0 
proteolipid rings because the subunit c/c’ gene duplication event took place very early in 
the evolutionary trajectory of Eurkaryotes.  The entire V-ATPase complex has a history 
of repeated gene duplications, and it is possible that other subunits---such as A and B50---
have an evolutionary history involving ancestral subfunctionalization of subunit identity, 
similar to subunits c and c’.   
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Figure 12.  V-ATPase complexes containing ancestral proteolipids display V0 assembly 
defects.  (A) Whole cell extracts were prepared from yeast lacking Vma11 (11!) 
expressing either Anc.c-c’, Anc.c’, Anc.c-c’ V15F, or S. cerevisiae subunit c’ F20A and 
compared to controls.  Equal amounts of protein were loaded, separated by SDS-PAGE, 
transferred to nitrocellulose membrane, and probed with anti-Vph1 and anti-Vma1 
antibodies.  Levels of Vma1 did not change in any of the tested strains.  Dpm1 was used 
as loading control.  The molecular mass (kilodaltons) of the nearest marker is shown on 
the left.  (B) Extracts were also probed by Western blot from strains lacking Vma3 (3!) 
expressing either Anc.c-c’, Anc.c, Anc.c-c’ M22I, or S. cerevisiae subunit c I21A 
including controls and were treated in a similar manner.  (C) Yeast lacking Vma3 and 
containing either Anc.c-c’ or Anc.c-c’ and a high-copy vector overexpressing VMA21 
were plated onto media containing 25 mM Ca2+ with controls strains. 
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 Thinking beyond the V-ATPase, our results empirically demonstrate a general 
evolutionary and molecular process by which physiological phenotypes can be buffered 
against underlying increases in multiprotein complexity. 
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CHAPTER V 
DISCUSSION AND SUMMARY 
1. Genetic screens and the V-ATPase 
 Study of the V-ATPase enzyme complex will allow for a more complete 
understanding of how this critical molecular machine functions in all eukaryotes.  Aside 
from its highly conserved role in organelle acidification, the V-ATPase has been 
implicated in a wide range of other biological processes (FORGAC 2007).  Additionally, 
the recent discoveries of V-ATPase involvement in human diseases (including cancer) 
prompts additional research and makes the V-ATPase enzyme an attractive target for 
drug development (FORGAC 2007).   
 Over the past two decades, genetic screens have played important roles in 
providing critical components and pathways that involve the V-ATPase enzyme (OHYA 
et al. 1991; HO et al. 1993; SAMBADE et al. 2005).  However, recent work has 
provided evidence that additional factors, pathways, and regulators might exist that have 
eluded detection in prior work (RYAN et al. 2008).  As mentioned in Chapter II, the 
overwhelming levels of V-ATPase activity within the yeast cell are thought to mask 
subtle contributors to enzyme function.  Therefore, reducing the total V-ATPase enzyme 
content of the cell by using specific alleles of assembly factors creates a sensitized 
genetic background that allows for a new screening strategy. 
 Not surprisingly, a large number of genes emerged from the SGA screens 
presented in Chapter II.  Some of the pathways identified from these screens merit further 
investigation.  Of particular interest would involve genes whose protein products localize 
to the ER, Golgi/endosomal network, as well as genes that are uncharacterized and have 
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no known molecular function.  Components of ER-localized protein degradation 
pathways provide an interesting tangent to the life history of the V-ATPase complex.  It 
is possible that there may be regulated interplay between components of the V0 assembly 
machinery and ER quality control systems.  Prior work has shown that upon disruption of 
V0 assembly, subunit a (Vph1p or Stv1p), is targeted for degradation (GRAHAM et al. 
1998; HILL and COOPER 2000).  Additionally, other isoforms of subunit a that are not 
inherent to budding yeast (such as the ancestral Anc.a, or subunit a from N. crassa or S. 
pombe) are also still targeted for degradation if there is a V0 assembly defect 
(unpublished results). 
 Secondly, these SGA screens have provided a large number of trafficking-related 
genes that are important for full V-ATPase function (Table 3, Chapter II and Table S1, 
Appendix A).  While many of these belong to the well-characterized components of 
vesicular trafficking pathways that transit through the Golgi and endosome (such as the 
ESCRT machinery), some are involved in other trafficking functions.  These provide 
interesting genetic interactions with the V-ATPase that have otherwise been 
unappreciated.  Some of these might provide future insight into (i) V0 exit from the ER to 
the early Golgi and (ii) differential trafficking of the two isoforms of the V-ATPase. 
 One of the many open questions regarding V-ATPase assembly and trafficking 
involves the specific factor(s) that govern recognition of the completed, assembled V0 
subcomplex in conjunction with Vma21p by vesicular budding machinery and 
subsequent exit from the ER.  One of the difficulties in searching for factors that might 
serve as “cargo recognition” adaptor proteins is that redundancy can exist between cargo 
adaptors such as those belonging to the p24 family (MARZIOCH et al. 1999; 
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SPRINGER et al. 2000).  Also, loss of the adaptor molecule might not cause a complete 
shift in the steady-state levels of the cargo.  Rather, it may cause slowed, anterograde 
vesicular transit (BUE et al. 2006).  Finally, many of the components required for 
vesicular transport from the ER to the Golgi are essential and are not included within the 
non-essential haploid deletion collection (GAYNOR et al. 1998). 
 However, current progress is being made to address these different technical 
problems.  For one, future work will attempt to create a reporter protein out of one of the 
subunits of the V-ATPase that will allow for a kinetic, pulse-chase analysis.  Many of the 
cargo proteins for which adaptor proteins (such as alkaline phosphatase) have been 
characterized can be detected by a pulse-chase assay because they undergo proteolytic 
cleavage within particular cellular compartments (COWLES et al. 1997; PIPER et al. 
1997; STEPP et al. 1997).  Supplementing the V-ATPase enzyme with a reporter protein 
that will allow for a kinetic assay of transit through the endo-membrane system will be 
invaluable for the investigation of V0 ER exit. 
 Also, future genetic screens are being developed that will aid in specifically 
assaying whether Vph1p has been degraded rather than assaying survival on zinc or 
buffered calcium.  Previous genetic screens have demonstrated that many genes are 
involved in zinc and/or calcium sequestration and homeostasis (SAMBADE et al. 2005; 
PAGANI et al. 2007).  Separating genes that have no impact on V-ATPase function (such 
as HPH1/HPH2) from genes that may have an effect on V0 assembly is crucial.  Current 
work has shown that creating a triple gene fusion between Vph1p, GFP, and His3p will 
allow for a targeted genetic screen (either enhancer or suppressor) that will directly 
address the degradation of subunit a at steady-state (unpublished results). 
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 Finally, trafficking genes that have been uncovered by the work in Chapter II will 
aid in projects targeted at characterizing the differential trafficking between Vph1p and 
Stv1p (also see Chapter III).  While these SGA screens have not been designed with this 
purpose in mind, it is interesting to note that a number of genes that have emerged out of 
these screens also overlap with screens searching for trans effectors of Stv1p1.  However, 
it is unclear how these genes interact with the V-ATPase.  For example, components of 
the AP-3 complex, HOPS complex, and others (including Arl1), show strong genetic 
links to the V-ATPase (unpublished data; COSTANZO et al. 2010).  It is important to 
mention that the SGA screens from Chapter II are designed with both Stv1p and Vph1p 
present in the cell.  Therefore, comparison of these interaction networks to those 
generated by the Stv1p trans SGA screens might provide insight into which genes do not 
differentiate between subunit a isoforms and represent more generalized, genetic links to 
the V-ATPase. 
 Another prominent category of genes uncovered by the SGA screens in Chapter II 
involves lipids and membrane biology.  Our work on ORM1 and ORM2 demonstrate that 
sphingolipid composition has a subtle effect on V-ATPase activity.  However, additional 
genes involved in lipid composition are listed in Table 3 (Chapter II) such as those for 
ergosterol biogenesis (erg3! and erg6!) and others involved with sphingolipids (sur4!).  
Other reports have studied how alterations in the lipidome can affect cargo assembly, 
transport, and function (CHUNG et al. 2003; ZHANG et al. 2010).  It appears that the V-
ATPase is also sensitive to the lipid environment.  Future work would likely include 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 These SGA screens for trans effectors of the Stv1p-containing complex are performed in a vph1! genetic 
background and crossed to the haploid deletion collection as described in Chapter II.  The purpose is to 
search for effectors that, when deleted, will cause Stv1p to be mislocalized to the vacuolar membrane in the 
absense of the Vph1p subunit. 
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understanding how the local lipid states (within particular subcellular organelles) can 
affect the V-ATPase.  Prior to these genetic screens, others have provided evidence that 
membrane-bound compartments can have differential effects on V-ATPase function.  
Reversible dissociation of V1 and V0 only occurs when the V-ATPase enzyme (including 
either isoform of subunit a) is present on the vacuolar membrane and not on the Golgi 
(KAWASAKI-NISHI et al. 2001a).  It seems likely that the local lipid environment is 
affecting the V-ATPase.  Other future work might investigate whether other constituents 
of the lipidome (aside from sphingolipids) have similar effects on enzyme function and/or 
trafficking of cargo proteins. 
 The work from Chapter II is of great importance to understanding the evolution of 
the V-ATPase.  Many of the different genetic pathways identified from these SGA 
screens are highly conserved in other eukaryotes.  Of particular interest is the 
Orm1p/Orm2p duplicate protein pair.  These proteins have been implicated in early 
childhood asthma in humans (FERREIRA et al. 2010).  Many of the components of 
sphingolipid biogenesis are highly conserved (BRESLOW et al. 2010).  Similarly, 
trafficking pathways are well conserved across different lineages and yeast has served as 
a useful model system for characterizing vesicular trafficking.  Future work should 
involve separating yeast-specific phenomenon from processes that are well conserved in 
other creatures.  While species-specific mechanisms are still of interest, a more global 
view of the V-ATPase and especially work in mammalian systems will require the 
separation of components that might not exist outside a small group of budding yeast 
species.  (For example, it is likely that assembly factors Voa1p and Pkr1p evolved 
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recently within the budding yeasts and that these proteins are not found within other 
eukaryotes or distant fungi). 
 The use of genetic screens within yeast and other model organisms (such as flies, 
worms, and even mammalian cell culture) has the potential to provide a clear 
evolutionary picture of the cellular processes that affect the V-ATPase.  Comparison of 
this genetic data will be critical in categorizing general versus species-specific V-ATPase 
mechanisms. 
 
2.  The evolutionary history of the two subunit a isoforms in budding yeast 
 The 100 kDa subunit a “stator” subunit of the V-ATPase is a critical component 
of the enzyme complex.  Recent studies have focused on this subunit because of its 
proposed involvement in other cellular processes (such as pH sensing, membrane fusion, 
and enzyme transport) (FORGAC 2007).  A thorough investigation of subunit a is critical 
because in many organisms, differential targeting of the V-ATPase is central to proper 
acidification of different organelle systems (TOEI et al. 2010).  Mammals have four 
distinct isoforms of the V-ATPase including one that resides on the plasma membrane 
(OKA et al. 2001; TOYOMURA et al. 2003).  This particular isoform has been 
implicated in a number of human diseases including cancer metastasis (FORGAC 2007).  
Understanding the mechanism(s) governing transport of the different isoforms of the V-
ATPase will be critical in utilizing this enzyme as a pharmaceutical target. 
 However, subunit a presents a number of challenges that have impeded progress 
in evaluating its role in differential trafficking.  For one, there is no high-resolution 
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crystal structure of subunit a (nor the V-ATPase in its entirety2).  Secondly, the V-
ATPase as a protein cargo is substantially more complex and larger in size and structure 
than other well characterized cargo proteins.  Finally, horizontal evolutionary approaches 
(expressing V-ATPase subunits from one species into budding yeast) have not been 
successful for subunit a (unpublished data; AVIEZER-HAGAI et al. 2000); lineage-
specific mutations and potential epistatic intramolecular interactions are not appreciated 
in this type of analysis.  Even attempts to create chimeras between Vph1p and Stv1p have 
had very limited success (unpublished data, Bowers and Stevens).  Thus, even different 
subunit a genes within the same species might also be constrained by isoform-specific 
changes that have evolved following gene duplication events. 
 Within budding yeast, Stv1p and Vph1p are proposed to have arisen from a gene 
duplication event within the fungal lineage (Figure 1, Chapter III).  It is interesting to 
note that this does not include all fungal species; organisms such as N. crassa and S. 
pombe are basal to this duplication event and are proposed to have only a single isoform 
of subunit a (Figure 1, Chapter III).  Understanding how to characterize the evolutionary 
history of Stv1p and Vph1p has been difficult with current molecular techniques.  
However, the use of ancestral reconstruction had the potential to provide a unique 
experimental system to study the evolution of Stv1p and Vph1p.   
 Given the results from Chapter III, it is likely that the ancestral isoform of 
budding yeast of subunit a functioned on both the Golgi/endosomal network and the 
vacuolar membrane.  This seems to fit current observations that the V-ATPase in many 
organisms is found throughout the endo-membrane system and not exclusively on the 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
2 There are crystal structures for individual subunits of the V-ATPase and several models that provide gross 
structural information of the yeast V-ATPase complex (ZHANG et al. 2008).  This model is at 25 angstrom 
resolution. 
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vacuole (FORGAC 2007).  Comparison of the localization of Anc.a to other organisms 
that have evolved with only a single isoform of the V-ATPase would provide support for 
these observations.  However, work in N. crassa has shown that selectively marking the 
Golgi/endosome has been challenging (BOWMAN et al. 2009).  While the V-ATPase 
complex is clearly found on vacuoles in N. crassa, it is unclear if it also localizes to the 
Golgi (although it clearly localizes to other vesicular structures that are not labeled by 
vacuolar markers). 
 To supplement our analysis of Anc.a, preliminary work was performed on the N. 
crassa subunit a isoform expressed in budding yeast.  Surprisingly, the N. crassa isoform 
was able to provide a low level of complementation and localization data (unpublished 
results).  While the majority of the N. crassa protein was present in the ER (indicative of 
a severe assembly defect), there was also fluorescent signal (for a GFP fusion protein) 
present on both the vacuole as well as punctate structures (unpublished results).  Further 
study will be required to determine whether these puncta colocalize with Golgi and 
endosomal markers (like Anc.a) and whether these puncta will be transported to the 
vacuole upon treatment with cycloheximde.  Creatures such as N. crassa, S. pombe, and 
D. discoideum are likely to localize the V-ATPase to not only the vacuole/lysosome, but 
other vesicular structures such as the Golgi and endosome.  Work in the slime mold D. 
discoideum has shown that the V-ATPase localizes throughout the endo-membrane 
system (NOLTA et al. 1993; TEMESVARI et al. 1996; LIU and CLARKE 1996). 
 The proposed model of the evolution of Vph1p and Stv1p also proposes that a 
number of other regulatory elements have played a crucial role in the development of the 
current two-isoform system in budding yeast.  It is interesting that the shift in Stv1p 
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localization had to be tightly coupled with changes in the (i) assembly and (ii) expression 
levels.  Future work could investigate the evolution of the DNA regulatory regions 
driving Stv1p and Vph1p expression.  While challenging, a similar process of ancestral 
reconstruction could be applied to these DNA regulatory elements.  However, this type of 
approach would make the assumption that the extant transcriptional machinery would 
still recognize an ancient promoter sequence.  However, if possible, this experiment 
would help confirm the evolutionary shift in STV1 expression following the gene 
duplication event. 
 It has been speculated that Stv1p and Vph1p undergo differential assembly within 
the ER and that there is a connection between these two isoforms at the level of V0 
assembly (PERZOV et al. 2002; unpublished results).  As mentioned in Chapter III, the 
observation that has prompted this model is that steady-state levels of Stv1p increase 
upon a loss of Vph1p.  One possibility is that there is merely competition for assembly 
machinery within the ER and that Vph1p is more efficient at binding and sequestering 
factors such as Vma21p compared with Stv1p.  It might be possible to assay levels of 
assembly factors that associate with either yeast subunit a isoform.  However, one of the 
technical difficulties with such an approach has been the extremely low levels of Stv1p.  
Also, there is no current (promoter) system to drive Vph1p and Stv1p at identical 
expression levels.  Therefore, the tight interplay between Vph1p and Stv1p levels might 
suggest a type of regulatory role of Vph1p in assembly of Stv1p (rather than 
competition).   
 A more thorough investigation of “intermediate” ancestors (see Figure 1, Chapter 
III) that exist along the Stv1p and/or Vph1p trajectories will provide a more complete 
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understanding of subunit a assembly, expression, and localization.  It will be interesting 
to determine where along the Vph1p and Stv1p lineage did (i) the evolving Vph1p 
isoform stop localizing to the Golgi/endosome and when (ii) Stv1 became restricted to 
the Golgi/endosome.  Further analysis could then characterize the sets of residues 
responsible for these gross phenotypic changes.   
 An analysis of the Stv1p sorting signal(s) that causes retention and/or retrieval 
within the Golgi/endosome network could also be possible using the Anc.a protein as a 
template to introduce potential targeting signals to determine if they are sufficient to 
cause a shift in localization of the V-ATPase.  Given the complexity of the structure of 
subunit a (ZHANG et al. 2008), the sorting signal(s) within modern Stv1p may require 
the correct structural context in order to be fully recognized by the corresponding sorting 
machinery.  The ancestral approach would help provide the more recent reconstructed 
subunit along the Stv1p trajectory that would allow for this gain of function experiment. 
 This work on Anc.a serves as a proof of principle for future reconstructions of 
other ancestral V-ATPase subunits including subunit a.  Distinguishing between the 
different mammalian and human isoforms would greatly benefit from this type of 
evolutionary approach.  Finally, coupling future biochemical studies of the V-ATPase 
complex (including a high-resolution structure of subunit a as part of the assembled 
enzyme) will greatly assist in translating information from sets of residues responsible for 
assembly, trafficking, or enzyme function to specific mechanisms that depict binding 
surfaces and protein-protein interactions. 
 
 
! 113!
3. The evolution of complexity 
 The work presented in Chapter III describes the subfunctionalization of the two 
fungal subunit a isoforms.  While these reconstructed ancestral proteins still assembled 
and functioned with the other thirteen subunits of the V-ATPase, only a single isoform of 
the stator is incorporated into each complex.  These findings describe the separate 
evolution of the two V-ATPase complexes.  As previously described, there may be an 
intricate level of regulation and genetic interactions between the Stv1p and Vph1p-
containing complexes.  However, it is unknown whether the subunit isoforms directly 
interact.   
 Within the V-ATPase complex, a number of additional subunits also show some 
degree of homology (such as the V1 subunits A and B).  We chose one of the most 
challenging and intriguing portions of the V-ATPase complex, the proteolipid ring for 
further evolutionary study.  This basic unit of ATPase function remains highly conserved 
across the tree of life; V, A, and F-type ATPase enzymes all contain an analogous 
structure that serves to translocate protons (either up or down an electrochemical 
gradient) (GRÜBER et al 2001).  However, the size and composition of the ring has 
shifted dramatically within specific domains of life.   
 While the F-type ATP synthase complex has twelve identical subunits (each with 
two transmembrane passes) that make up the ring, other rings differ in both the size of the 
individual subunits (ie, number of transmembrane domains randing from two up to six) 
and the number of separate subunits that are incorporated into the ring (GRÜBER et al 
2001).  Some explanations for the diverse architectural shifts in ring membership include 
(i) regulation of the coupling efficiency and (ii) reversible proton flow (or its prevention 
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in the case of the V-ATPase ring) (ZHANG et al. 1992; GRABE et al. 2000; 
KAWASAKI-NISHI et al. 2001b; SAROUSSI and NELSON 2009).  While these factors 
might be subject to selection, they are not sufficient to explain ring composition in 
several different scenarios.  Comparison of the V-ATPase ring between the fungal and 
animal lineages is one example. 
 Therefore, we chose to use the proteolipid ring as a model system to test the 
hypothesis that increasing (protein) complexity can arise through neutral processes 
following gene duplication.  It is important to note that this type of ancestral 
reconstruction is challenging for several reasons.  While the ancestral subunit(s) have to 
also function in the context of the extant V-ATPase components, they also have to 
maintain ring integrity and function.  As demonstrated in Chapter IV, the ancestral c-c’ 
subunit has to compensate for a loss of two different yeast ring subunits. 
 The findings that the ancestral c-c’ functioned within the extant V-ATPase are 
very surprising.  The ring interacts with a number of other V0 subunits as well as the 
primary assembly factors in yeast.  The Anc.c-c’ protein did not result in a large amount 
of functional complementation yet we were able to leverage this to perform our 
evolutionary analysis of the ring.  Subsequent ancestral reconstructions of the 
“intermediate” c and c’ ancestors along the subunit lineages provided critical information 
about (i) the relative timing3 by which subfunctionalization of the two fungal subunits 
took place and (ii) the set of residues responsible for this molecular shift.   
 The work presented in Chapter IV leads us to propose a model by which the 
neutral inclusion of an additional subunit (ie, an increase in protein complexity) can occur 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
3 The term “timing” here is not based on a temporal analysis, but rather to comment on the fact that these 
changes occurred basal to all fungal species that were sampled and would therefore be predicted to account 
for ring evolution within this entire clade. 
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through degenerataion of subunit-subunit interfaces.  This applies to a unique scenario 
where all parts of this system (the proteolipid ring) are required for full enzymatic 
activity.  Thus, the shift in ring architecture occurred while maintaining V-ATPase 
function.  This work is significant because it presents a model of molecular evolution that 
might be present within other biochemical systems.  There is an overwhelming amount of 
data supporting the notion that biological systems have increased in complexity through 
evolutionary time (ADAMI et al. 2000).  Prior work has described how proteins can (i) 
acquire new functions following gene duplication events or (ii) partition the ancestral 
function of a protein into two (or more) new proteins (INNAN and KONDRASHOV 
2010).  
 However, proteins that are part of multisubunit complexes present additional 
challenges; these peptides are often restricted in their ability to acquire new function(s) 
because their original role in the enzyme function and/or structure of the complex to 
which they belong to must be maintained.  Clearly, complexes that have numerous 
subunits have evolved new subunits with new functions (WOLLENBERG and 
SWAFFIELD 2001; GABALDÓN et al. 2005).  However, for some enzyme domains 
such as the V-ATPase proteolipid ring, it is unclear whether the difference in subunit 
number or composition causes a significant increase in enzyme function and therefore 
organism fitness.   
 The idea that complexity (in the context of a large, multisubunit protein complex) 
can also evolve via neutral processes is an interesting model for several reasons 
(ARCHIBALD et al. 1999; RUANO-RUBIO et al. 2007).  Firstly, increasing the 
complexity of a protein complex also increases the amount of energy input required to 
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assemble and/or regulate the incorporation of the new subunit(s).  The opportunity for 
mistakes in expressing and assembling more protein components also increases.  It is also 
possible that additional factors will need to be recruited to aid in the more complex 
assembly process.   
 The model we describe in Chapter IV supports the idea that additional subunits 
might have been included within the proteolipid ring through asymmetric degeneration of 
the subunit interfaces and that the V0 became “ratcheted” into this new conformation.  
We show that once the two new subunits c and c’ have begun to acquire their “c-like” 
and “c’-like” identities (in terms of their structural interfaces within the ring), they are 
unable to substitute for the c’ and c position, respectively.  The ring has increased in 
subunit number by locking the new subunits into a specific position and they are unable 
to reverse this structural specificity.  Others have shown that evolution is directional; 
mutational changes that have given rise to a new enzymatic function only work when 
introduced in a unidirectional fashion (BRIDGHAM et al. 2009). 
 Finally, our results provide an interesting tangent to V0 assembly (see Chapter II) 
and the co-evolution of the V-ATPase and its supporting factors.  One explanation for the 
large number of dedicated V0 assembly factors in budding yeast is that there are three 
proteolipid subunits present within the ring rather than two.  A ring that is composed of 
only two subunits will only have a single structural conformation (assuming that one 
subunit, in this case, c”, is restricted to one copy per complex) (see Figure 10, Chapter 
IV).  A ring that has three subunits (assuming two of the subunits are restricted to one per 
complex and the third is present at multiple copies as in the case of the yeast ring) has 
many different structural conformations possible.  While our results suggest that the 
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inclusion of the third subunit occurred through degeneration of subunit interfaces, this 
does not explain the placement of the c’ subunit adjacent to the c” subunit and why the c’ 
subunit evolved to only be present at a single copy within the ring. 
 One area of study that might address these questions includes the interplay with 
dedicated assembly factors.  Recent unpublished work suggests that yeast Vma21p 
associates with subunit c’ in yeast and does not interface with subunit c very strongly.  
Also, Voa1p associates with subunit c (unpublished results, Ryan and Stevens).  Since 
humans (and metazoans) only contain a c subunit (and lack c’), it is likely that human 
Vma21p interfaces with the c subunit.  While the role of Vma21p as an assembly factor 
has not changed, its association with the proteolipid ring has undergone a dramatic 
structural shift given the change in ring composition.  Future experiments should 
determine whether Vma21p is found in multiple copies per complex.  The current model 
suggests that yeast Vma21p binds to yeast c’.  Compared to the mammalian ring, it is 
possible that Vma21p in these species associates with the numerous copies of c.  Future 
experiments on expressing both the human proteolipid ring (subunit c) as well as the 
human Vma21p in yeast cells lacking c and c’ will add to this model.  Since Voa1p is not 
conserved at all outside of budding yeasts (unpublished results), it is possible that S. 
cerevisiae has recruited a new factor to assist in V0 assembly in this species.  However, it 
is unknown how other fungi (that also have three proteolipid subunits) have responded to 
the addition of a new subunit. 
 The sets of residues identified within Chapter IV that are responsible for c or c’ 
“identity” will require future investigation to determine the precise molecular contacts 
that are necessary for these interactions.  Others (such as J. W. Thornton and colleagues) 
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have been working on a similar type of question that involves sorting through groups of 
residues to describe their order and function through evolutionary time to bring about a 
mechanistic shift in enzyme function.  This type of analysis is extremely powerful yet 
challenging for several reasons.  While our work has reduced the set of residues to 
approximately 25-30 total residues (out of a protein containing 160 residues), there are 
many, many combinations of how these sets of residues could have evolved.  
Unfortunately, our phylogeny will require additional species that are more basal than the 
intermediate nodes yet occurred after the c-c’ duplication event to separate these 
groupings into smaller sets.   
 Additionally, modeling of these residues within the predicted structure of the 
proteolipids might allow for a rudimentary classification of residues based on their 
approximate positioning within the membrane-bound portion of the ring.  Sites on 
lumenal or cytosolic faces of the membrane might help to eliminate residues that are 
unlikely to interface with adjacent subunits (although little has been described for how 
the cytosolic and/or lumenal portions of the proteolipids are required for function).  Since 
the lumenal portions face away from the V-ATPase complex there is far less sequence 
conservation across species.  Cytosolic regions of the proteolipids are highly conserved 
(and restricted in the lengths connecting adjacent transmembrane domains) and may 
interface with (i) other ring subunits, (ii) the N or C-terminal portion of subunit a, (iii) 
subunit d, and/or (iv) other V1 subunits. 
 Ultimately, a future goal for this work would be to be able to describe the precise 
molecular events that took place after the duplication of c-c’ into c and c’ and which 
residues are responsible for shifting the subunit interactions to accommodate the new ring 
! 119!
member.  Additional ancestral reconstructions of the V-ATPase subunits (and perhaps a 
full reconstruction of the entire V-ATPase enzyme) and its assembly factors will help 
provide a complete evolutionary history and allow for a more rigorous molecular analysis 
of this critical molecular machine. 
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APPENDIX A 
SUPPLEMENTAL INFORMATION FOR CHAPTER II 
Table S1.  Genes identified by genome-wide SGA screens for V-ATPase effectors.  The 
standard gene name and systematic names of all the genes identified from the 3 SGA 
enhancer screens are listed.  X's indicate which of the three different SGA screens genes 
were identified from.  The three different query strains used are labeled above each 
column.  These data include scoring of double mutants on media containing either Ca2+ 
or Zn2+. 
 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
AAT2 YLR027C X  X 
ACO1 YLR304C X   
ACO2 YJL200C X   
ADA2 YDR448W X   
ADI1 YMR009W  X  
ADO1 YJR105W   X 
AGE2 YIL044C  X  
AIM14 YGL160W   X 
ALG6 YOR002W X  X 
ALG8 YOR067C X  X 
ANP1 YEL036C X   
APE3 YBR286W   X 
API2 YDR525W  X  
APL5 YPL195W X X  
APL6 YGR261C  X X 
APM1 YPL259C  X  
APM3 YBR288C X X  
APS3 YJL024C X X  
ARF1 YDL192W  X  
ARG2 YJL071W  X  
ARG82 YDR173C X   
ARL1 YBR164C X X X 
ARL3 YPL051W  X X 
ARO1 YDR127W X X  
ARO2 YGL148W X X X 
ARO7 YPR060C X X X 
ARP6 YLR085C  X X 
ARR4 YDL100C  X  
ASC1 YMR116C  X X 
ASF1 YJL115W  X  
ATG15 YCR068W   X 
ATG21 YPL100W   X 
ATG27 YJL178C  X  
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
ATG8 YBL078C  X  
ATS1 YAL020C  X X 
AVT7 YIL088C  X  
BAP2 YBR068C  X  
BCK1 YJL095W   X 
BCK2 YER167W X X X 
BDF1 YLR399C   X 
BEM1 YBR200W X   
BEM2 YER155C X X X 
BEM4 YPL161C X X X 
BMH1 YER177W  X  
BRE1 YDL074C X X X 
BRE2 YLR015W  X  
BSD2 YBR290W  X X 
BST1 YFL025C  X  
BTS1 YPL069C X   
BUD14 YAR014C  X  
BUD30 YDL151C X   
CAJ1 YER048C  X  
CAT5 YOR125C   X 
CBF1 YJR060W X X X 
CCC2 YDR270W  X  
CCR4 YAL021C X  X 
CCW12 YLR110C  X  
CCZ1 YBR131W X X  
CDC50 YCR094W X   
CEX1 YOR112W  X  
CHD1 YER164W   X 
CHS5 YLR330W  X X 
CHS6 YJL099W   X 
CKA1 YIL035C  X  
CKB1 YGL019W X X X 
CKB2 YOR039W X X X 
CLA4 YNL298W  X X 
CNB1 YKL190W   X 
CNE1 YAL058W  X  
COG5 YNL051W  X X 
COG6 YNL041C  X  
COG7 YGL005C  X X 
COG8 YML071C  X X 
COY1 YKL179C  X  
CPR2 YHR057C   X 
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
CPR7 YJR032W  X  
CRZ1 YNL027W X X X 
CSF1 YLR087C X X X 
CSG2 YBR036C X X X 
CTF18 YMR078C  X  
CTF4 YPR135W   X 
CTK1 YKL139W X X X 
CUE1 YMR264W  X  
CWH41 YGL027C  X  
CYK3 YDL117W  X  
CYS3 YAL012W X   
DAL81 YIR023W   X 
DBF2 YGR092W  X  
DBP7 YKR024C X  X 
DFG16 YOR030W   X 
DFG5 YMR238W X   
DIA2 YOR080W  X  
DLT1 YMR126C X X X 
DOA1 YKL213C  X  
DOM34 YNL001W  X  
DPH1 YIL103W  X  
DPH2 YKL191W  X  
DPH5 YLR172C  X  
DRS2 YAL026C X X X 
DST1 YGL043W  X  
DUF1 YOL087C   X 
EAF3 YPR023C   X 
EAF7 YNL136W   X 
ECM38 YLR299W  X  
ECM40 YMR062C   X 
EFT2 YDR385W  X  
ELF1 YKL160W   X 
ELM1 YKL048C  X X 
ELP2 YGR200C  X  
ELP3 YPL086C  X  
ELP4 YPL101W  X  
ELP6 YMR312W  X X 
EMC1 YCL045C  X  
ERD1 YDR414C   X 
ERG3 YLR056W X X X 
ERG6 YML008C X X X 
ERP3 YDL018C X   
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
ERV46 YAL042W  X  
FET3 YMR058W X X  
FET4 YMR319C   X 
FIG4 YNL325C  X  
FKS1 YLR342W  X  
FLC2 YAL053W X   
FMC1 YIL098C   X 
FMP21 YBR269C   X 
FPS1 YLL043W   X 
FRA1 YLL029W   X 
FRT1 YOR324C   X 
FTR1 YER145C  X  
FUI1 YBL042C  X  
FUM1 YPL262W X   
FYV10 YIL097W   X 
GAL11 YOL051W   X 
GAS1 YMR307W  X  
GCN1 YGL195W  X  
GCR2 YNL199C  X  
GCS1 YDL226C  X  
GEF1 YJR040W  X  
GET1 YGL020C X X  
GET2 YER083C X X X 
GIM4 YEL003W X   
GIS4 YML006C  X  
GLY1 YEL046C X   
GOS1 YHL031C X X  
GPA2 YER020W  X  
GSF2 YML048W   X 
GSG1 YDR108W X X X 
GSH1 YJL101C X X  
GSH2 YOL049W  X  
GUP1 YGL084C  X X 
GVP36 YIL041W  X  
GYP1 YOR070C X X X 
HAC1 YFL031W X   
HAL5 YJL165C  X X 
HCR1 YLR192C X X  
HEX3 YDL013W  X  
HGH1 YGR187C  X  
HMT1 YBR034C  X  
HOC1 YJR075W X   
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
HSC82 YMR186W  X  
HTZ1 YOL012C  X X 
ICE2 YIL090W X X  
IDH2 YOR136W X X  
IKI3 YLR384C  X  
ILM1 YJR118C  X  
ILV1 YER086W   X 
IMG2 YCR071C X   
INO2 YDR123C  X  
INP53 YOR109W  X  
IOC2 YLR095C  X  
IRA2 YOL081W X   
IRC13 YOR235W  X  
IRC14 YOR135C X X  
IRC21 YMR073C   X 
IRC25 YLR021W  X  
ISW1 YBR245C  X  
JJJ3 YJR097W  X  
KAR3 YPR141C  X  
KCS1 YDR017C X   
KEM1 YGL173C X X X 
KES1 YPL145C  X  
KEX1 YGL203C   X 
KEX2 YNL238W X X  
KRE1 YNL322C   X 
KRE28 YDR532C X X  
KTI12 YKL110C  X  
LCL1 YPL056C X   
LEO1 YOR123C  X X 
LGE1 YPL055C X X X 
LIP2 YLR239C X X  
LIP5 YOR196C X   
LPD1 YFL018C   X 
LSB3 YFR024C-A  X  
LSM1 YJL124C X X  
LSM6 YDR378C X   
LST4 YKL176C  X  
LYS14 YDR034C X X X 
MAC1 YMR021C X X  
MAF1 YDR005C  X  
MBF1 YOR298C-A  X  
MCK1 YNL307C   X 
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
MDM10 YAL010C  X  
MDM20 YOL076W   X 
MDM34 YGL219C   X 
MDY2 YOL111C X   
MET18 YIL128W  X  
MET22 YOL064C  X  
MGA2 YIR033W  X  
MGM101 YJR144W   X 
MKS1 YNL076W  X X 
MMS1 YPR164W  X  
MMS22 YLR320W  X  
MNN10 YDR245W X X  
MNN2 YBR015C  X  
MOG1 YJR074W  X  
MON1 YGL124C X X X 
MPD2 YOL088C X   
MRC1 YCL061C  X  
MRPL35 YDR322W   X 
MSC1 YML128C  X  
MSN5 YDR335W X X X 
MTC2 YKL098W X X X 
MTC4 YBR255W  X X 
MTC6 YHR151C  X  
NAM7 YMR080C   X 
NBP2 YDR162C X X X 
NCS2 YNL119W  X  
NCS6 YGL211W  X  
NHX1 YDR456W X   
NMD2 YHR077C  X  
NPL3 YDR432W   X 
NPT1 YOR209C   X 
NST1 YNL091W  X  
NUP133 YKR082W  X  
OCA5 YHL029C  X  
OCT1 YKL134C   X 
OPI1 YHL020C  X X 
OPI8 YKR035C X X X 
ORM2 YLR350W X X X 
OST3 YOR085W X X  
OST4 YDL232W  X X 
PAR32 YDL173W   X 
PBS2 YJL128C   X 
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
PCL6 YER059W   X 
PCT1 YGR202C   X 
PDA1 YER178W  X  
PDB1 YBR221C X   
PER1 YCR044C  X X 
PET191 YJR034W   X 
PEX31 YGR004W X  X 
PFK1 YGR240C   X 
PGD1 YGL025C   X 
PHO2 YDL106C  X  
PHO4 YFR034C X X X 
PHO80 YOL001W X X X 
PHO81 YGR233C X X  
PHO85 YPL031C X  X 
PHO86 YJL117W X X X 
PIL1 YGR086C   X 
PIN4 YBL051C  X  
PKR1 YMR123W  X  
PMC1 YGL006W X X X 
PMP3 YDR276C  X  
POC4 YPL144W  X  
POP2 YNR052C X  X 
PPM1 YDR435C   X 
PPR1 YLR014C  X  
PSD2 YGR170W  X  
PSP2 YML017W  X  
PTK2 YJR059W   X 
QRI8 YMR022W  X  
RAV1 YJR033C  X X 
RAV2 YDR202C X X X 
RBG2 YGR173W   X 
RCY1 YJL204C  X  
RIF1 YBR275C  X  
RIM101 YHL027W  X X 
RIM20 YOR275C  X X 
RIM21 YNL294C  X  
RIM8 YGL045W  X X 
RIM9 YMR063W  X X 
RKR1 YMR247C  X  
RMD8 YFR048W  X  
RNR4 YGR180C   X 
ROT2 YBR229C  X  
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
RPA34 YJL148W  X  
RPL13A YDL082W  X  
RPL13B YMR142C   X 
RPL17B YJL177W   X 
RPL22B YFL035C-B   X 
RPL29 YFR032C-A  X  
RPL2A YFR031C-A  X  
RPL41B YDL133C-A  X  
RPL9A YGL147C  X  
RPN4 YDL020C  X  
RPO41 YFL036W  X  
RPP1A YDL081C X   
RPS11A YDR025W   X 
RPS11B YBR048W  X  
RPS16B YDL083C  X  
RPS19A YOL121C   X 
RPS21B YJL136C X X X 
RPS24A YER074W   X 
RPS27B YHR021C  X  
RPS28B YLR264W  X  
RPS29B YDL061C  X  
RPS4A YJR145C X   
RPS4B YHR203C  X  
RPS6B YBR181C  X  
RRF1 YHR038W   X 
RRT2 YBR246W  X  
RSM28 YDR494W   X 
RTG1 YOL067C  X X 
RTG2 YGL252C X X X 
RTG3 YBL103C  X X 
RTS1 YOR014W X X X 
RTT103 YDR289C  X X 
RTT109 YLL002W  X  
RUD3 YOR216C  X  
RVS161 YCR009C  X  
SAC1 YKL212W  X X 
SAC3 YDR159W  X X 
SAC7 YDR389W X X X 
SAP155 YFR040W  X X 
SAT4 YCR008W  X  
SBP1 YHL034C  X  
SCJ1 YMR214W  X  
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
SCS2 YER120W  X  
SCW10 YMR305C   X 
SDC1 YDR469W X   
SEC22 YLR268W X X  
SEC28 YIL076W  X  
SEC66 YBR171W X X X 
SER2 YGR208W X X  
SET2 YJL168C  X X 
SHE1 YBL031W  X  
SHE4 YOR035C  X X 
SHP1 YBL058W   X 
SIM1 YIL123W  X  
SIN4 YNL236W  X  
SIS2 YKR072C X X X 
SIT1 YEL065W  X  
SKG1 YKR100C  X  
SKN7 YHR206W  X X 
SLA1 YBL007C   X 
SMF1 YOL122C   X 
SMF3 YLR034C   X 
SMI1 YGR229C X X  
SMP2 YMR165C X X  
SNA2 YDR525W-A  X  
SNF1 YDR477W  X  
SNF11 YDR073W   X 
SNF2 YOR290C X  X 
SNF4 YGL115W   X 
SNF5 YBR289W X   
SNF6 YHL025W  X  
SNX4 YJL036W   X 
SOD2 YHR008C   X 
SOH1 YGL127C  X  
SOK2 YMR016C X   
SOY1 YBR194W X   
SPE1 YKL184W  X  
SPE3 YPR069C  X  
SPF1 YEL031W  X X 
SPT3 YDR392W  X  
SPT4 YGR063C   X 
SQS1 YNL224C  X  
SRB2 YHR041C  X X 
SRB8 YCR081W  X  
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
SRN2 YLR119W   X 
SRO7 YPR032W  X  
SSE1 YPL106C  X  
STO1 YMR125W   X 
STP1 YDR463W X  X 
STV1 YMR054W X   
SUR1 YPL057C  X X 
SUR4 YLR372W   X 
SWC3 YAL011W  X  
SWC5 YBR231C  X X 
SWD1 YAR003W X   
SWD3 YBR175W X   
SWF1 YDR126W  X X 
SWI4 YER111C X X X 
SWI6 YLR182W   X 
SWP82 YFL049W   X 
SWR1 YDR334W  X  
SYS1 YJL004C X X X 
TAE1 YBR261C  X  
TCO89 YPL180W   X 
TDA4 YJR116W   X 
TEF4 YKL081W  X X 
THR1 YHR025W X X X 
THR4 YCR053W X X X 
TLG2 YOL018C X   
TMA17 YDL110C  X  
TMA23 YMR269W  X  
TOP1 YOL006C  X  
TOS2 YGR221C  X  
TOS9 YEL007W   X 
TPD3 YAL016W X   
TPM1 YNL079C  X  
TPS1 YBR126C  X X 
TRK1 YJL129C   X 
TRP1 YDR007W  X  
TRP2 YER090W  X  
TRP4 YDR354W  X  
TSR2 YLR435W  X  
TUF1 YOR187W X   
UBA3 YPR066W X   
UBA4 YHR111W  X  
UBP13 YBL067C X X  
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
UBP14 YBR058C  X  
UBP15 YMR304W X X  
UBP3 YER151C   X 
UBP6 YFR010W  X  
UBX4 YMR067C  X  
UFD2 YDL190C  X  
UME6 YDR207C X X X 
UPF3 YGR072W  X  
URA4 YLR420W   X 
URE2 YNL229C  X  
URM1 YIL008W  X  
VAC14 YLR386W  X X 
VAC8 YEL013W X X X 
VAM10 YOR068C X X X 
VAM6 YDL077C X X  
VAM7 YGL212W  X  
VHS2 YIL135C   X 
VID21 YDR359C  X  
VID22 YLR373C  X  
VPH1 YOR270C X X X 
VPS1 YKR001C X   
VPS13 YLL040C  X  
VPS17 YOR132W X X  
VPS19 YDR323C X   
VPS2 YKL002W X   
VPS21 YOR089C  X X 
VPS22 YPL002C X   
VPS23 YCL008C X   
VPS24 YKL041W X X X 
VPS25 YJR102C X   
VPS26 YJL053W X X X 
VPS27 YNR006W X X  
VPS29 YHR012W X X X 
VPS3 YDR495C X   
VPS33 YLR396C X  X 
VPS35 YJL154C X X X 
VPS36 YLR417W X   
VPS4 YPR173C X X X 
VPS41 YDR080W  X  
VPS46 YKR035W-A X X X 
VPS5 YOR069W X X X 
VPS52 YDR484W X   
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
VPS53 YJL029C X   
VPS55 YJR044C  X X 
VPS6 YOR036W X   
VPS60 YDR486C  X X 
VPS62 YGR141W  X  
VPS71 YML041C   X 
VPS72 YDR485C   X 
VPS73 YGL104C  X  
VPS9 YML097C  X  
VTA1 YLR181C  X X 
VTC1 YER072W X X X 
VTC4 YJL012C X X X 
VTS1 YOR359W  X X 
XRS2 YDR369C  X  
YAK1 YJL141C   X 
YAL058C-A YAL058C-A  X  
YAP1801 YHR161C  X  
YAR029W YAR029W  X  
YBL071C YBL071C   X 
YBL094C YBL094C X   
YBR174C YBR174C X   
YBR226C YBR226C  X  
YBR284W YBR284W   X 
YCK3 YER123W X X X 
YCL046W YCL046W  X  
YCR007C YCR007C  X  
YCR061W YCR061W   X 
YDJ1 YNL064C  X  
YDL172C YDL172C   X 
YDL218W YDL218W X   
YDR048C YDR048C  X  
YDR049W YDR049W  X  
YDR089W YDR089W X   
YDR203W YDR203W X  X 
YDR269C YDR269C  X  
YDR271C YDR271C X X  
YDR336W YDR336W X   
YDR433W YDR433W   X 
YDR455C YDR455C X X  
YDR537C YDR537C   X 
YEH1 YLL012W   X 
YEL045C YEL045C X   
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
YER119C-A YER119C-A  X  
YER156C YER156C X   
YFR024C YFR024C  X  
YGL024W YGL024W  X X 
YGL218W YGL218W  X X 
YGR064W YGR064W   X 
YGR122W YGR122W  X  
YGR237C YGR237C  X  
YJL169W YJL169W  X X 
YJL175W YJL175W  X X 
YJR087W YJR087W   X 
YKE2 YLR200W X   
YKG9 YKL069W  X  
YKL023W YKL023W   X 
YKL061W YKL061W   X 
YKL118W YKL118W   X 
YKR051W YKR051W   X 
YLR111W YLR111W  X  
YLR143W YLR143W  X  
YLR402W YLR402W  X  
YML013C-A YML013C-A  X  
YML020W YML020W X   
YND1 YER005W   X 
YNL120C YNL120C  X X 
YNL140C YNL140C   X 
YNL171C YNL171C  X  
YNL198C YNL198C  X  
YNL228W YNL228W  X  
YNL296W YNL296W  X  
YNR005C YNR005C   X 
YOL050C YOL050C   X 
YOR300W YOR300W   X 
YPL102C YPL102C  X  
YPL168W YPL168W   X 
YPL205C YPL205C X   
YPR090W YPR090W  X  
YPR123C YPR123C X X  
YPR153W YPR153W X X X 
YPT7 YML001W X X X 
YTA7 YGR270W  X X 
YUR1 YJL139C  X  
ZRC1 YMR243C  X X 
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Table S1. (continued). 
Gene ORF vma21QQ::NatR 
vma21QQ 
voa1::Hyg
R
 
vma21QQ 
voa1!::Nat
R
 
ZUO1 YGR285C   X 
 
Table S2.  Gene Ontology (GO) analysis was performed using the Saccharomyces 
Genome Database (SGD) “Gene Ontology Term Finder” (v. 0.83).  Of the 538 genes 
identified from our three SGA screens, 492 were included within the GO analysis 
(overlapping ORFs were excluded).  The GO term ID# and GO categories are listed.  The 
cluster and background frequency are shown for each GO term and hits with p-values of 
less than 0.01 were included.  Results are listed beginning with GO categories with the 
lowest p-values. 
   
GO ID# GO Term Cluster frequency 
Background 
frequency P-value 
7034 vacuolar transport 
47 out of 492 
genes, 9.6% 
124 out of 5797 
background 
genes, 2.1% 4.94E-17 
7034 vacuolar transport 
47 out of 492 
genes, 9.6% 
124 out of 5797 
background 
genes, 2.1% 4.94E-17 
9987 cellular process 
443 out of 492 
genes, 90.0% 
4336 out of 5797 
background 
genes, 74.8% 2.56E-16 
16192 
vesicle-mediated 
transport 
82 out of 492 
genes, 16.7% 
357 out of 5797 
background 
genes, 6.2% 3.48E-15 
65007 biological regulation 
174 out of 492 
genes, 35.4% 
1199 out of 5797 
background 
genes, 20.7% 1.56E-12 
46907 
intracellular 
transport 
101 out of 492 
genes, 20.5% 
596 out of 5797 
background 
genes, 10.3% 9.46E-10 
65008 
regulation of 
biological quality 
75 out of 492 
genes, 15.2% 
389 out of 5797 
background 
genes, 6.7% 2.28E-09 
51649 
establishment of 
localization in cell 
105 out of 492 
genes, 21.3% 
648 out of 5797 
background 
genes, 11.2% 5.71E-09 
48193 
Golgi vesicle 
transport 
45 out of 492 
genes, 9.1% 
181 out of 5797 
background 
genes, 3.1% 1.49E-08 
51641 cellular localization 
114 out of 492 
genes, 23.2% 
747 out of 5797 
background 
genes, 12.9% 3.20E-08 
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Table S2. (continued).    
GO ID# GO Term Cluster frequency 
Background 
frequency P-value 
6623 
protein targeting to 
vacuole 
26 out of 492 
genes, 5.3% 
71 out of 5797 
background 
genes, 1.2% 3.57E-08 
6355 
regulation of 
transcription, DNA-
dependent 
74 out of 492 
genes, 15.0% 
406 out of 5797 
background 
genes, 7.0% 5.71E-08 
6892 
post-Golgi vesicle-
mediated transport 
25 out of 492 
genes, 5.1% 
70 out of 5797 
background 
genes, 1.2% 1.61E-07 
45449 
regulation of 
transcription 
76 out of 492 
genes, 15.4% 
433 out of 5797 
background 
genes, 7.5% 1.99E-07 
51252 
regulation of RNA 
metabolic process 
74 out of 492 
genes, 15.0% 
419 out of 5797 
genes, 7.2% 2.67E-07 
31326 
regulation of cellular 
biosynthetic process 
89 out of 492 
genes, 18.1% 
549 out of 5797 
background 
genes, 9.5% 3.46E-07 
9889 
regulation of 
biosynthetic process 
89 out of 492 
genes, 18.1% 
551 out of 5797 
background 
genes, 9.5% 4.21E-07 
10468 
regulation of gene 
expression 
85 out of 492 
genes, 17.3% 
518 out of 5797 
background 
genes, 8.9% 5.04E-07 
44249 
cellular biosynthetic 
process 
201 out of 492 
genes, 40.9% 
1666 out of 5797 
background 
genes, 28.7% 9.93E-07 
16197 endosome transport 
23 out of 492 
genes, 4.7% 
65 out of 5797 
background 
genes, 1.1% 1.10E-06 
51179 localization 
152 out of 492 
genes, 30.9% 
1162 out of 5797 
background 
genes, 20.0% 1.35E-06 
10556 
regulation of 
macromolecule 
biosynthetic process 
85 out of 492 
genes, 17.3% 
530 out of 5797 
background 
genes, 9.1% 1.64E-06 
2000112 
regulation of cellular 
macromolecule 
biosynthetic process 
85 out of 492 
genes, 17.3% 
530 out of 5797 
background 
genes, 9.1% 1.64E-06 
9058 biosynthetic process 
202 out of 492 
genes, 41.1% 
1690 out of 5797 
genes, 29.2% 2.09E-06 
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Table S2. (continued).    
GO ID# GO Term Cluster frequency 
Background 
frequency P-value 
19538 
protein metabolic 
process 
153 out of 492 
genes, 31.1% 
1180 out of 5797 
background 
genes, 20.4% 2.26E-06 
51234 
establishment of 
localization 
140 out of 492 
genes, 28.5% 
1057 out of 5797 
background 
genes, 18.2% 3.62E-06 
6810 transport 
137 out of 492 
genes, 27.8% 
1030 out of 5797 
background 
genes, 17.8% 4.35E-06 
70727 
cellular 
macromolecule 
localization 
61 out of 492 
genes, 12.4% 
340 out of 5797 
background 
genes, 5.9% 6.64E-06 
19219 
regulation of 
nucleobase, 
nucleoside, 
nucleotide and 
nucleic acid 
metabolic process 
80 out of 492 
genes, 16.3% 
502 out of 5797 
background 
genes, 8.7% 7.43E-06 
51171 
regulation of 
nitrogen compound 
metabolic process 
80 out of 492 
genes, 16.3% 
504 out of 5797 
background 
genes, 8.7% 8.97E-06 
8104 protein localization 
66 out of 492 
genes, 13.4% 
384 out of 5797 
background 
genes, 6.6% 9.07E-06 
45053 
protein retention in 
Golgi apparatus 
9 out of 492 genes, 
1.8% 
11 out of 5797 
background 
genes, 0.2% 1.05E-05 
60255 
regulation of 
macromolecule 
metabolic process 
89 out of 492 
genes, 18.1% 
588 out of 5797 
background 
genes, 10.1% 1.24E-05 
6351 
transcription, DNA-
dependent 
87 out of 492 
genes, 17.7% 
571 out of 5797 
background 
genes, 9.8% 1.36E-05 
32774 
RNA biosynthetic 
process 
87 out of 492 
genes, 17.7% 
573 out of 5797 
background 
genes, 9.9% 1.62E-05 
34613 
cellular protein 
localization 
58 out of 492 
genes, 11.8% 
324 out of 5797 
background 
genes, 5.6% 1.78E-05 
31323 
regulation of cellular 
metabolic process 
95 out of 492 
genes, 19.3% 
648 out of 5797 
background 
genes, 11.2% 1.91E-05 
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Table S2. (continued).    
GO ID# GO Term Cluster frequency 
Background 
frequency P-value 
19222 
regulation of 
metabolic process 
98 out of 492 
genes, 19.9% 
677 out of 5797 
background 
genes, 11.7% 2.10E-05 
80090 
regulation of 
primary metabolic 
process 
92 out of 492 
genes, 18.7% 
622 out of 5797 
background 
genes, 10.7% 2.17E-05 
6350 transcription 
90 out of 492 
genes, 18.3% 
607 out of 5797 
background 
genes, 10.5% 2.85E-05 
34067 
protein localization 
in Golgi apparatus 
9 out of 492 genes, 
1.8% 
12 out of 5797 
background 
genes, 0.2% 3.91E-05 
6896 
Golgi to vacuole 
transport 
13 out of 492 
genes, 2.6% 
26 out of 5797 
background 
genes, 0.4% 3.94E-05 
44267 
cellular protein 
metabolic process 
144 out of 492 
genes, 29.3% 
1136 out of 5797 
background 
genes, 19.6% 4.17E-05 
33036 
macromolecule 
localization 
77 out of 492 
genes, 15.7% 
499 out of 5797 
background 
genes, 8.6% 6.36E-05 
55082 
cellular chemical 
homeostasis 
30 out of 492 
genes, 6.1% 
123 out of 5797 
background 
genes, 2.1% 6.94E-05 
6873 
cellular ion 
homeostasis 
30 out of 492 
genes, 6.1% 
123 out of 5797 
background 
genes, 2.1% 6.94E-05 
7033 vacuole organization 
20 out of 492 
genes, 4.1% 
62 out of 5797 
background 
genes, 1.1% 8.36E-05 
34645 
cellular 
macromolecule 
biosynthetic process 
152 out of 492 
genes, 30.9% 
1231 out of 5797 
background 
genes, 21.2% 8.90E-05 
9059 
macromolecule 
biosynthetic process 
152 out of 492 
genes, 30.9% 
1233 out of 5797 
background 
genes, 21.3% 9.95E-05 
50801 ion homeostasis 
30 out of 492 
genes, 6.1% 
127 out of 5797 
background 
genes, 2.2% 0.00015 
48878 
chemical 
homeostasis 
30 out of 492 
genes, 6.1% 
128 out of 5797 
background 
genes, 2.2% 0.00018 
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Table S2. (continued).    
GO ID# GO Term Cluster frequency 
Background 
frequency P-value 
6357 
regulation of 
transcription from 
RNA polymerase II 
promoter 
48 out of 492 
genes, 9.8% 
269 out of 5797 
background 
genes, 4.6% 0.00038 
9892 
negative regulation 
of metabolic process 
46 out of 492 
genes, 9.3% 
253 out of 5797 
background 
genes, 4.4% 0.00038 
32447 protein urmylation 
6 out of 492 genes, 
1.2% 
6 out of 5797 
background 
genes, 0.1% 0.00038 
31327 
neg reg. of cellular 
biosynthetic process 
43 out of 492 
genes, 8.7% 
230 out of 5797 
background, 4.0% 0.00042 
9890 
negative regulation 
of biosynthetic 
process 
43 out of 492 
genes, 8.7% 
230 out of 5797 
background 
genes, 4.0% 0.00042 
31324 
negative regulation 
of cellular metabolic 
process 
45 out of 492 
genes, 9.1% 
249 out of 5797 
background 
genes, 4.3% 0.00062 
50789 
regulation of 
biological process 
124 out of 492 
genes, 25.2% 
985 out of 5797 
background 
genes, 17.0% 0.00083 
10605 
negative regulation 
of macromolecule 
metabolic process 
43 out of 492 
genes, 8.7% 
236 out of 5797 
background 
genes, 4.1% 0.00089 
6325 
chromatin 
organization 
40 out of 492 
genes, 8.1% 
214 out of 5797 
background 
genes, 3.7% 0.00111 
30003 
cellular cation 
homeostasis 
26 out of 492 
genes, 5.3% 
111 out of 5797 
background 
genes, 1.9% 0.00124 
16568 
chromatin 
modification 
35 out of 492 
genes, 7.1% 
177 out of 5797 
background 
genes, 3.1% 0.00139 
50794 
regulation of cellular 
process 
118 out of 492 
genes, 24.0% 
935 out of 5797 
background 
genes, 16.1% 0.0015 
6366 
transcription from 
RNA polymerase II 
promoter 
61 out of 492 
genes, 12.4% 
395 out of 5797 
background 
genes, 6.8% 0.00177 
10558 
negative regulation 
of macromolecule 
biosynthetic process 
40 out of 492 
genes, 8.1% 
218 out of 5797 
background 
genes, 3.8% 0.00181 
! 138!
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GO ID# GO Term Cluster frequency 
Background 
frequency P-value 
2000113 
negative regulation 
of cellular 
macromolecule 
biosynthetic process 
40 out of 492 
genes, 8.1% 
218 out of 5797 
background 
genes, 3.8% 0.00181 
19725 cellular homeostasis 
30 out of 492 
genes, 6.1% 
142 out of 5797 
background 
genes, 2.4% 0.00194 
10629 
negative regulation 
of gene expression 
37 out of 492 
genes, 7.5% 
197 out of 5797 
background 
genes, 3.4% 0.00253 
55080 cation homeostasis 
26 out of 492 
genes, 5.3% 
115 out of 5797 
background, 2.0% 0.00253 
40007 growth 
30 out of 492 
genes, 6.1% 
144 out of 5797 
background 
genes, 2.5% 0.00264 
48519 
negative regulation 
of biological process 
56 out of 492 
genes, 11.4% 
356 out of 5797 
background 
genes, 6.1% 0.00275 
43486 histone exchange 
7 out of 492 genes, 
1.4% 
10 out of 5797 
background 
genes, 0.2% 0.00308 
45934 
negative regulation 
of nucleobase, 
nucleoside, 
nucleotide and 
nucleic acid 
metabolic process 
39 out of 492 
genes, 7.9% 
215 out of 5797 
background 
genes, 3.7% 0.00329 
51172 
negative regulation 
of nitrogen 
compound metabolic 
process 
39 out of 492 
genes, 7.9% 
215 out of 5797 
background 
genes, 3.7% 0.00329 
48523 
negative regulation 
of cellular process 
55 out of 492 
genes, 11.2% 
350 out of 5797 
background 
genes, 6.0% 0.00352 
2097 
tRNA wobble base 
modification 
11 out of 492 
genes, 2.2% 
26 out of 5797 
background 
genes, 0.4% 0.00368 
2098 
tRNA wobble 
uridine modification 
11 out of 492 
genes, 2.2% 
26 out of 5797 
background 
genes, 0.4% 0.00368 
16043 
cellular component 
organization 
187 out of 492 
genes, 38.0% 
1680 out of 5797 
genes, 29.0% 0.00373 
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Table S2. (continued).    
GO ID# GO Term Cluster frequency 
Background 
frequency P-value 
32507 
maintenance of 
protein location in 
cell 
13 out of 492 
genes, 2.6% 
36 out of 5797 
background 
genes, 0.6% 0.00396 
16481 
negative regulation 
of transcription 
36 out of 492 
genes, 7.3% 
194 out of 5797 
background 
genes, 3.3% 0.00466 
42592 homeostatic process 
38 out of 492 
genes, 7.7% 
210 out of 5797 
background 
genes, 3.6% 0.00471 
45892 
negative regulation 
of transcription,  
35 out of 492 
genes, 7.1% 
187 out of 5797 
background, 3.2% 0.00519 
11 vacuole inheritance 
9 out of 492 genes, 
1.8% 
18 out of 5797 
background 
genes, 0.3% 0.00543 
6914 autophagy 
21 out of 492 
genes, 4.3% 
85 out of 5797 
background 
genes, 1.5% 0.00545 
51253 
negative regulation 
of RNA metabolic 
process 
35 out of 492 
genes, 7.1% 
188 out of 5797 
background 
genes, 3.2% 0.00589 
6464 
protein modification 
process 
76 out of 492 
genes, 15.4% 
549 out of 5797 
background 
genes, 9.5% 0.0065 
6886 
intracellular protein 
transport 
45 out of 492 
genes, 9.1% 
271 out of 5797 
background 
genes, 4.7% 0.00678 
45185 
maintenance of 
protein location 
13 out of 492 
genes, 2.6% 
38 out of 5797 
background 
genes, 0.7% 0.00791 
!
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APPENDIX B 
SUPPLEMENTAL INFORMATION FOR CHAPTER III 
Table S1. Protein sequences used to generate the maximum likelihood phylogeny of 
Anc.a.  Sequences are labeled with the first letter of their genus and the full name of their 
species followed by their GenBank accession ID number. 
 
GenBank protein sequences used to generate phylogeny of 
Anc.a 
A.capsulatus_EEH08148  
A.capsulatus_EER39772  
A.capsulatus_XP_001544538  
A.clavatus_XP_001271993  
A.dermatitidis_EEQ85687  
A.fumigatus_XP_751699  
A.nidulans_predicted_XP_663210  
A.niger_NP_984223  
A.oryzae_predicted_XP_001820188  
A.terreus_XP_001213128  
A.thaliana_NP_179736 - 
B.fuckeliana_predicted_XP_001559630  
C.albicans_EEQ44988  
C.albicans_predicted_XP_712251  
C.albicans_predicted_XP_712308  
C.cinerea.okayama_predicted_XP_001839899  
C.globosum_XP_001225834  
C.immitis_XP_001247773  
C.neoformans_XP_570271  
D.discoideum_Q54E04 - 
D.hansenii_CAG86124  
E.bieneusi_XP_001827782  
F.neoformans_AAK81705  
G.zeae_predicted_XP_380994  
M.globosa_predicted_XP_001732767  
M_grisea_predicted_XP_361473  
N.crassa_predicted_XP_956054  
N.fischeri_predicted_XP_001266930  
P.anserina_XP_001909914  
P.brasiliensis_EEH20928  
P.brasiliensis_EEH40703  
P.brasiliensis_EEH45553  
P.chrysogenum_CAP97862  
P.marneffei_predicted_XP_002151272  
P.nodorum_predicted_XP_001796790  
P.tritici-repentis_XP_001931738  
 
! 141!
Table S1. (continued). 
GenBank protein sequences used to generate phylogeny of 
Anc.a 
S.japonicus_XP_002171793  
S.pombe_NP_594219  
S.sclerotiorum_predicted_XP_001587166  
T.stipitatus_XP_002341761  
 
 
 
 
Figure S1.  Support for the Anc.a reconstruction was characterized by binning 5%-sized 
bins and counting the proportion of total amino acid sites within each bin. 
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Table S2. Testing the robustness to uncertainty for the Anc.a sequence.  50 residues from 
the entire Anc.a sequence were chosen at random to represent the 134 independent sites 
with posterior probabilities of less than 80%.  Single amino acid substitutions to Anc.a 
were introduced using a modified Quikchange protocol (Zheng et al., 2004).  Vectors 
were transformed into vph1! stv1! yeast and tested on rich media containing 100 mM 
Ca2+ or rich media containing 3.5 mM Zn2+.  Alternative Anc.a genes were under control 
of the STV1 promoter. 
 
  
100 mM 
Ca2+  3.5 mM Zn2+   
100 mM 
Ca2+  3.5 mM Zn2+ 
WT  +++++  +++++ WT  +++++  +++++ 
vph1! 
 stv1!  -  - 
vph1!  
stv1!  -  - 
Anc.a  ++++  +++ Anc.a  ++++  +++ 
G25S  ++++  +++ S268T  ++++  +++ 
N46K  ++++  +++ D274N  ++++  +++ 
E76D  ++++  +++ E278D  ++++  +++ 
I82L  ++++  +++ S279T  ++++  +++ 
E83D  ++++  +++ V302I  ++++  +++ 
A90S  ++++  +++ T337A  ++++  +++ 
K99Q  ++++  +++ E347D  ++++  +++ 
D111N  ++++  +++ E352D  ++++  +++ 
E119Q  ++++  +++ E361K  ++++  +++ 
R120K  ++++  +++ K364R  ++++  +++ 
A134T   ++++  +++ Q392R  ++++  +++ 
G144A  ++++  +++ S449T  ++++  +++ 
T148S  ++++  +++ I459V  ++++  +++ 
E150D  ++++  +++ K484E  ++++  +++ 
Q160A  ++++  +++ Q496E  ++++  +++ 
E165D  ++++  +++ I562V  ++++  +++ 
S171A  ++++  +++ V611I  ++++  +++ 
D183E  ++++  +++ V632I  ++++  +++ 
E218D  ++++  +++ H649N  ++++  +++ 
E233Q  ++++  +++ H650R  ++++  +++ 
A236S  ++++  +++ Q653E  ++++  +++ 
K240R  ++++  +++ S666A  ++++  +++ 
D252N  ++++  +++ D678E  ++++  +++ 
F256Y  ++++  +++ V747A  ++++  +++ 
D261E  ++++  +++ I750F  ++++  +++ 
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Figure S2. Stability of Anc.a protein is dependent on the presence of the V-ATPase 
assembly factor, Vma21p.  Whole cell extracts were prepared from yeast expressing 
Anc.a-GFP under control of the VPH1 promoter (PrVPH1::Anc.a-GFP; GFY256), and a 
strain expressing Anc.a-GFP deleted for VMA21 (PrVPH1::Anc.a-GFP vma21!; GFY300).  
Western blot analysis was performed using anti-HA and anti-Dpm1p (loading control) 
antibodies.  The size of the nearest molecular marker (kDa) is shown. 
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